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ABSTRACT 
 
Premature luteal regression occurs on average in 30% of superovulated 
sheep ewes. This phenomenon occurs early in the cycle before the embryo’s can be 
collected and is a major contributor to failure in embryo transfer programs.  This 
research was done to understand the physiological mechanisms involved.  
 
Chapter two provides a general background of the physiology of natural 
luteolysis and the maternal recognition of pregnancy.  The chapter introduces some 
new concepts on the topic of cell death and provides a recent literature review on 
research done on the phenomenon of premature luteal regression.  This chapter 
forms the base of ideas and arguments that follows in the two studies containing 
new original work in this field. 
 
The research contained in this thesis comprises of two in vivo studies.  The 
first study (Chapter 3) compare premature luteal regression to Prostaglandin F2α 
(PGF2α) induced regression with emphasis on the changes in levels of the steroid 
hormones progesterone (P4) and estradiol - 17β (E2-17β) and changes in structure 
and ultra structure.  The following conclusions were made: 
 
 
1. Premature luteal regression is not merely inadequate luteal support, but 
indeed early luteal regression, since seasonal influences could merely be 
nutritional influences, and a definitive increase in P4 were recorded in 
animals exhibiting the phenomena. 
2. Nutritional influences could play a role, but the type and quality of nutrients 
and mechanism involved, is still unclear. 
3. PGF2α-induced regression differs from premature luteal regression in that: 
a) The progression of functional and structural regression in PGF2α -
induced regression is slower than in premature luteal regression. 
b) Regressed corpora lutea do not occur with normal functioning corpora 
lutea. 
4. There is a distinct second E2-17β peak preceding the decline in P4 in animals 
that exhibits signs of premature luteal regression. 
A threshold initiating premature luteal regression was not established. 
 
The second study (Chapter 4) compares the changes in the ovine β estradiol - 
17 β receptor  (oERβ) between  premature luteal regression  and PGF2α induced 
regression.  The study concludes that there could be a potential role for oERβ in 
premature luteal regression. 
 
The findings of these two studies raise some questions about the 
conventional perception that early release of PGF2α is the cause of premature luteal 
regression. The thesis concludes in a hypothesis (Chapter 4) explaining the 
phenomenon. 
OPSOMMING 
 
Premature luteale regressie kom gemiddeld in 30% van gesuperovuleerde 
skaap-ooie voor.  Die verskynsel kom vroeg in die siklus voor, voor die embrios 
gekollekteer kan word, en is een van die belangrikste oorsaake van mislukkings in ‘n 
embrio-oorplaasingsprogram.  Die huidige navorsing poog om die fisiologiese 
meganismes betrokke by premature luteale regressie te verstaan. 
 
Hoofstuk twee verskaf ‘n algemene agtergrond van die fisiologiese aspekte 
betrokke by natuurlike luteale regressie en maternale herkenning van swangerskap. 
Die hoofstuk stel nuwe konsepte voor oor sel afsterwing en verskaf ‘n opgedateerde 
literatuuroorsig met betrekking tot die navorsing wat in die veld oor die verskynsel 
gedoen is. Die hoofstuk vorm die basis vir die idees en argumente, wat volg in die 
twee studies en wat oorspronklike nuwe navorsing bevat oor die onderwerp. 
 
Die navorsing in die tesis bestaan uit twee in vivo studies.  Die eerste studie 
(Hoofstuk 3) vergelyk premature luteale regressie en prostaglandien F2α (PGF2α) ge-
induseerde regressie met ‘n klem op die vlakke van die steröiedhormone 
progesteroon (P4) en estradiol - 17β (E2-17β)  en veranderinge in die mikroskopiese 
struktuur en ultra struktuur van die corpus luteum.  Die studie bevind: 
 
1. Premature luteale regressie is nie slegs onvoldoende luteale funksie nie, 
maar vroë luteale regressie aangesien seisoenale invloede eitlik voedings 
invloede kan wees en P4 gestyg het in diere waar die verskynsel voorgekom 
het. 
2. Voeding kan ‘n rol speel maar die tiepe en gehalte van die voedingstowwe en 
die meganismes betrokke is nie duidelik nie. 
3.  PGF2α - ge-induseerde regressie verskil van premature regressie in dat: 
a) Die verloop van funksionele en strukturele regressie is stadiger in 
PGF2α - ge-induseerde regressie in vergelyking met premature luteale 
regressie. 
b) Corpora lutea wat regressie ondergaan het kom nie voor saam met 
corpora lutea wat normal voorkom nie. 
4. Daar die ‘n duidelike tweede piek van E2-17β gaan die afname in P4 vooraf in 
diere waar premature regressie voorkom. 
5. Daar is nie geslaag om ‘n drempel vas te stel waar premature regressie ge-
inisieer  word nie. 
 
Die tweede studie vergelyk die veranderinge in estradiol-17β reseptore 
(oERβ) in die skaap tydens premature luteale regressie en PGF2α geinduseerde 
regressie.  Die studie bevind dat daar ‘n moontlike rol is vir ERβ in premature luteale 
regressie. 
 
Die bevindinge van die twee studies bevraagteken die konvensionele 
opvatting dat vroë vrystelling van PGF2α verantwoordelik is vir premature luteale 
regressie. Die tesis sluit af met ‘n nuwe hipotese om die verskynsel te verduidelik. 
Table of Contents 
 
          Page 
 
 
CHAPTER 1 
 
1.1 Introduction--------------------------------------------------------  1 
 
CHAPTER 2 
 
General Background & Literature Review 
 
SECTION A:  NATURAL LUTEOLYSIS 
 
2.1 Uterine involvement in luteal regression ----------------  4 
 
2.2 Identification of PGF2α as the uterine luteolytic factor 7 
 
2.3 Pattern of PGF2α secretion------------------------------------  9 
 
2.4 Synthesis of prostaglandins ---------------------------------  15 
 
2.5 Control of PGF2α secretion -----------------------------------  18 
 
2.6 The mechanism of PGF2α action ----------------------------  32 
 
2.6.1 Inhibition of progesterone synthesis  33 
 
2.6.1.1 Progesterone biosynthesis  33 
2.6.1.2 Regulation of progesterone biosynthesis  36 
2.6.1.3 The effect of luteolysis on progesterone biosynthesis  37 
 
2.6.2 Cell lysis  39 
 
2.6.2.1 Morphological changes  39 
2.6.2.2 Mechanism of apoptosis in the corpus luteum  41 
 
 
 
 
2.7 Maternal recognition of pregnancy ------------------------  44 
2.7.1 Antiprostaglandin secreting effect  46 
 
2.7.2 Luteoprotective effect  47 
 
SECTION B:  PREMATURE LUTEAL REGRESSION 
 
2.8 The phenomenon of premature luteal regression ----  49 
2.9 The effect of season --------------------------------------------  50 
2.9.1 Neuro-endocrine mechanisms mediating photoperiodic  50 
 regulation of gonadotropin secretion 
 
2.9.2 The effect of season on the occurrence of premature  54  
regression in the superovulated sheep ewe 
 
2.10 The effect of nutrition ------------------------------------------  56 
 
2.10.1 The effect of nutrition on reproductive performance  56 
 
2.10.2 The effect of nutrition on the occurrence of premature  58 
regression  in the superovulated sheep ewe 
 
2.11 Superovulatory hormones used and the influence of  60 
 dosage --------------------------------------------------------------  
 
2.11.1 Superovulation theory and methods of inducing   60 
superovulation 
 
2.11.1.1 Equine chorionic gonadotropin  61 
 
2.11.1.2 Follicle stimulating hormone  67 
 
2.11.1.3 Combination of equine chorionic gonadotropin and  69  
follicle stimulating hormone 
 
2.11.2 The influence of the type and dose of superovulatory  70  
hormones on the incidence of premature luteal  
regression 
 
 
 
2.11.3 The influence of the day of administration of  72  
superovulatory hormones on the incidence of premature  
luteal regression      
 
 
 
  
2.12 Gonadotropin releasing hormone administration ----  73 
 
2.13 Implication of estrogen ----------------------------------------  74 
 
2.14 Implication of PGF2α --------------------------------------------  76 
 
2.15 References ---------------------------------------------------------  80 
 
 
CHAPTER 3 
 
PGF2α Induced Regression and Premature Luteal 
Regression a Comparative Study 
 
3.1 Introduction--------------------------------------------------------  107 
 
3.2 Material & methods----------------------------------------------  110 
 
3.2.1 Experimental animals and experimental design   110 
 
3.2.2 Macroscopic examination of ovaries  112 
 
3.2.3 Progesterone and estrogen analysis  112 
 
3.2.3.1 Blood collection  113 
3.2.3.2 Microparticle enzyme immuno assay  113 
3.2.3.3 Calibration  117 
3.2.3.4 Specific performance characteristics  123 
 
3.2.3.4.1 Precision  123 
3.2.3.4.2 Recovery  126 
3.2.3.4.3 Sensitivity  128 
3.2.3.4.4 Specificity  129 
3.2.3.4.5 Interference  131 
 
3.2.3.5 Quality control  132 
 
3.2.4 Histology  132 
 
3.2.4.1 Preparation and staining  132 
3.2.4.2 Evaluation of apoptotic nuclei  134 
3.2.4.3 Evaluation of connective tissue replacement  135 
 
3.2.5 Scanning electron microscopy  137 
 
3.2.5.1 Selection  137 
3.2.5.2 Preparation  137 
3.2.5.3 Evaluation of stage of apoptosis  141 
 
3.2.6 Statistics Methodology  146 
 
3.2.6.1 Incidence of premature regression  146 
3.2.6.2 Ovulatory response  147 
3.2.6.3 Steriodogenic profiles  147 
3.2.6.4 Histology  148 
 
3.2.6.4.1 Evaluation of the amount of apoptotic nuclei  148 
3.2.6.4.2 Evaluation of the amount of connective tissue infiltration 148 
 
3.2.6.5 Scanning electron microscopy  149 
 
3.3 Results --------------------------------------------------------------  150 
 
3.3.1 Occurrence of premature luteal regression  150 
 
3.3.2 Ovulatory response  151 
 
3.3.3 Steroidogenic profiles  152 
 
3.3.3.1 Progesterone profiles  153 
3.3.3.2 Estrogen profiles  155 
3.3.3.3 Progesterone:estrogen ratio on molar base  157 
3.3.3.4 Correlation of peak estrogen concentration on the 6th day 159 
 after sponge removal and progesterone concentration on 
    the 7th day after sponge removal 
 
3.3.4 Histology  160 
 
3.3.4.1 Evaluation of apoptotic nuclei  165 
3.3.4.2 Evaluation of connective tissue replacement  166 
 
3.3.5 Scanning electron microscopy  166 
 
3.4 Discussion ---------------------------------------------------------  169 
 
3.5 Conclusions -------------------------------------------------------  177 
 
3.6 References ---------------------------------------------------------  179 
 
 
 
 
 
 
CHAPTER 4 
 
A Potential Role for Estrogen Receptors in Premature 
Luteal Regression 
 
4.1 Introduction--------------------------------------------------------  196 
 
4.2 Materials & methods--------------------------------------------  199 
 
4.2.1 Experimental animals & experimental design  199 
 
4.2.2 Progesterone & estrogen analysis  199 
 
4.2.2.1 Blood collection  199 
4.2.2.2 Progesterone  199 
4.2.2.3 Estrogen  199 
 
4.2.3 Immunohistochemistry  200 
 
4.2.4 Statistical analysis  202 
 
4.2.4.1 Progesterone & estrogen analysis  202 
4.2.4.2 Immunohistochemistry  203  
 
4.3 Results --------------------------------------------------------------  203 
 
4.3.1 Steroidogenic profiles  203 
 
4.3.1.1 Progesterone Profiles  203 
4.3.1.2 Estrogen Profiles  205 
 
4.3.2 Immunohistochemistry  211 
 
  
 
4.4 Discussion ---------------------------------------------------------  218 
 
4.5 Conclusion---------------------------------------------------------  226 
 
4.6 References ---------------------------------------------------------  227 
 
 
Closing Remarks  233 
 
 
 
 
 
 
 
 
 
 
 
List of Tables 
 
     
   Page 
1. The incidence of superovulated ewes with premature   54 
 regressed corpora lutea as affected by season[250, 296]. 
 
2. The effect of supplementary lupin grain feeding on the   59 
 endocrine and  steroidogenic responses and luteal  
 function of superovulated Merino ewes[296]. 
 
3. Numbers of corpora lutea (Cl) and total ovarian   66 
 response (Cl +  persistent large follicles (< 5 mm))  
 (mean ± SD) assessed on day 6 of the oestrous cycle  
 for ewes treated with PMSG[350] 
 
4. Proportion of ewes that fail to superovulate in response  67 
 to treatment with PMSG[350]. 
 
5. Numbers of corpora lutea (Cl) and total ovarian response  69 
 (Cl + persistent large follicles (> 5 mm)) (mean ± SD)  
 assessed on day 6 of the oestrous cycle for ewes treated  
 with FSH-P[317]. 
 
6. Proportion of ewes that fail to superovulate in response  69 
 to treatment with FSH-P[317]. 
 
7. The dose responsive increase in the incidence of   71 
 premature luteal regression in PMSG treated  
 ewes[316, 350]. 
 
8. The dose responsive increase in the incidence of   71 
 premature luteal regression in FSH treated  
 ewes[316, 350]. 
 
9. The dose responsive increase in the incidence of    72 
 premature luteal  regression in ewes treated with a  
 combination of PMSG and FSH[316, 350]. 
 
10. Progesterone concentration (ng/ml) in superovulated   77 
 ferral goats with and without premature ovulations  
 on the first two days after sponge removal[360]. 
 
11. Progesterone calibrator concentrations. 117 
 
12. Calibration data for progesterone analysis. 119 
 
13. Estrogen calibrator concentrations. 120 
 
14. Calibration data for estrogen analysis. 122 
 
15. Progesterone precision determined by panel member 1 123 
 
16. Progesterone precision determined by panel member 2 124 
 
17. Progesterone precision determined by panel member 3 124 
 
18. Progesterone precision determined by panel member 4 124 
 
19. Estrogen precision determined by panel member 1 125 
 
20. Estrogen precision determined by panel member 2 125 
 
21. Estrogen precision determined by panel member 3 126 
 
22. Estrogen precision determined by panel member 4 126 
 
23. Recovery of exogenous progesterone added to  127 
 biological specimens. 
 
24. Recovery of exogenous estrogen added to biological  128 
 specimens. 
 
25. Cross-reactivity of progesterone related compounds in  129 
 the Abbott AxSYM progesterone MEIA assay. 
 
26. Cross-reactivity of estrogen related compounds in the  130 
 modified Abbott AsXYM estrogen MEIA assay. 
 
27. Interference from billirubin, hemoglobin and triglycerides  131 
 in the Abbott AxSYM progesterone MEIA assay. 
 
28. Interference from billirubin, hemoglobin and triglycerides 132  
 in the modified AxSYM estrogen MEIA assay. 
 
29. Ovulatory response in Mutton Merino ewes superovulated  151 
 in the breeding season (Autumn, August-October 1996). 
 
30. Ovulatory response of ewes superovulated in the  152 
 non-breeding season. 
 
 
 
31. Percent homology between the rERβ and the oERβ  211 
 per region[22]. 
 
  
 
List of Figures 
     
  Page 
 
 
1. Diagram of the utero-ovarian vasculature in the sheep and 7 
 the route the uterine luteolytic factor travels from the  
 uterus to the ovary 
 
2. The daily mean plasma PGF2α concentration in the uterine 10   
 vein during the estrous cycle of the ewe (n=148)[126]. 
 
3. Hourly PGF2α concentration in the uterine vein during  13 
 luteolysis.  Note that there is only 2 to 4 pulses from days  
 11 to 15, but 5 pulses occur between days 15 to 0 (17)  
 within 25 hours[131]. 
 
4. Hourly PGF2α concentration in the ovarian artery during  13 
 luteolysis.  Note that there is only 2 to 4 pulses from days  
 11 to 15, but 5 pulses occur between days 15 to 0 (17)  
 within 25 hours[131]. 
 
5. Average daily PGF2α concentration in the uterine vein of 14  
 the ewe around the time of luteolysis[131]. 
 
6. Preferred sites of hydrolysis of different phospholipases 16 
(Plase)[133]. 
 
7. Summary of some  important  aspects of prostaglandin 17 
 biosynthesis.  The  path from PGH2 differs from tissue  
 to tissue[133]. 
 
8. Utero-ovarian vein plasma concentration of PGF2α  and  19 
 E2-17β  in a sheep bearing a utero-ovarian autotransplant  
 sampled every 2 hours during the estrous cycle.  (Note that  
 peaks of  E2-17β   precedes  pulses of PGF2α  by 6 hours  
 from day 13 - 0 (17).  Also the dramatic rise in  E2-17β  on  
 day 0 (17) is not followed by an rise in PGF2α)[116]. 
 
9. Effect of intra-arterial infusions of E2-17β on PGF2α 20  
 secretion from the utero-ovarian transplant model in the  
 sheep.  (Note that the superimposed infusion of  
 indomethacin diminishes the synthesis of PGF2α  
 on day 14)[116]. 
 
 
10. Peak concentration of PGF2α in uterine venous   21 
 plasma after mechanical  stimulation of the in situ ovine  
 uterus on different days of the estrous cycle[154, 155]. 
 
11. Peak concentration of PGF2α  in uterine venous plasma  23 
 after intra-arterial  infusion of  Ox  into the  in  situ  ovine   
 uterus  on  different  days  of  the  oestrous cycle[154, 155]. 
 
12. Concentration of high-affinity binding sites for oxytocin in  25 
 the endometrium and myometrium obtained from in situ  
 ovine uterus on different days of the estrous cycle.[157] 
 
13. The effect of different 12 hour infusions of E2-17β on  27 
 oxytocin-induced PGF2α secretion from the  
 autotransplanted uterus in  ovariectomized ewes.   
 A Control placebo, B only Ox, C 0.5 ug/hr E2-17β & Ox  
 and D 1.0 ug/hr E2-17β & Ox . The ability of Ox to evoke  
 PGF2α secretion was used as an in vivo marker for the  
 appearance of the rOx[138]. 
 
14. The effect of different progesterone treatments on 28  
Ox-induced PGF2α secretion from the autotransplanted  
uterus in ovariectomized ewes. A Control placebo,  
B only Ox, C 6 days P4 infusion & Ox and D 10 days P4  
infusion & Ox . P4  alone cannot evoke Ox-induced  
PGF2α secretion[138] 
 
15. The effect of different P4 pretreatments and E2-17β 29  
 infusion on Ox-induced PGF2α secretion from the  
 autotransplanted uterus in ovariectomized ewes. The  
 combination of P4 and E2-17β evoke a 50 to 100-fold  
 greater response than when E2-17β is given alone.   
 Also note that pretreatment with P4 for 2 and 6 days  
 abolishes the effect of E2-17β alone at the dose of  
 0.5 µg per hour[138]. 
 
16. Working hypothesis on the hormone-mediated   32 
 events controlling PGF2α secretion from the endometrial  
 cell[138]. 
 
17. The Pathway of the biosynthesis of steroid hormones[176] 35 
 
18. Schematic diagram of some hormonal and second- 39 
 messengers systems that  interact to regulate secretion  
 of progesterone from small  and  large  ovine  luteal   
 cells[176]. 
 
 
19. Concentrations of eCG (PMSG) measured by  62 
 hemagglutination-inhibition (H-I) assay in the serum  
 of nine pony mares between 40 and 110 days of gestation.   
 Note  the  individual  variation  between  mares  in the     
 peak concentrations (31 to 173 IU/ml) reached between  
 days 54 and 73[322]. 
 
20. An comparison of the duel capacity of PMSG as an   64 
 FSH and LH like hormone when administered  
 to various domesticated animals[316, 336]. 
 
21. Serum E2 - 17β levels (mean ± SD) in ferral does    73 
 given 1000 IU PMSG.  Progestagen pessaries removed  
 (PR) either at the same time or two days after  
 treatment[348] 
 
22. Serum E2-17β profiles of ewes superovulated with  75  
 1000 IU PMSG compared to normal cycling ewes  
 not treated with PMSG[48, 355]. 
 
23 Mutton Merino’s grassing on Kikuyo at Elsenberg  111 
 Agricultural College, near Stellenbosch in the Western  
 Cape Province in South Africa. 
 
24. Typical MEIA schematic reaction sequence[371]. 114 
 
25. Immune complex bound to glass fibre matrix[371]. 115 
 
26. Calibration curve for progesterone analysis. 118 
 
27. Calibration curve for estrogen analysis. 121 
 
28. Apoptotic nuclei (A) are indicated by the arrows  134 
 (H & E at 400 times enlargement) 
 
29. Category 1: Little or no connective tissue infiltration.   135 
This amount of connective tissue is present in healty  
normal functioning corpora lutea. Numerical value : 1 
 
30. Category 2: Moderate connective tissue infiltration. 136 
 Numerical value: 2 
 
 
 
31. Category 3: Extensive connective tissue infiltration. 136 
 Numerical value: 3 
 
32. A range of specimen holders for the CT 1500 cryotrans 138 
 
33. The vacuum transfer device used to transfer the lquid  139 
 nitrogen cooled specimen to the slushing chamber  
 at – 200 °C. 
 
34. CT 1500 preparation chamber and gold stage nitrogen 140  
 dewar with transfer device interfaced to an SEM chamber. 
 
35. 15-318 fracturing and honing device. 140 
 
36. Early shrinking apoptotic cell rounding up and loosing  142 
 contact with neighbouring cells. During this shrinkage they  
 loose surface features such as microvilli (MV) and  
 desmosomes. Notice the spongy appearance (S) typical of  
 this early stage. 
 
37. Collapsing early shrinking apoptotic cell.  During early  143 
 apoptosis cells loose water, leading to increased cell  
 density and sometimes collapsing into flattened cells as 
 can be seen here. 
 
38. Margination of chromatin (M) and dilation of the nuclear 143 
 envelope (NE). 
 
39. Stage 2 apoptotic cell displaying large membrane bound  144 
 vacuoles (MV) with well-preserved organelle remnants (OR).   
 The cell membrane buds (BM) around these vacuoles to  
 prevent leaking of proteolytic enzymes. 
 
40. Well-preserved mitochondria inside apoptotic vesicles.   145 
Note the clearly visible cristae and matrix. 
 
41. Blebbing apoptotic cell with several membrane bound   146 
apoptotic bodies of various sizes visible (AB). 
 
42. Incidence of premature luteal regression in ewes  150  
superovulated in the breeding season  
(Autumn, August-October 1996). 
 
43. Incidence of premature luteal regression in ewes  150 
superovulated in the non-breeding season  
(Spring, March-May 1996). 
 
44. Progesterone profiles of ewes superovulated in the   154 
breeding season  
 
45. Progesterone profiles of ewes superovulated in the  154 
non-breeding season 
 
46. Estrogen profiles of ewes superovulated in the breeding  156 
season. 
 
47. Estrogen profiles of ewes superovulated in the non-breeding 156 
season. 
 
48. Profiles of the progesterone/estrogen ratio on a molar base 158  
in the breeding season 
 
49. Profiles of the progesterone/estrogen ratio on a molar base  158 
in the non-breeding season 
 
50. Correlation of the peak estrogen concentration on the  159 
6th day after sponge removal and the progesterone  
concentration on the 7th day after songe removal in all the  
ewes tested in the breeding and non-breeding season. 
 
51. H & E stained section of a normal corpus luteum as seen 161 
on x 100 enlargement.  Note the clearly visible connective  
tissue septa (CS) with groups of epithelioid small  
lutein cells (SL) and vascular elements (VE).  The stroma (S)  
has numerous pale staining enlarged polyhedral large lutein  
cells (LL). 
 
52. H & E stained normal corpus luteum seen at x 400  162 
enlargement.  Note the pale staining polyhedral large lutein  
cells (LL) with dispersed chromatin (DC) and spongy  
cytoplasm (SC). 
 
54. Masson’s Trichrome stained normal corpus luteum at 162  
x 800 enlargement.  There is very little connective tissue  
infiltration (CI) staing green with Masson’s Trichrome  
stain.  Clearly visible is the lipid accumulation (LA)  
staining orange. 
 
55. H & E stained section of a regressed corpus luteum as  163 
seen on x 100 enlargement.  Note the clusters of connective  
tissue infiltration (CI) and discrete singular apoptotic  
bodies (DSAB). 
 
56. H & E stained section of a regressed corpus luteum as  163 
seen on x 400 enlargement.  Note the scattered discrete  
singular apoptotic bodies (DSAB) roughly round or oval in  
shape with rims of cytoplasm.  On occasion multiple  
apoptotic bodies with various amounts of nuclear material  
can be seen in a singular cell (MABSC). 
 
57. Masson’s Trichrome stained regressed corpus luteum  164 
at x 800 enlargement.  There is extensive connective  
tissue infiltration (CI) staining green with Masson’s  
Trichrome stain. 
 
58. Number of apoptotic nuclei recorded per 100 cells   165 
between the five defined groups represented as  
means + SEM. 
 
59. Relative connective tissue infiltration recorded between 166 
 the five defined groups represented as group  
means + SEM. 
 
60. Evaluation of the stage of apoptosis between the five  167 
defined groups represented as % of cells plus scanning  
electron microscope. 
 
61. Normal large lutein cell freeze fractured and enlarged 167 
x 10 000 with a scanning electron microscope.  Note the  
extensive development of the cyto-sceleton typical of  
steroid producing cells.  
 
62. Apoptotic lutein cell freeze fractured and enlarged  168  
x 10 000 with a SEM.  Note that the cyto-sceleton is  
almost completely broken down by the action of  
proteases like CASPASES. 
 
63 Progesterone and estrogen profiles of superovulated 207  
Mutton Merino ewes with normal appearing corpora  
lutea.  The ewes were superovulated in the breeding  
season (March – May 1997). 
 
64. Progesterone and estrogen profiles of superovulated 207 
Mutton Merino ewes with normal appearing corpora  
lutea.  The ewes were superovulated in the non-breeding  
season (August - October 1997). 
 
65. Progesterone and estrogen profiles of superovulated  208 
Mutton Merino ewes with premature regressed corpora 
lutea.  The ewes were superovulated in the breeding  
season (March – May 1997). 
 
66. Progesterone and estrogen profiles of superovulated  208 
Mutton Merino ewes with premature regressed corpora  
lutea.  The ewes were superovulated in the non-breeding  
season (August - October 1997). 
 
 
 
 
67. Progesterone and estrogen profiles of superovulated 209  
Mutton Merino ewes with PGF2α induced regression  
of the corpora lutea.  The ewes were superovulated in  
the breeding season (March – May 1997). 
 
68. Progesterone and estrogen profiles of superovulated  209 
Mutton Merino ewes with PGF2α induced regression of the  
corpora lutea.  The ewes were superovulated in the  
non-breeding season (August - October 1997). 
 
69. Progesterone and estrogen profiles of superovulated  210 
Mutton Merino ewes with mixed responses.  The ewes  
were superovulated in the breeding season  
(March – May 1997). 
 
70. Progesterone and estrogen profiles of superovulated  210 
Mutton Merino ewes with mixed responses.  The ewes  
were superovulated in the non-breeding season  
(August - October 1997). 
 
71. A Cross section of skeletal muscle cells from the  212 
Musculus Biceps Brachii of the Mutton Merino stained 
immunohistochemically and counterstained with  
hematoxylin.  LM x 800  As can be seen there is no brown  
insoluble precipitate confirming the absence of ERβ in the  
skeletal muscle cell. A Note the multiple elongated peripheral  
nuclei typical of skeletal mucle. B Cross section of mucles  
cells. Skeletal muscle served as a negative control. 
 
72. A Cross section from an antral follicle in the mutton merino. 212 
LM x 800  The granulosa cells G stain strong positive while  
the theca interna T stain weak positive.  The antal follicle  
served as a positive control. 
 
73. Premature regressed corpus luteum staind by a 213 
non-specific polyclonal rabbit antibody staining negative  
proving there is no non-specific binding present.  LM x 800  
Note apoptotic nuclei A present. 
 
74. Normal corpus luteum pre-adsorbed with the control 214  
peptide.  LM x 800 
 
75. Number of ERβ positive cells recorded per 100 cells  214 
between the five defined groups represented as  
means + SEM. 
 
76 Immunostaining for oERβ in a Mutton Merino with only  215 
normal functioning corpora lutea.  There is no positive  
staining present. LM x 800 
 
77. Immunostaining for oERβ in a Mutton Merino with  216 
normal functioning and premature regressed corpora  
lutea.  There is no positive staining present. LM x 800. 
 
78. Immunostaining for oERβ in a Mutton Merino where  216 
regression was induced by PGF2α.  There is no positive  
staining present. Note the clearly visible apoptotic  
bodies. LM x 800 
 
79. Immunostaining for oERβ in a Mutton Merino with  217 
only premature regressed corpora lutea.  There is very 
pronounced nuclear and cytoplasmic staining for  
immuno-reactive oERβ. LM x 800 
 
80. Immunostaining for oERβ in a Mutton Merino with   218 
premature regressed corpora lutea occurring with  
normal corpora lutea on the same ovary.  There is 
very pronounced nuclear and cytoplasmic staining for 
  immuno-reactive oERβ. LM x 800 
 
81. The schematic structure of the domains of the  222 
nuclear receptors[55] 
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Chapter 1 
1.1 Introduction 
 
 
“In the midst of life we are in death” – ID Bowen [1]; from day to day, 
season to season we are reminded of this strange paradox.  Without death 
there can be no life, as we know it.  In an ecological context, life and death 
form essential parts of a natural cycle.   
 
The estrous cycle of farm animals and menstrual cycle of humans is a 
beautiful illustration of these philosophical ideas by the inventors of the 
cellular process known as apoptosis.  For a female to conceive a follicle must 
develop to a mature dominant follicle.  During this development phase 
granulosa cells reproduce and are born by means of a cellular process of cell 
division, or rather multiplication, called mitosis.  After ovulation the nurturing 
granulosa and theca cells differentiate into progesterone producing granulosa 
lutein cells and theca lutein cells that specialize in the production of 
progesterone.  The remains of the follicle after ovulation, are used to form the 
vital structure known as the corpus luteum.   If the female fails to conceive, 
the cells in the corpus luteum must die or regress to make another cycle 
possible. Failure or imbalance of this natural cycle of birth, change and death 
of these interesting cells will make the creation of a new living being 
impossible. 
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Recent interest in the fate of the corpus luteum was generated by the 
abnormal phenomenon of premature luteal regression seen in superovulated 
females.  Premature luteal regression can be defined as regression of the 
corpus luteum earlier in the estrous cycle before the onset of natural luteal 
regression were regression takes place between day 13 and 14 of the cycle in 
the sheep. Superovulation can be defined as an increase in the amount of 
ovulating follicles in females by increasing circulating gonadotropins.   This 
can be accomplished by supplementing exogenous gonadotropins or 
stimulating release of endogenous gonadotropins. 
 
Superovulation is one of the ways for improving reproductive efficiency.  
We live in an era in which new ways to rapidly propagate or design domestic 
animals are being developed.  These new techniques take advantage of 
procedures in cellular and molecular biology, including the identification of 
genes or chromosome restriction fragment length polymorphisms (RFLP’s) 
that are associated with important production traits, and the ability to transfer 
genes into the genome of domestic animals.  These techniques assist in the 
direct and rapid selection of a particular trait. The molecular approach 
compliments techniques in reproductive physiology, like in vitro fertilization 
(IVF), multiplication of embryos by cloning and splitting, nuclear transfer (NT), 
the production of transgenic animals and embryo transfer (ET). 
 
Premature luteal regression occurs on average in 30% of 
superovulated sheep ewes.  The phenomenon results in the loss of embryos 
in these animals.  This impacts in two ways : a) it slows progress in these 
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programs and b) the phenomenon adds to the cost of these programs.  
Prevention of the phenomenon or the reduction of the incidence of premature 
luteal regression will be an important contribution in assuring future survival of 
these programs and accelerating development in this exciting field.  
Prevention or reduction in incidence can only be achieved if the physiological 
mechanism of the phenomenon is known.   
 
The aim of this thesis is: 
1 To try and unravel the mechanism behind premature luteal regression. 
 
2. To formulate a new hypothesis that explain the mechanism behind 
the phenomena.                   
 
1.2 References  
1. Bowen ID, Bowen,S.M., Jones,A.H. Mitosis and apoptosis matters of 
life and death. London: Chapman & Hall; 1998  
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  Chapter 2 
 
General Background and Literature Review 
SECTION A : NATURAL LUTEOLYSIS 
 
2.1 Uterine involvement in luteal regression 
 
The first evidence of uterine invilvement in the luteolytic process was 
presented in 1923, when Loeb [1] reported that removal of the uterus (hysterectomy) 
lengthened the lifespan of the corpus luteum in guinea pigs. Extension of the 
lifespan of the corpus lutuem after hysterectomy was later also demonstrated in 
pseudo-pregnant rat [2, 3], mice [4, 5], hamsters [6-8] and rabbits [9-11]. Temporary 
maintenance of the corpus luteum also occurs after hysterectomy in cattle [12], 
sheep [12], swine [13] and horses [14, 15]. 
 
In other species, presence of the uterus is not required for luteolysis.  Most 
notably, in several species of primates, including the rhesus monkey[16], 
cynomologus monkey [17], and humans [18, 19], removal of the uterus has no effect 
on normal cyclic activity.  Also, hysterectomy has no effect on the life span of the 
corpus luteum in the opossum [20], dog [21, 22], or ferret [23].  In contrast to 
pseudopregnant animals, the normal estrous cycle of the rat [24], mouse [25] and 
hamste [26, 27] is not prolonged by hysterectomy. 
 
 Page 4 
Although there is variation among species in the period that corpora lutea are 
maintained in hysterectomized animals, corpora lutea generally retain both structural 
and functional integrity for at least the duration of a normal pregnancy in guinea pigs 
[28-30], sheep [31-33], cattle [34, 35], pigs [13, 36-38] and rats [39].  In rabbits or 
horses, luteal function is maintained at levels lower than those established during the 
luteal phase after hysterectomy [14, 40-42]. 
 
In many species, effects of the uterus on luteal function are exerted only on 
one side of the median plane.  Unilateral hysterectomy (removal of one uterine horn) 
in sheep [43, 44], cattle [45], guinea pigs [46-48], pseudopregnant hamsters [49], 
and pseudopregnant rats [50] results in luteal regression in the ovary adjacent to the 
intact horn, but prevents regression in the opposite ovary.  The rabbit and horse are 
exceptions in that corpora lutea will undergo regression despite unilateral removal of 
the adjacent horn [15, 51].  It is thus apparent that the luteolytic factor emanating 
from the uterine horn in most species (with the exception of the rabbit and the 
horse), exerts its effect only on the adjacent ovary.  Therefore, it is unlikely that the 
luteolytic factor of uterine origin is transported from the uterus to the ovary through 
the systemic circulation in these species.  This,however, is not true for the rabbit and 
the horse. 
 
Corpora lutea are maintained when the vascular, nervous and lymphatic 
connections between the ovary and the uterus are severed in ewes [44], cows [52], 
guinea pigs [53-55], and pseudopregnant rats [47, 50, 56].  Autotransplantation of 
either the uterus or ovary, while leaving the other organ in situ, results in extended 
luteal function in ewes [57, 58] and guinea pigs [59-61].  However, when the uterus 
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and ovaries are transplanted to the neck of the animal as a unit, normal ovarian 
behaviour continues in ewes [62]. 
 
The uterine luteolitic factor appears to pass directly from uterine vein to the 
ovarian artery in the ewe.  This conclusion is based primarily on the results of the 
elegant studies of Ginter and colleagues [63].  If the uterine vein draining the intact 
horn of the unilaterally hysterectomized ewes is anastomosed to the uterine vein 
from the hysterectomized side, only corpora lutea on the hysterectomized side will 
regress [64, 65].  Reversal of the normal pattern of luteal regression in unilaterally 
hysterectomized ewes also occurs if the ovarian artery supplying the ovary on the 
intact side is anastomosed to the artery on the hysterectomized side [64, 65].  A 
similar effect of uterine venous and arterial anastomoses has been described for 
cattle [66].  
 
Although there do not appear to be vascular connections between the uterine 
vein and ovarian artery, there are regions of extensive contact between these 
vessels throughout the broad ligament and up to their respective junctions with the 
Vena cava and aorta [67, 68] (Figure 1).  The ovarian artery is extremely tortuous, 
and collateral channels and venules separate from the uterine vein, wrapping around 
the artery and thus increasing the area of contact between the two vessels [69].  The 
vessels share a common tunica adventitia and have thinner walls in the regions 
where they make contact [70].  Similar gross morphologic venoarterial relationships 
have been observed in guinea pigs, rats, hamsters [71], pigs [67] and cows [72].   
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Noteworthy is that there is very little contact between the uterine vein and 
ovarian artery in the rabbit and horse, two species in which the uterine luteolytic 
effect is not exerted locally [67, 71, 73]. 
Figure 1 Diagram of the utero-ovarian vasculature in the sheep and the route 
the uterine luteolytic factor travels from the uterus to the ovary [68].  
 
2.2 Identification of PGF2α as the uterine luteolytic factor 
 
Although the luteolytic effect of the uterus was recognized more than 60 years 
ago, the biochemical signal(s) involved were difficult to elucidate. A major 
breakthrough occurred in 1969 when the luteolytic actions of PGF2α were 
demonstrated in pseudopregnant rats [74].  This initial observation was rapidly 
extended to other species, and PGF2α has been shown to exert a luteolytic effect in 
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cattle [75-78], sheep [79-81], guinea pigs [82], goats [83], horses [84-86], 
pseudopregnant mice [87], hamsters [88], rabbits [89, 90], and to a limited extent in 
swine [91, 92]. 
 
On the other hand in rhesus monkeys [93, 94], humans [95, 96] and dogs 
[97], species in which the uterus has no clear luteolytic effect, there is a transitory 
suppression in the secretion of progesterone (P4) after short term infusions (up to 12 
hours) with PGF2α during the luteal phase of the cycle.  In fact, premature luteal 
regression can be induced in rhesus monkeys [98] and dogs [99] by more prolonged 
treatment regimes with high levels of PGF2α.  Extremely high doses of PGF2α are 
ineffective in causing luteal regression in the cat [100].  If endogenous PGF2α is 
involved in the normal luteolitic process in these species, it is probably not of uterine 
origin. 
 
Although the treatment of animals with PGF2α causes premature luteolysis, 
this does not conclusively prove that it is the uterine factor involved in the process.  
However, considerable evidence has accumulated to suggest that PGF2α is the 
factor of uterine origin responsible for luteolysis in domestic species and rodents. 
 
Treatment of intact animals with inhibitors of prostaglandin synthesis, such as 
indomethacin and aspirin, will block spontaneous luteolysis in cattle, sheep and 
guinea pigs.  Length of pseudopregnancy can be prolonged in rabbits, rats and mice 
by treatment with indomethacin.  Thus, the synthesis of prostaglandins (presumably 
PGF2α) appears to be required for luteolysis in these species [101, 102]. 
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Perhaps the best evidence of PGF2α as the uterine luteolytic factor, is the fact 
that spontaneous luteal regression can be prevented by active or passive 
immunization against PGF2α of sheep [103, 104], cattle [105]  and guinea pigs [28]. 
 
PGF2α has been isolated from endometrial tissue of several species, and its 
concentration is maximal during the period of luteal regression in cattle [106], sheep 
[107], guinea pigs [108], horses [109], swine [110], pseudopregnant rats [111] and 
pseudopregnant rabbits [112]. 
 
Based on the available data, it seems reasonable to conclude that PGF2α is 
the factor, of uterine origin, responsible for luteolysis in large domestic species and 
rodents. 
2.3 Pattern of PGF2α secretion 
With the discovery in 1970 that PGF2α is luteolytic in sheep [113], interest 
immediately arose to the pattern of PGF2α during the cycle.  However, it was soon 
discovered that assessment of uterine PGF2α secretion in vivo is complicated by two 
factors. First, it must be measured in blood collected from the utero-ovarian artery, or 
uterine vein.  The peripheral PGF2α concentrations is not a reliable index of uterine 
secretion rate, because a variety of tissues contribute to this pool.  Prostaglandins 
are also almost completely metabolized in one passage through the lungs [114]. 
Secondly, because PGF2α is secreted episodically [115-119], blood samples must be 
collected relatively frequently to determine the actual secretory pattern. Investigators 
have used a number of approaches to overcome these technical problems, including 
blood collection via laparotomy [115], a cannula placed in the utero-ovarian vein 
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[117, 120-124], or autotransplantation of the ovary and uterus to the neck of the 
animal [115, 116, 125]. 
 
In early experiments, PGF2α was measured in a flock of sheep once daily to 
determine the secretory pattern.  It was found that from day 2 to day 10 of the 
estrous cycle, there is little or no PGF2α release from the uterus [115, 120, 124, 125].  
PGF2α first starts to rise between day 11 and 13 of the cycle, and it increases over 
the next 2 to 3 days [112, 117-122].  The mean PGF2α concentration [126-128], in a 
group of animals when measured once daily show an increase late in the luteal 
phase, it remains relatively stable during the early follicular phase and then 
increases again to peak just before estrus [126] (Figure 2). 
 
Very early it became clear that there was a high degree of variation in the 
mean concentration of PGF2α measured in the uterine vein in a flock of sheep at the 
time of luteolysis.  This can clearly be seen in Figure 2, as a high standard error of 
the means (SEM’s) from day 11 to 16 of the estrous cycle in the ewes was observed. 
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Figure 2 The daily mean plasma PGF2α concentration in the uterine vein during 
the estrous cycle of the ewe (n=148) [126]. 
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Horton & Poyser (1972) using a radio-immuno assay (RIA) method, reported 
that the concentration of PGF2α in the sheep ranges from 4 - 40 ng/ml in the uterine 
vein around the time of luteolysis [127].  This was confirmed by McCracken & 
coworkers (1976) using gaschromatography and mass spectrophotometry [128].  
This would amount to a maximum secretion rate of 25 µg of PGF2α per hour into the 
uterine vein.  It was estimated that the counter current transfer between the uterine 
vein and the ovarian artery was about 10%.  This gives an effective dose of 
approximatly 2.5 µg per hour that reaches the ovarian artery. Using the 
autotransplanted uterus and ovary as a model, it was shown that a constant infusion 
of 2.0 to 2.5 µg PGF2α per hour, for 6 to 18 hours into the arterial supply of the ovary, 
can cause complete luteolysis in sheep [128]. 
 
The concentration of PGF2α in the ovarian artery was based on the 
assumption that the counter current transfer between the uterine vein and the 
ovarian artery was 10%.  Using tritium labelled prostaglandin F2α  (3H-PGF2α), 
McCracken et al (1976) found that the transfer between the uterine vein and the 
ovarian artery was not 10% as assumed but only 2% [128]. 
 
This was confirmed by the laboratory of Scaramuzzi [129].  Thus, the 
concentration of PGF2α in the ovarian artery should range between 80 and 400 pg/ 
ml.   This was confirmed by actual measurements of PGF2α in the ovarian arterial 
supply [128, 129], when a more sensitive RIA was developed.  These new facts 
implicated an effective dose of 0.5 µg of PGF2α per hour in the ovarian arterial 
supply.  Using the autotransplanted uterus and ovary as a model, it was shown that 
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a constant infusion of 0.1 to 0.5 µg PGF2α per hour, for 6 to 18 hours into the arterial 
supply of the ovary, does not  bring about complete luteolysis in sheep [130, 131].  
 
In 1983 McCracken et al unravelled the problem.  In a heroic effort hourly 
specimens were taken in both the uterine vein and ovarian artery.  The typical 
pattern of secretion in sheep is shown in Figure 3 and Figure 4 [132]. 
 
As can be seen in Figure 3, the concentration of PGF2α in the uterine vein 
during luteolysis varies dramatically.  A pulse of PGF2α  last  about 1  hour, ranges  
from 8 ng/ml to 38 ng/ml and return to baseline of 1 - 2 ng /ml.  This is consistent 
with the fact that PGF2α is almost completely metabolized with one passage through 
the lungs [114]. 
 
The pattern observed also explains the high degree of variation that was 
observed in PGF2α concentrations between days 11 to 16 of the estrous cycle, when 
blood samples were obtained only once a day (see Figure 2).  Calculating the 
average and SEM of the 24 observations per day from the data in Figure 3, a pattern 
similar to that in Figure 2 is found (Figure 5). 
 
As mentioned earlier, 3H-PGF2α showed that 2% of the PGF2α in the uterine 
vein is transferred to the ovarian artery.  Actual measurements of PGF2α in the 
ovarian artery confirmed this (see Figure 4).  The same basic pattern is seen as in 
the uterine vein, but the amplitude of the pulses is much lower and varies between 
80 to 400 pg/ml. 
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Figure 3 Hourly PGF2α concentration in the uterine vein during luteolysis.  Note 
that there are only 2 to 4 pulses from days 11 to 15, but 5 pulses occur 
between days 15 to 0 within 25 hours[131]. 
 
igure 4 Hourly PGF2α concentration in the ovarian artery during luteolysis.  
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 Page 13 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
18.00
11 12 13 14 15 16 0
Day of the estrous cycle
Pl
as
m
a 
PG
F2
 a
lp
ha
 c
on
ce
nt
ra
tio
n 
(n
g/
m
l)
 
Figure 5 Average daily PGF2α concentration in the uterine vein of the ewe 
around the time of luteolysis[131]. 
 
An interesting observation in these experiments was that between day 15 and 
0, there were five pulses that occurred in 25 hours.  Using the autotransplanted 
uterus and ovary model, it was shown that infusion of PGF2α using ultra low 
concentrations could bring about luteolysis in the ewe if the PGF2α  is administered in 
pulses.  By infusing PGF2α in five pulses of one hour at a rate of 0.5 µg/hour, 5 hours 
apart, complete luteolysis can be achieved.  Four or less pulses would result only in 
a temporally decline in progesterone that could be reversed [132]. 
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2.4 Synthesis of prostaglandins 
 
Membrane lipids undergo “turnover”, that is, they are constantly being formed 
and degraded.   Degradation involves the enzyme-catalysed hydrolysis of the 
various esterbonds to release the constituents.  These enzymes are called 
phospholipases (P-lase) and are found in all types of cells.  Before P-lase can act on 
amphipathic phosphor-acylglycerols, these components must be mobilized from the 
membrane into lipid droplets in the cytoplasm.  This mobilization of amphipathic 
phosphor-acylglycerols is stimulated by P4.  Phospholipases is divided into different 
categories on the basis of their sites of hydrolysis of esterbonds in the structure of 
phosphor-acylglycerols (see Figure 6).  After hydrolysis of esterbonds by P-lase A2 & 
A1, fatty acids like arachidonic acid, are released.  In general hydrolysis by P-lase A2 
results in more free arachidonic acid than hydrolysis by P-lase A1. 
 
Prostaglandin biosynthesis begins with the conversion of arachidonic acid into 
two endoperoxide intermediates, first prostaglandin G2 (PGG2) and then 
prostaglandin H2 (PGH2).  The reactions are catalysed by the same enzyme, 
prostaglandin endoperoxide synthase (PES), which has two separate catalytic 
components, prostaglandin endoperoxide synthase cyclooxygenase (PEScyc) (O2 
incorporation and cyclopentane formation) and prostaglandin endoperoxide synthase 
peroxidase (PESper) (reduction of OOH group to OH group).  The PGG2 species has 
an endoperoxide bridge (-O-O-) across the cyclopentane ring and a hydroperoxide (-
OOH) group on a side chain.  The PGH2 retains the (-O-O-) function, but the (-OOH) 
group on the side chain is reduced to (-OH).  PGH2 serves as the precursor for the 
assembly of other prostaglandins (see Figure 7). 
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Figure 6 Preferred sites of hydrolysis of different phospholipases (Plase) [133]. 
 
In the case of prostaglandin F2 (PGF2), the (-O-O-)  endoperoxide group is 
reduced to two (-OH) groups by the enzyme  prostaglandin endoperoxide reductase 
(PESred).  Only the α isomer of PGF2 is stable in nature.  The other important 
prostaglandin as far as the reproductive cycle of the ewe is concerned is 
prostaglandin E2 (PGE2).  PGE2 is converted from PGH2 by the enzyme 
prostaglandin endoperoxide isomerase (PESiso) to a (-OH) and a (=O) group.  
Despite minor structural differences, PGF2α and PGE2 exert completely the opposite 
effects on vascular tissue.   PGF2α causes contraction and PGE2 relaxation of 
smooth muscle in vascular tissue [133]. 
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Figure 7 Summary of some important aspects of prostaglandin biosynthesis.  
The  path from PGH2 differs from tissue to tissue [133]. 
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2.5 Control of PGF2α secretion 
 
There is still considerable controversy as to which factors are responsible for 
the increase in PGF2α that causes luteolysis.  It is generally agreed that uterine 
secretion of PGF2α is controlled by ovarian hormones, since little release occurs in 
overectomized ewes [134-138].  Three ovarian hormones have been implicated in 
regulation of uterine PGF2α namely P4, E2-17β and oxytocin (Ox), which are 
produced by the ovine corpus luteum [139-141] and ovarian follicle.   In this section 
the effect of these hormones that can affect PGF2α secretion and physiological 
significance of each will be discussed.  One general difficulty in evaluating the 
evidence, is the frequent use of peripheral concentrations of the major metabolite of 
PGF2α, 13,14-dihydro-15-keto-PGF2  (PGFM) as an index of PGF2α release. The 
usefulness of PGFM measurement has been questioned [127] and continues to be a 
point of controversy in this field.  However, for the sake of completeness, studies 
using both direct and indirect assessment of PGF2α secretion have been included in 
this section.  
 
Around the time of corpus luteum regression, peaks of E2-17β  precede peaks 
of PGF2α  by approximately 6 hours (Figure 8) [116].  It has also been shown that 
inhibition of endogenous E2-17β secretion by follicle ablation [142-144] or x-
irradiation [145, 146], prolongs luteal lifespan for a few days. Experiments were 
therefore conducted to examine the effect of exogenous E2-17β  on  PGF2α  
secretion by infusing physiological amounts of E2-17β  into the arterial supply of the 
autotransplanted uterus at different times of the ovine estrous cycle [116]. It was 
observed that E2-17β  has no effect on PGF2α  secretion early in the cycle, whereas 
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on day 14 (the approximate time of onset of corpus luteum regression), there was a 
50-to100-fold increase in PGF2α, an effect that could be decreased by indomethacin 
as can be seen in Figure 9. This suggests that   E2-17β   promotes the de novo 
synthesis of PGF2α, rather than simply the release of stored material.  From these 
results, it appeares that prior exposure of the uterus to progesterone was necessary 
to evoke a maximal response to E2-17β in terms of PGF2α secretion [116]. 
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Figure 8 Utero-ovarian vein plasma concentration of PGF2α  and E2-17β  in a 
sheep bearing a utero-ovarian autotransplant sampled every 2 hours 
during the estrous cycle.  (Note that peaks of  E2-17β   precedes  
pulses of PGF2α  by 6 hours from day 13 - 0 (17).  Also the dramatic 
rise in  E2-17β  on day 0 (17) is not followed by an rise in PGF2α) [116]. 
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Figure 9 Effect of intra-arterial infusions of E2-17β on PGF2α secretion from the 
utero-ovarian transplant model in the sheep.  (Note that the 
superimposed infusion of indomethacin diminishes the synthesis of 
PGF2α on day 14) [116]. 
 
 
Other studies on intact animals have shown that E2-17β treatment increased 
PGF2α production and caused a slight advance of luteolysis [147-151], but it was not 
clear, especially when very large doses were given, whether this effect of E2-17β  
was a direct one on the uterus or an indirect effect e.g. via the pituitary gland.  
However, when E2-17β  was infused systemically at a rate that was  effective via the  
uterine artery (0.5 to 1.0 ng / hour), there was no effect on  PGF2α  secretion by the 
uterus [116].  This latter finding indicates that the stimulus of  E2-17β  in terms of 
PGF2α  release is a direct one on the uterus. 
 
In guinea pigs  it was observed that mechanical stimulation of the isolated 
lung [152]  or uterus [153] evoked release of prostaglandins.  Furthermore, since the 
values reported for the concentration of PGF2α in uterine venous plasma of sheep 
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varies considerably among laboratories, it was suggested that this variation might be 
due to differences in manipulation of the uterus during blood sampling procedures.  
Experiments were therefore conducted to examine the effect of mechanical 
stimulation of the in situ ovine uterus on different days of the estrous cycle [154, 
155].  The results are shown in Figure 10, where it can be seen that mechanical 
stimulation caused a small release of PGF2α  early in the cycle, which had little or no 
effect during the luteal phase and produced a very marked increase in the secretion 
of  PGF2α  late in the luteal phase around day 14, which was abolished if the animal 
was pregnant. 
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Figure 10 Peak concentration of PGF2α in uterine venous plasma after 
mechanical  stimulation of the in situ ovine uterus on different days of 
the estrous cycle [154, 155]. 
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Since mechanical stimulation of the female reproductive tract causes an 
elevation of Ox in the peripheral blood of sheep and goats [156, 157] via the 
centrally acting Ferguson reflex [158], it was considered that Ox might play a role in 
the mechanically induced secretion of  PGF2α.  This proposal appeared quite 
plausible since exogenous Ox had been shown to curtail the estrous cycle of the 
cow [159], an effect which had  been postulated to be due to Ox-induced stimulation 
of PGF2α  secretion from the uterus. 
 
Thus the ability of mechanical stimulation of the uterus to release PGF2α  
appears to depend on two distinct but simultaneously operating variables (i) the 
variation in the Ox releasing reflex during the cycle and (ii) the variation in the ability 
of the uterus to release PGF2α  in response to Ox.  According to Roberts (1975) et al. 
It is likely that both parameters are under ovarian steroid hormone regulation [154]. 
 
By infusing Ox on different days of the estrous cycle into the arterial supply of 
the autotransplanted uterus and ovary, a pattern similar to the effect of mechanical 
stimulation of the uterus was found.  Ox infusions evoked small amounts of PGF2α 
secretion early in the cycle, had essentially no effect during the early luteal phase 
and caused a very pronounced increase in PGF2α secretion in the late-luteal phase 
around day 14, which is abolished once the animal is pregnant (Figure 11) [154, 
155]. 
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Figure 11 Peak concentration of PGF2α  in uterine venous plasma after intra-
arterial  infusion of  Ox  into the  in  situ  ovine  uterus  on  different  
days  of  the  oestrous cycle [154, 155].  
 
Because there was no evidence that Ox was elevated at the time of the 
luteolytic release of PGF2α, and since the autotranspanted uterus (which no longer 
had any connections to the CNS) exhibited spontaneous peaks of PGF2α  secretion, 
it seemed likely that E2-17β, rather than causing Ox  release, conditioned the uterus 
to make it responsive to endogenous levels of Ox and hence evoked secretion of 
PGF2α.  Evidence for this was seen in the apparent association of peaks of E2-17β 
secretion and peaks of PGF2α from the transplanted uterus (Figure 11).  Moreover, 
small amounts of  E2-17β  infused into the arterial supply of the uterus evoked PGF2α  
secretion, but not when the same amount of E2-17β  was infused into the systemic 
circulation. 
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Furthermore, it had been demonstrated in anestrus sheep that Ox alone did 
not stimulate the release of PGF2α  from the sheep uterus unless the animals were 
pretreated with E2-17β. A slight increase in  PGF2α was caused by E2-17β treatment 
alone [160]. 
 
It therefore seemed likely that the concentration of oxytocin receptors (rOx) in 
the endometrium would change during the estrous cycle in parallel with the 
previously observed cyclical variation in the ability of Ox to evoke PGF2α secretion.  
This prediction proved to be correct in that the relative concentration of rOx in the 
endometrium, the principal site of PGF2α production in the ovine uterus [161], was 
found to vary cyclically [157]  with the highest concentration appearing late in the 
estrous cycle (Figure 12).  Thus, it appeared that E2-17β acts directly on the uterus, 
causing the appearance of rOx which then interacted with endogenous levels of Ox.  
The interaction of Ox with its receptor apparently evoked PGF2α secretion. 
 
McCracken (1980) investigated the relationship between the ovarian 
hormones in regulating the production and secretion of PGF2α [138].  This research 
led to the working hypothesis on the hormone-mediated events controlling PGF2α 
secretion from the endometrial cell. 
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Figure 12 Concentration of high-affinity binding sites for oxytocin in the 
endometrium and myometrium obtained from in situ ovine uterus on 
different days of the estrous cycle. [157] 
 
 
Since it appeared that Ox could evoke PGF2α secretion only late in the cycle, 
the only time when high-affinity binding sites for Ox were increasing in the uterus 
[157], it seemed likely that both E2-17β and P4 might control PGF2α production by 
regulating the formation or availability of ROx in the endometrium.  In his 
experiments McCracken (1980) used ovariectomized ewes with the uterus 
transplanted to the neck.  The ability of arterial infusions of Ox to evoke PGF2α 
secretion from the transplanted uterus was utilised as an in vivo marker for the 
appearance of the ROx. 
 
E2-17β and P4, either alone or in combination, were infused intravenously 
(i.v.) into the systemic circulation in amounts that correspond to the ovarian secretion 
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rate of these hormones in sheep [48].  At suitable intervals (-1, 3, 6 & 12 hours) the 
uterus was challenged intra-arterially with a 10 min infusion of Ox at 5.0 IU / min.  
This dose had previously been shown to evoke the maximum release of PGF2α from 
the in situ uterus under optimal conditions [154, 162].  PGF2α was measured by RIA 
in timed samples of uterine venous blood collected throughout the experiments, and 
was expressed as secretion rate (ng/min). 
 
In the first experiment, the uterus was infused with different concentrations of 
E2-17β and then challenged with Ox.  As can be seen in Figure 13 (A): there was no 
placebo effects, (B): Ox challenge without E2-17β pre-treatment has no effect on 
PGF2α  release because there are no ROx, (C): ROx appeared after 6 hours 
(approximate time needed for protein synthesis) induced by E2-17β and then again 
after 12 hours based on the significant increase in Ox induced PGF2α secretion.  The 
amplitude of the second increase was higher than the first.  The minimum rate of E2-
17β needed to evoke the response was 0.5 µg per hour. 
 
In the second experiment, the autotransplanted uterus was pretreated with P4 
before the experiment and only challenged with Ox without the E2-17β  infusion.  As 
can be seen in Figure 14 (A): there was no placebo effects, (B):  Ox challenge 
without P4 pre-treatment has no effect on PGF2α  release because there are no ROx, 
(C): P4  pretreatment for 0, 6 or 10 days could not evoke the synthesis of rOx based 
on the absence of Ox induced PGF2α  release. 
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Figure 13 The effect of different 12 hour infusions of E2-17β on oxytocin-induced PGF2α 
secretion from the autotransplanted uterus in  ovariectomized ewes.  A 
Control placebo, B only Ox, C 0.5 ug/hr E2-17β & Ox and D 1.0 ug/hr E2-17β 
& Ox . The ability of Ox to evoke PGF2α secretion was used as an in vivo 
marker for the appearance of the ROx  [138]. 
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Figure 14 The effect of different progesterone treatments on Ox-induced PGF2α 
secretion from the autotransplanted uterus in ovariectomized ewes. A 
Control placebo, B only Ox, C 6 days P4 infusion & Ox and D 10 days 
P4 infusion & Ox . P4 alone cannot evoke Ox-induced PGF2α secretion 
[138]. 
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Figure 15 The effect of different P4 pretreatments and E2-17β infusion on Ox-
induced PGF2α secretion from the autotransplanted uterus in 
ovariectomized ewes. The combination of P4 and E2-17β evoke a 50 to 
100-fold greater response than when E2-17β is given alone.  Also note 
that pretreatment with P4 for 2 and 6 days abolishes the effect of E2-
17β alone at the dose of 0.5 µg per hour [138]. 
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The third experiment used the combination of P4 pretreatment and  E2-17β  
infusion at the minimum effective dose of 0.5 µg per hour (Figure 15).  (A): ROx 
appeared after 6 hours (approximate time needed for protein synthesis) induced by 
E2-17β and then again after 12 hours based on the significant increase in Ox 
induced PGF2α secretion.  The amplitude of the second increase was higher than the 
first. (B): Pretreatment with P4 for 2 or  (C): 6 days abolished the effect of E2-17β 
infusion alone.  The interesting observation,however, was that (D): pretreatment with 
P4 for 10 days caused a 50 to 100-fold increase on Ox induced PGF2α release after 
6 hours and again after 12 hours (Figure 15). 
 
It seems that P4 inhibits the action of E2-17β if it precedes infusion for 2 or 6 
days, but enhances the effect of E2-17β if it precedes an E2-17β  infusion by  10 
days.  Thus, for the release of a luteolytic amount of PGF2α a 10 day P4 prime 
followed by E2-17β exposure for at least 30 hours was needed to produce 5 pulses in 
25 hours that could bring about complete irreversible luteolysis. 
 
McCracken et al (1980) [138] constructed the following hypothesis to explain 
the observations they observed: 
 
i) E2-17β receptors (rE2-17β )(cytoplasmic) in the endometrium, when activated 
by E2-17β, appear to elaborate the rOx after a 6 hour delay (activation of 
protein synthesis) i.e. using Ox-induced PGF2α secretion as an in vivo marker 
for the appearance of the rOx. 
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ii) The interaction of Ox with its receptor (plasma membrane-bound) immediately 
appears to evoke PGF2α secretion.  The latter event is thought to involve the 
prostaglandin synthetase system (microsomal) probably through the release 
of precursor fatty acid via phospholipase action. 
 
iii) P4 inhibits R-E2-17β replenishment, thus probably explaining why E2-17β 
could not cause the formation of the ROx after P4 administration for 2 and 6 
days.  This explains why the system becomes unresponsive to Ox after 
pretreatment for 2 or 6 days. 
 
iv) Eventually, (after 10 days), R-E2-17β replenishment is no longer inhibited by 
P4 and ROx are once again induced by E2-17β after the usual 6 hour delay.  
In their article they explain this result by the report that P4 appears to catalyse 
the destruction of its own receptor [163], so that P4 can no longer inhibit R-E2-
17β  replenishment.  When the uterus is now challenged with Ox, there is a 
50- to 100-fold greater enhancement of PGF2α secretion than when E2-17β 
alone is infused.  This enhancement may be due either to an increase in the 
number of ROx, or more likely, to an amplification of the prostaglandin 
synthesizing system.  This latter event may be due to an arachidonic acid 
cascade effect from the P4 induced accumulation of lipid droplets in 
endometrial cells as reported by Brinsfield & Hawk [164] (Figure 16). 
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Figure 16 Working hypothesis on the hormone-mediated events controlling 
PGF2α secretion from the endometrial cell [138] 
 
2.6 The Mechanism of PGF2α action 
Several different mechanisms have been proposed to explain the luteolytic 
effects of PGF2α. These include: 
 
- a rapid and dramatic decrease in luteal blood flow [165, 166], 
- a reduction in the number of receptors for Luteinizing Hormone (LH) [167], 
- an uncoupling of the LH receptor from adenylate cyclise [168], 
- activation of protein kinase C (PK-C) [169], 
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- influx of  high levels of calcium [18, 170] and 
- and a cytotoxic effect [171]. 
 
Although there is good evidence for all these actions, the effects of PGF2α 
appear to differ among species, and the actions demonstrable in vivo differ from 
those observed in vitro.  Two important destinations that must be made in studying 
the effects of PGF2α are (a) the effect on progesterone synthesis and (b) the so 
called cytotoxic effect or cell lysis.  These two steps are not necessarily caused by 
the same stimulus.  In this section these two processes will be dealt with separately. 
2.6.1 Inhibition of Progesterone synthesis 
2.6.1.1 Progesterone biosynthesis 
Progesterone is produced from cholesterol derived from one of three possible 
sources (i) cholesterol taken up from the blood, primarily in the form of circulating 
lipoproteins, (ii) cholesterol stored within the ovarian cell, either as free cholesterol, a 
constituent of cell membranes, or liberated from cholesterol esters stored within 
cytoplasmic lipid droplets and (iii) cholesterol synthesized de novo in the ovarian cell 
from 2-carbon components derived from metabolism of carbohydrate, fat or protein 
within the cell.  In the corpus luteum cholesterol in circulating lipoproteins appears to 
be the most important source of steroidogenic cholesterol [172].  Considerable 
evidence has been accumulated supporting a mechanism of uptake that involves 
binding of extracellular lipoproteins via their apoprotein component to specific 
receptors located on the cell membrane, followed by internalization of the 
lipoprotein-receptor complex, uptake of the complexes by lysosomes, degradation of 
lipoproteins by lysosomal esterases, and release of free cholesterol, which is then 
able to gain access to the steroidogenic enzymes.  Cholesterol from both low-density 
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lipoproteins (LDL) and high-density lipoproteins (HDL) has been implicated as a 
steroidogenic precursor in the corpus luteum[173].  Species differences occur in the 
relative importance of the two classes of lipoproteins. HDL appears to be of greater 
quantitative importance in rodents, whereas cholesterol associated with LDL is the 
major circulating form of steroidogenic cholesterol in other species including humans 
and sheep. 
 
The first step in the conversion of cholesterol to progesterone, and the step 
generally believed to be rate limiting in progesterone biosynthesis under most 
conditions, is cleavage of the C-20,22 bond resulting in the C21 compound 
pregnenolone, and a 6-carbon fragment, isocaproic aldehyde.  The enzyme system 
that catalyzes this reaction C27 side chain cleavage cytochrome P-450 (P-450SCC), is 
located on the matrix side of the inner mitochondrial membranes[174].  It is a multi-
enzyme complex comprising three components (i) cholesterol 22-hydroxylase,  (ii) 
cholesterol 20 -hydroxylase and (iii) C20,22 lyase.  The reaction utilizes nicotinamide 
adenine dinucleotide phosphate hydrogenase  (NADPH), generated within the 
mitochondria by oxidation of Krebs cycle intermediates or fatty acids.  Three moles 
of NADPH and thee moles of oxygen are utilized per mole of cholesterol undergoing 
side-chain cleavage.   The generally accepted pathway for biosynthesis of 
pregnenolone from cholesterol undergoing side chain cleavage is shown in Figure 
17.  Evidence summarized by Lieberman et al (1984) suggests that the overall 
reaction in vivo probably does not involve stable, free hydroxylated intermediates as 
shown here[175].  Instead, it has been proposed that the substrate cholesterol and 
subsequent transient hydroxylated intermediates remain bound to the P-450SCC until 
the ultimate product, pregnenolone, is formed and released. 
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 Pregnenolone is the key steroidogenic intermediate of progesterone produced 
by the corpus luteum.  It is converted to progesterone by a microsamal enzyme, or 
enzyme complex, Δ5-3β -hydroxysteroid dehydrogenase: Δ5-4 - isomerase (3β -HSD).  
Although separation of the dehydrogenase from the isomerase activities has been 
achieved for a bacterial enzyme system, the two enzyme activities in mammalian 
steroidogenic tissues, including the ovary, have not been separated and appear to 
function physiologically as a single entity.  The enzyme utilizes nicotinamide adenine 
dinucleotide (NAD+)   as  an electron acceptor, and the reaction is essentially 
irreversible under physiological conditions[176]. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 Pathway of the biosynthesis of steroid hormones [176]. 
 
 Page 35 
2.6.1.2 Regulation of progesterone biosynthesis by gonadotropins 
 
After the LH surge and luteinization, both granulosa and theca cells 
differentiate to become progesterone secreting large and small lutein cells 
respectively.  The enzyme systems of these cells undergo modification and this is 
mediated by gonadotropins and other factors.   
 
Before the LH surge, the theca cells in the ovarian follicle produce almost 
exclusively androstenedione.  In the mitochondria of the theca cell, cholesterol is 
converted to pregnenolone by the C27 P-450SCC complex.  A low-molecular-weight 
activator peptide increase the supply of cholesterol to the mitochondria via a 
cytoskeleton-mediated process involving tubulin [176].  Pregnenolone is converted to 
androstenedione by the C21 P-450SCC and 3β-HSD, two enzymes present in the 
microsomes.  This androstenedione is then transported to the avascular granulosa 
cells where it is converted to E2-17β  by aromatase P-450 (P-450AR) and 17β-
hydroxysteroid dehydrogenase (17β-HSD) present in the microsomes.  Granulosa 
cells lack C21 P-450SCC , and it is uncertain if it has active C27-P-450SCC.  Thus, for 
granulosa cells to be able to produce E2-17β, androstenedione from the theca cells 
is needed  (Figure 17).  In order for these cells to produce P4 exclusively after the LH 
surge, the following modifications in the enzyme system are necessary for theca and 
granulosa cells respectively.   
 
In small lutein cells (theca cells) there must be down regulation of C21 P-
450SCC.  With all the other enzymes in place, this will ensure production of only P4 as 
the final product.  Binding of LH to its membrane receptor produces an increase in 
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adenosine 3'-5' cyclic monophosphate (c-AMP) that stimulates phosphokinase A 
(PK-A).  It appears that PK-A downregulate C21 P-450SCC in these cells [177, 178].      
 
Large lutein cells (granulosa cells) need more extensive changes. There is 
evidence that follicle stimulating hormone  (FSH) stimulate the activity of C27-P-
450SCC [179].  It is not clear if it is up-regulation of the enzyme-complex or increased 
supply of cholesterol to the mitochondria that mediate the stimulus to produce more 
pregnenolone.  Additional actions of LH in luteal tissue of various species, include 
enhancement of cholesterol availability by (a) stimulating 3-hydroxy-3-methylglutaryl 
coenzyme A reductase, which is rate limiting for cholesterol biosynthesis, (b) acutely 
stimulating cholesterol esterase, thereby increasing the availability of free cholesterol 
from intracellular stores or fatty acid esters and (c) increasing the number of 
lipoprotein receptors, thereby enhancing uptake of cholesterol in the form of 
lipoprotein.    FSH [180] and subsequently LH [181-184], greatly stimulate 
transcription of 3β-HSD.  With no C21 P-450SCC present in granulosa cells and in the 
absence of androstenedione from theca cells, this will make progesterone the 
exclusive endproduct of steroid synthesis.  It is not clear if the enzymes aromatase 
P-450 and 17β-hydroxysteroid dehydrogenase is down regulated. 
 
2.6.1.3 The effect of luteolysis on progesterone biosynthesis 
 
In ewes, the first effect of PGF2α appears to be a rapid decrease in luteal 
blood flow [168, 185, 186].  The decrease in blood flow is highly correlated with 
decreased levels of P4 in the serum.  The result of the drop in blood flow, will be 
decreased oxygen delivery to the luteal cells. The production of P4 is very sensitive 
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to oxygen tension.  The production of pregnenolone needs 3 moles of oxygen as 
well as NADPH from the oxygen dependant Krebs cycle.  The supply of cholesterol 
from all the sources is also oxygen dependant [166].  There is no drop in the number 
of LH receptors (RLH) in ewes administered a luteolytic dose of PGF2α, until well 
after a dramatic decrease in serum levels of P4 has occurred [185].  Several effects 
of PGF2α have also been demonstrated in vitro.  There is a total block of LH-induced 
increases in the production of c-AMP and P4 secretion [168, 187].  This observation 
is particularly interesting because most receptors for LH are on small steroidogenic 
cells, whereas receptors for PGF2α are on large luteal cells.  This suggests that there 
must be large cell - small cell communication in the corpus luteum.  This concept is 
further sustained by the observation that the number of large luteal cells and the 
levels of serum cholesterol are reduced significantly within 12 hours of a luteolytic 
dose of PGF2α, but that the number of small cells does not decrease until 24 hours 
after the introduction of PGF2α  [186]. 
 
PGF2α activates phosphokinase C (PK-C) in large luteal cells which inhibits 
secretion of P4 in large luteal cells and possibly indirectly in small luteal cells as can 
be seen in Figure 18.  However, PK-C does not induce cytotoxic effects [188] or 
cause luteolysis [178].  Interestingly, treatment of ewes with a luteolytic dose of 
PGF2α also results in a rapid decrease in messenger ribonucleic acid (mRNA) 
encoding 3β -HSD without an effect on levels of mRNA encoding C27-P-450SCC or 
tubulin[189].  Thus, it appears that PGF2α  acting via PK-C may have a specific effect 
on transcription of the gene for 3β -HSD or influence the rate of degrading of this 
mRNA. 
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Figure 18 Schematic diagram of some hormonal and second-messengers 
systems that  interact to regulate secretion of progesterone from small  
and  large  ovine  luteal  cells [176]. 
 
 
2.6.2 Cell lysis 
2.6.2.1 Morphological changes  
During regression of the corpus luteum, several distinct morphological 
changes occur.  The first morphological alteration that can be distinguished is a 
decrease in the percentage volume occupied by vascular elements [166].  There is a 
rapid decrease in the number of red blood cells and luminal volume of capillaries in 
the corpus luteum after treatment with PGF2α  [165].  Swelling of endothelial cells 
appears to be responsible for the initial reduction in luminal volume.  The decreased 
luminal volume most likely results in decreased perfusion of luteal tissue and 
probably causes blood to be shunted away from the corpus luteum [166, 190, 191]. 
 
As luteal regression continues, there is accumulation of lipid droplets in cells 
and steroidogenic cells decrease in size.  Shrinkage of cells results in clumping of 
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sub-cellular components, particularly mitochondria.  Normally there is little, if any, 
evidence of lipid accumulation in cells of the ovine corpus luteum, however, during 
regression there is a striking increase in intracellular lipid, with the lipid droplet 
becoming the most prominent organelle near the end of the estrous cycle.  It has 
been shown that triglycerides increase tenfold during luteal regression [192-195].  
This might be due to inactivation of the production of pregnenolone due to 
insufficient oxygen supply, while there is still normal recruiting of cholesterol. 
 
The plasma membrane of cells from the regressing corpus luteum contain 
membrane specializations, including gap junctions, maculae adherns, coated 
invaginations, and microvilli similar to those of the corpus luteum of pregnancy.  This 
is consistent with the fact that only large luteal cells contain receptors for PGF2α. The 
PGF2α induces inhibition of progesterone via PK-C, which inhibits 3β -HSD either via 
reduced transcription or increased breakdown of this mRNA.  This is communicated 
via these membrane specializations to the small luteal cells.  Also, the signal for cell 
lysis seems to be communicated via these specializations, because the small luteal 
cells decrease 12 hours later than the large luteal cells.   
 
The densely staining secretory granules observed during periods of maximal 
secretion of P4 decrease in number throughout the period of luteal regression.  
Concurrent with the decrease in numbers of secretory granules is the appearance of 
autophagosomes [165].  Autophagosomes appear to be sites of cytoplasmic 
involution, and their numbers increase as regression of the corpus luteum procedes.  
Lysosomes are present in luteal cells throughout the estrous cycle, however, they 
appear to increase in number as regression of the corpus luteum progress [196].  
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 During the midluteal phase of the cycle, acid phosphatase activity is restricted 
to lysosomes and inner cisternae of the Golgi apparatus.   During regression, an 
increase in the number of primary lysosomes appears to occur as a result of 
pinching off from the lateral margins of inner Golgi cisternae.  The quantity of smooth 
endoplasmic reticulum (SER) decrease as regression progresses, intracellular 
organelles become increasingly disorganized, and acid phosphatase activity is found 
with degenerating organelles.  The histological hallmark of the regressing corpus 
luteum, however, is the presence of discrete, well-preserved apoptotic bodies.  
During apoptosis chromatin is segregated and sharply circumscribed masses aline 
against the nuclear envelope.  Due to the action of a Ca 2+ / Mg 2+ - dependent 
endonuclease,  nuclear  fragmentation takes place and the DNA helix is broken 
down into fragments of different sizes.  Condensation of the cytoplasm and 
convolution of the nuclear and cell outlines takes place.  In the next phase, the 
nucleus fragments and the cell as a whole buds to produce membrane-bounded 
apoptotic bodies of varying size and structure, which are phagocytosed by nearby 
cells and degraded within lysosomes. Finally, the bodies are reduced to 
unrecognizable residues  [197-201]. 
 
2.6.2.2 Mechanism of apoptosis in the corpus luteum 
Apoptosis is the cellular mechanism of ovarian follicular atresia and luteal 
regression [202-204]. A common biochemical feature of apoptosis, the degradation 
of genomic DNA by the action of a Ca 2+ / Mg 2+ - dependent endonuclease [205], 
has been demonstrated in atretic follicles and regressing luteal tissue of diverse 
species [206, 207]. It was shown that the Ca 2+ / Mg 2+ - dependent endonuclease 
responsible for apoptotic DNA degradation in the ovary is Dnase I [208-210]. 
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 Imunohistochemistry revealed that DNase I was present in nuclei of granulosa 
and luteal cells in healthy follicles and corpora lutea [210].  This suggests that 
DNase I is present, but inactive, in granulosa and luteal cells and that a signal to 
activate DNase I is necessary for apoptotic DNA degration during follicular atresia or 
luteal regression.  However, the signal that activates DNase I during ovarian 
apoptosis, has not been identified.  
 
Recently it has become evident that apoptosis is triggered by the activation of 
cystein aspertate-specific proteases (caspases), a family of enzymes related to 
interleukin-1β converting enzyme (ICE, caspase-1) [211].  A cascade of proteolysis 
beginning with activation of caspase-8 leads to the activation of caspase-3, which is 
the principal downstream effector of cell death [212-217]. Caspase 3 is activated by 
a variety of apoptotic signals including serum withdrawl, binding of Fas ligand/CD95 
ligand to the Fas/CD95 membrane receptor protein, radiation and pharmacological 
agents [218]. Specific tetrapeptide inhibitors of caspase-3 block activation of the 
apoptotic program (nuclear fragmentation and endonuclease activation) in intact 
cells and cytosolic extracts [218, 219], whereas addition of active caspase-3 to 
normal cytosol activates the apoptotic program [218, 219].  These findings point to a 
central role for caspase-3 in apoptosis and demonstrate that caspase-3 activity 
results in the activation of the endogenous endonuclease. 
 
A limited number of substrates are cleaved by activated proteases during 
apoptosis, including poly (ADP-ribosis) polymerase (PARP), sterol regulatory 
element binding protein (SREBP), U1-70 small nuclear riboprotein, DNA dependent 
protein kinase, and structural proteins such as actin, fodrin, and lamins [220].  Both 
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PARP and actin are inhibitors of DNase I [221-223].  Therefore cleavage of these 
proteins might be one mechanism where by DNase I is activated during apoptosis in 
the ovary.  This was  investigated by Bone & Tsang but they concluded that although 
actin and PARP can be degraded during ovarian apoptosis, extensive cleavage of 
these proteins is not necessary for the activation of DNase I [224]. 
 
A noval heterodimeric protein, DNA fragmentation factor (DFF), has been 
identified as a potential link between caspase-3 activation and DNA fragmentation 
[219].  Caspase-3 cleaves DFF to produce an active factor that induces DNA 
fragmentation in isolated nuclei.  Cleavage of DFF in the absence of PARP 
cleavage, is sufficient to reproduce all the events of nuclear fragmentation observed 
during apoptosis [219].  Whether DFF is present and cleaved during apoptosis, in 
ovarian cells, is not known. 
 
Although PARP and actin cleavage are not necessary for the activation of 
DNase I, it is possible that the degration of these proteins have other functions 
during luteal regression.  For example, since steroidogenisis is dependent on the 
cytoskeleton [225], actin degradation during apoptosis could account for the rapid 
loss of steroidogenesis associated with luteal regression [226].  SREBP has also 
been identified as a substrate of caspase-3 [227].  SREBP is a membrane-bound 
transcription factor that is released and activated by proteases in response to low 
cellular cholestrol levels [227, 228].  The cleaved SREBP acts as a transcription 
factor to increase the synthesis of low-density lipoprotein receptor (RLDL), 
cholestrol-biosynthetic enzymes and enzymes of fatty acid synthesis [228].  The 
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cleaved SREBP may be responsible for the accumulation of large amounts of 
cholestrol esters in lipid droplets in the regressing corpus luteum. 
 
2.7 Maternal recognition of pregnancy 
In most mammalian species, P4 must be secreted throughout gestation to 
maintain a uterine environment conducive to pregnancy [229].  In some species (e.g. 
carnivores and marsupials), gestation lasts no longer than a normal luteal phase 
[229].  Therefore, there is no need for the conceptus to alter luteal function because 
the corpus luteum provides adequate progestational support.  Most other 
mammalian species have developed a means of shortening the life span of the 
corpus luteum in event of a non-fertile cycle to increase reproductive efficiency.  
Along with development of a uterine luteolitic mechanism, some means of 
maintaining the uterus in a progestational state during pregnancy must also be 
developed if successful reproduction is to occur.  The simplest solution would be for 
the conceptus itself to secrete progesterone and ensure its own survival [229].  
 
In many species, the placenta is a very active endocrine organ, secreting 
several hormones, including progesterone.  However, in most species, ability of the 
conceptus to secrete progesterone is not developed until after the corpus luteum of 
the estrous cycle would have normally regressed (e.g. sheep) [229].  Thus, to 
maintain adequate progestational support for developing pregnancy, it is necessary 
to prevent luteal regression.  The process by which the conceptus acts to maintain 
luteal secretion of P4 has been termed maternal recognition of pregnancy.  The 
mechanism by which this process is accomplished differs from species to species.  
In this section the mechanism in sheep will be considered.     
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In the ewe, the corpus luteum must be present through the first 50 days of 
gestation to maintain pregnancy [230].  Pregnancy can be maintained in 
ovariectomized ewes by treatment with P4 [32, 231].  The placenta begins to secrete 
P4 by approximately the 50th day of gestation [229] and provides adequate 
progestational support for the remainder of gestation.  After removal of embryos on 
day 13 or thereafter, the lifespan of the corpus luteum is extended [232], indicating 
that the embryo has a luteotropic effect by this time.  However early studies in the 
sheep by Moor & Rowson (1966) [43] demonstrated that the transfer of an embryo to 
the uterus of a synchronized non-pregnant recipient sheep would prevent cyclic 
regression of the corpus luteum in the recipient even if transferred as late as day 12 
of the cycle. Thus the critical period for maternal recognition of pregnancy is days 12 
to 13. 
 
Following the identification of PGF2α as a luteolytic hormone in the sheep 
[233-235], it seemed likely that the capacity of the embryo to prevent corpus luteum 
regression might be related to either (a) suppression of PGF2α  release from the 
uterus by the embryo or it products (anti-prostaglandin secreting effect) or (b) the 
ability of a secretory product of the embryo to protect the corpus luteum against 
potentially luteolytic releases of PGF2α  from the uterus (luteoprotective effect).  One 
or both of these mechanisms would allow the corpus luteum to continue to secrete 
the P4 which is necessary for the maintenance of early gestation in most species.  
These two different mechanisms have been loosely termed “antiluteolytic effect of 
the embryo”, which is an unfortunate phrase, since it does not indicate the nature of 
the effect, i.e. an indirect one via suppression of PGF2α secretion from the uterus or 
a direct one on the corpus luteum by protecting it against the effects of PGF2α.  In my 
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opinion the terms (a) “antiprostaglandin secreting” and (b) “luteoprotective”  
respectively would seem more appropriate. 
 
2.7.1 Antiprostaglandin secreting effect 
 
 
Until recently reports on the effect of the presence of an embryo on PGF2α 
secretion from the uterus in early pregnancy have been conflicting.  The levels of 
PGF2α at this time have been reported to be absent [116], diminished [117], 
unchanged [119-121, 236-238]  or higher [235, 239].  The reports used both PGF2α 
and its major metabolite PGFM as an indicator of PGF2α synthesis.  If reports that 
used PGFM and reports where samples were taken once a day were excluded 
because of the controversial nature of these methods, then there would be a 
consensus on PGF2α secretion during the time of maternal recognition of pregnancy.  
The basal concentrations of PGF2α are greater in pregnant animals, but the main 
episodic peaks of PGF2α which appear to be associated with luteolysis in cycling 
ewes, do not occur [116, 117, 240-242].  It must be mentioned, however, that there 
are some concerns that the method of analysis of PGF2α may pick up some 
interferences from PGE2.
 
 Secretion of ovine trophoblast protein 1 (o-TP-1) from the day 13 - 17 
sheep conceptus appears to be  responsible for the lack of major peaks of PGF2α  in 
pregnant ewes [243, 244].  o-TP-1 binds to the oxytocin receptor thus preventing the 
production of c-AMP and the activation of Plase-A2 and endoperoxide reductase 
necessary for the production of PGF2α . 
 
 Page 46 
 
2.7.2 Luteoprotective effect 
 
 
Sensitivity of the corpus luteum to the luteolytic action of PGF2α appears to be 
altered in early pregnancy.  Intrafollicular or periarterial injections of PGF2α were less 
effective in inducing luteal regression in pregnant than in nonpregnant ewes on day 
12 or 13 [64, 245, 246].  Also, the dose of PGF2α required to induce continued 
luteolysis when given intramuscularly, was less in cycling than in pregnant ewes 
[247].  Luteal resistance to PGF2α was absent on day 10 and  20 after mating, but 
the strongest between days 13 to 16 after mating.  Thus, resistance to PGF2α was 
transient and coincided with the time for maternal recognition of pregnancy.  The two 
factors that have been implicated in the luteoprotective effect of the embryo on the 
corpus luteum is PGE2 and a proteinaceous factor secreted by the embryo. 
 
Increased concentrations of PGE2α are observed in pregnant ewes in the 
critical period for maternal recognition of pregnancy.  It has been reported that 
PGE2α is secreted by the embryo and the endometrium of the gravid uterus.  The 
shift in production from PGF2α to PGE2 by the uterus can be achieved by down 
regulation or inactivation of endoperoxide reductase and up-regulation or activation 
of endoperoxide isomerase.  PGE2 is a potent vasodilator and antagonizes the effect 
of PGF2α which is a potent vasoconstrictor.  Thus, PGE2 will cause a shunt of blood 
to the corpus luteum and better oxygen delivery.  This, unlike PGF2α, PGE2 will be 
conducive to the early stages of P4 synthesis.  A direct effect for PGE2 on the luteal 
cell acting via a receptor remains speculative at this stage.  There are no conclusive 
studies that could show the presence of receptors for PGE2 present on these cells.  
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However incubation of luteal cell cultures with PGE2 prevents PGF2α induced 
regression [248]. 
 
Wiltbank et al (1992) demonstrated that the day-15 sheep conceptus secretes 
a proteinaceous factor that is capable of preventing both the antisteroidogenic and 
cytotoxic effects of PGF2α.  This factor does not bind PGF2α  or prevent it from 
binding to its luteal receptor [249].  A similar factor is secreted from cow embryos.  
Because the molecular weight of this factor is approximately 30 000, it is hard to 
envision its being transported locally from the uterus to the ovary via the uterine vein 
and ovarian artery similar to PGF2α . It is thus not clear how this proteinaceous factor 
provides its luteoprotective action. 
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SECTION B PREMATURE LUTEAL REGRESSION 
 
 
2.8 The phenomenon of premature luteal regression 
 
Premature luteal regression can be defined as: “Regression of the corpus 
luteum earlier in the estrous cycle before the onset of natural luteal regression 
between day 13 and 14 of the cycle”.  This phenomenon has been observed in 
various domesticated species including sheep [250] , goats [251], cows [252] and 
also wild deer species like the red deer (Cervus elaphus) [253]. This phenomenon is 
found in a diversity of stages in these animals life cycles.  The occurrence of 
subnormal luteal phases is particular significant in conditions where ovulation is 
induced [251, 252, 254] (anestrus, pre-puberty, postpartum) and stimulated 250, 
253, 255] (superovulation).  
 
Superovulation is an integral part of embryo transfer.  The term “embryo 
transfer” encompasses a variety of procedures which may include superovulation, 
embryo recovery, short-term culture of embryos in vitro and transfer of embryos into 
the recipient.  The success rates of embryo transfer are highly variable in small stock  
like sheep, because of  sub-optimal conditions associated with one or more of the 
above procedures.  One of these sub-optimal conditions is a short luteal phase.  
 
The processes of fertilization and early embryonic development are P4 
independent in vitro [256].  However, luteal P4 is essential to create a feasible 
environment for these processes to take place in vivo [257].   Premature regression 
of corpora  lutea  in  superovulated  sheep ewes prior  to the time  of embryo 
collection (7th  day of the cycle) results in very low rates of recovery.  In the majority 
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of animals with premature regression no ova /  embryos are found. In some cases 
only unfertilized ova were found, and in the exceptional cases where embryos were 
recovered they were of poor quality.  This might be attributed to expulsion of 
embryos / unfertilized ova via the cervix as a result of endocrine abnormalities 
associated with luteal failure and embryo toxicity of a regressing corpus luteum [250-
252]. 
 
The reported incidence of premature regression in the literature varies from 
as low as 2% to as high as 100% of superovulated ewes.  The incidence is 
influenced by season, nutrition, superovulatory hormone(s) used, timing of 
administration and dose of superovulatory hormones and method of synchronisation. 
These issues will be dealt with separately in the following sections.  To date, the 
cause of premature regression has not been elucidated. 
 
2.9    The effect of season 
 
2.9.1 Neuro-endocrine mechanisms mediating photoperiodic  
regulation of gonadotropin secretion 
 
 
In most breeds of sheep [258-262], normal estrous cycles occur in the fall and 
winter (breeding season), while cycles cease in the spring and summer.  From an 
adaptive point of view, this limitation of ovarian cycles to the fall and winter ensures 
that lambs are born in the spring, when environmental conditions are usually 
favourable for their survival.  There is, however, considerable variation in seasonal 
reproductive patterns.  At some extremes, some primitive mountain sheep have only 
one estrous cycle during the breeding season, whereas in Merino ewes, estrous 
cycles occur throughout most of the year [263, 264].  The seasonal ovarian cyclicity 
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in the ewe is mainly controlled by the photoperiod involving LH, E2-17β  and 
melatonin (MT) [263]. 
 
In sheep, the mechanisms by which a change in photoperiod is transformed 
into an alteration in LH secretion can be divided into three major steps.  First the day 
length is perceived, and an appropriate neural signal is transmitted to the pineal 
gland.  The second step is transduction of this neural information into an endocrine 
signal by the pineal gland.  Finally, the endocrine signal from the pineal is 
transformed into a change in gonadotropin secretion via the hypothalamo-
hypophyseal axis.  A detailed analysis of these steps in the sheep has been 
presented in several reviews [265-267].  This section is intended as a brief overview, 
with particular emphasis on current developments. 
 
Perception of day length requires a photoreceptor and a mechanism for 
measuring the hours of daylight.  The most important photoreceptor in sheep, as in 
other mammals, is the eye [268].  Following orbital enucleation, changes in 
photoperiod no longer alter either E2-17β negative feedback or ovarian cycles[269]. 
The mechanism by which sheep measure day length, most likely involves 
endogenous circadian rhythm in photosensitivity [270, 271].   In its simplest form, 
this endogenous rhythm is set that its photosensitive phase occurs more than 12 
hours after the start of the light phase.  If light is on during this photosensitive phase, 
the day is perceived as long (>12 hours of light); if no light occurs during that period, 
the day is perceived as short.  In sheep, however, the situation is more complex 
because the animal’s photoperiodic history can influence her response to day length.  
For example, an intermediate day length (13 hours light / day) is perceived as a 
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“long day” when ewes are switched from 10 hours to 13 hours of light per day, and 
as a “short day” following a switch from 16 hours to 13 hours of light per day [272].  
 
After the photoperiod is converted into a neural signal by the retina, the 
information is transmitted to the pineal gland.  The pathway for transmission of this 
information in the ewe remains largely unknown.  In the hamster, this pathway 
includes the suprachiasmatic nucleus, paraventricular nucleus, and the superior 
cervical ganglion, which innervates the pineal [273, 274]. The little information 
available in sheep is consistent with a similar pathway.  Lesions of the 
suprachiasmic nucleus produce ovulatory cycles during anestrus [275-277] and 
removal of the superior cervical ganglion blocks the photoperiodic response of rams 
[278, 279]. 
 
The crucial role of the pineal gland in mediating the effects of photoperiod in 
sheep was demonstrated by classic ablation experiments.  Pinealectomy prevents 
photoperiod-induced shifts in reproductive function in ewes [280-282].  Furthermore, 
the pineal is clearly required for both the stimulatory effects of short days [280, 281] 
and the ihibitory effects of long days [280, 282] on ovarian function.  Because of the 
large amount of work implicating melatonin as an important pineal hormone in other 
species [283], much of the work on the role of the pineal in sheep has focused on 
this indoleamine. 
 
Secretion of MT shows a circadian rhythm [284] that is influenced in two ways 
by photoperiod: (a) the rhythm is synchronized by light-dark cycle [281, 283], and (b) 
MT is directly inhibited by light [283, 285, 286].  The nett effect of these actions are 
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that under both natural[286-289] and artificial photoperiod [280, 281], MT secretion 
increases shortly after darkness and remains elevated until the beginning of the light 
phase.  Thus, the serum MT pattern can be considered a hormonal analogue of the 
light-dark cycle. 
 
Information on the possible sites where MT acts to control this endogenous 
rhythm has come from recent studies on the localization of melatonin receptors (R-
MT).  Surprisingly, the highest concentrations of R-MT are observed in the pars 
tuberalis [290-293], which is the portion of the adenohypophysis in close apposition 
to the median eminence.  Little, if any, binding occurs in the median eminence or 
pars distalis [290-293], but R-MT are distributed elsewhere throughout the ovine 
central nervous system, including the rostral hypothalamic areas, that contain 
gonadotropin releasing hormone (GnRH) cell bodies [291-293], and the medial basal 
hypothalamus [290].  Which of these R-MT are important for the control of 
reproductive function, remains to be determined. 
 
Information on the possible mechanisms of action of MT has come from 
studies on the changes in the hypothalamo- hypophyseal function that underlie 
seasonal breeding in the ewe.  Studies on the effects of pentobarbital anaesthesia 
have raised the possibility that these actions of photoperiod reflect activation of 
inhibitory neural systems [294].  In intact anestrus ewes, pentobarbital produces a 
dramatic increase in pulsatile LH secretion [294].  Based on the assumption that 
pentobarbital anaesthesia decreases neural activity [295], these data imply that 
during anestrus, LH pulse frequency is inhibited by a set of inhibitory neurons.  
Pentobarbital decreases the activity of these inhibitory neurons, allowing pulsatile LH 
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secretion to increase.  This interference, in turn, led to a model for seasonal control 
of LH secretion in the ewe.   
 
This model proposes that the long-day photoperiod of anestrus activates a set 
of E2 -17β sensitive neurons that inhibit the GnRH pulse generator.  E2-17β 
suppresses GnRH pulse frequency by increasing the activity of these neurons, but 
can only do so in anestrus.  The reason for this is because these inhibitory neurons 
are only sensitive for the effects of E2-17β  during anestrus.  The most logical 
mechanism to explain this is that estradiol - 17β receptors (R-E2-17β) is controlled by 
MT.  In the summer with its long days, there is a decrease in MT secretion and an 
upregulation in R-E2-17β in the inhibitory neurons of the GnRH pulse generator.  
This leads to a decrease in LH secretion and also in E2-17β secretion.   The result is 
that there is no preovulatory LH surge, the ewe doesn’t ovulate and goes into 
anestrus. 
 
2.9.2 The effect of season on the occurrence of premature  
regression in the superovulated sheep ewe 
 
The incidence of premature luteal regression in the superovulated sheep ewe 
is greater in autumn than in spring [250, 296].  In two reports it also seems that the 
incidence may differ  from year to year because the incidence was higher in the 
study by Ryan et al (1987) [250]  than in the study by Jabbour et al (1991) [296].  
Both studies were conducted in the same region in Western Australia (see Table 1). 
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Table 1 The incidence of superovulated ewes with premature regressed 
corpora lutea as affected by season [250, 296] 
 Autumn Spring 
 
Study 1[250] 
 
Study 2[296] 
 
  
53/143  (37%) 
 
 21/89    (24%) 
 
 
32/156  (21%)                    
 
5/88      (6%)                       
number of ewes with PLR / number of ewes superovulated 
 
During the non-breading season (spring) there is active suppression of the 
GnRH pulse generator by E2-17β sensitive inhibitory neurons [297].  This effect 
seems to be more obvious in some breeds, and less so in breeds like the Merino.  
Theoretically this would influence the formation and the normal functioning of the 
corpus luteum because of inadequate LH release.  Randel et al (1982) and 
Sumbung et al (1987) reported that season can alter the timing and magnitude of the 
LH surge [297, 298].  
 
In the superovulated sheep ewe with more follicles ovulating and more 
corpora lutea formed, one would expect this effect to be more pronounced.  
Theoretically there is the possibility that short luteal phases are not because of 
premature regression, but merely because of inadequate function.  The results from 
the studies by Ryan et al (1987) [250] and Jabbour et al (1991) [296], however, do 
not support this hypothesis.  They found that there is a lower incidence of premature 
regression in the non-breeding season when the inhibition of the GnRH pulse 
generator, and thus also the LH production, is at its strongest.  This finding raised 
the question of whether pastures with higher nutritional value in the spring and 
summer (non-breeding season) could influence the incidence of premature 
regression rather than photoperiod. 
 Page 55 
 
2.10 The effect of nutrition 
 
2.10.1 The effect of nutrition in reproductive performance 
There is considerable evidence in the literature that the ovulation rate in ewes 
is stimulated in response to increased feeding [263, 264, 299].  An increase in the 
amount of protein digested post-ruminally [300] or increased availability of energy-
yielding substrates like carbohydrates [301], may be responsible for increased 
ovulation rates in ewes.  Increased secretion of FSH [302] and increased ovarian 
sensitivity to gonadotropins [303]  have been suggested as a mechanism for the 
higher ovulation rates and higher fecundity seen in animals with increased levels of 
nutrition. 
 
Under normal circumstances, the inhibitory effect of photoperiod on LH 
secretion  overrides the stimulatory effects of an increased nutritional state in most 
breeds of sheep [302]. In the absence of inhibition of the GnRH pulse generator by 
E2-17β sensitive inhibitory neurons, better nutrition will increase reproductive 
performance.  This can clearly be seen in the practice of “flushing” where animals 
are fed a high-energy supplement prior to mating to improve their reproductive 
performance.  This practice is effective even when supplementation starts within six 
days prior to ovulation [299].  According to the same author, in breeds like the 
Merino where the effects of photoperiod is minimal, this effect is also seen in the 
non-breeding season. 
 
The exact mechanism whereby increased nutrition increases reproductive 
performance, has not been explained.  One proposed theory, is that a higher protein 
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intake increases the availability of essential amino acids being the building blocks of 
protein hormones like LH, FSH and GnRH [302, 303].  If the specific amino acids 
necessary to produce FSH are limited, FSH, LH and GnRH secretion will be 
decreased which will influence ovulation rate and reproductive performance.  Also, a 
decrease in LH secretion can lead to luteal failure and embryonic death.  For this 
theory to be valid, there has to be a deficiency in essential amino acids. At least one 
study proved that increased protein intake do not increase the amplitude of the LH 
surge, however, it did advance the LH surge by ± 10 hours in that particular study 
[296]. 
 
Another argument that is becoming increasingly popular among scientists, is 
the role of the intra-ovarian insulin like growth factor (IGF) system.  A large body of 
evidence now suggests the existence of an intra-ovarian IGF system complete with 
ligands, receptors and binding proteins [304].  Although IGFs may be acting in their 
own right, their most important role appears to be their ability to synergise with the 
pituitary gonadotropins, and to amplify their impact thus making the ovary more 
sensitive for pituitary gonadotropins.  It has now been clearly established in several 
species that the ovary is the site of hormonally regulated IGF-I gene expression 
[305-308].  The ovary displays the third highest level of IGF-I gene expression, with 
only the uterus and liver showing higher expression [305]. 
 
IGF-I and IGF-II are single chain polypeptides that have 70 and 67 amino acid 
residues, respectively, and structural features similar to those of insulin.  The regions 
of structural similarity of IGF-I and IGF-II to insulin are confined to the A-chain and B-
chain portions of the molecules where they are more homologous to insulin than 
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relaxin, another member of the insulin-like super-family of molecules.  Due to their 
structural similarity, insulin will bind to IGF-I receptors (R-IGF), but the receptor’s 
affinity for insulin is not as high as for IGF-I [309, 310]. 
 
Besides ligands and receptors, the ovary is well endowed in IGF binding 
proteins (IGFBPs), the exact role which remains largely unknown.  IGFBPs 
constitute a hetrogeneous group of at least six distinct proteins capable of binding 
IGFs (but not insulin), with affinities in the 10-10  to 10-9 M range.  The six known rat 
IGFBPs range in size from 21.5 to 29.6 kDa.  It is assumed, although by no means 
proven, that the IGFBPs subserve different functions, thereby justifying the existence 
of multiple IGFBPs types.  Although the exact role of the IGFBPs remains a matter of 
study, general consensus supports a role in the transport of IGFs and regulation of 
their bio-availability [311-314]. 
  
It is known that high energy supplementation due to increased carbohydrates 
in the diet, increases blood levels of insulin.  There is a distinct possibility that these 
high levels of insulin react with R-ILGF and mediate the effects on the level of the 
ovary.  It is known that sheep have a higher lambing rate if exogenous insulin is 
administered.  This effect contributes to more follicles ovulating.  The effect of insulin 
or IGF on luteal function, however, has not been studied [314]. 
 
2.10.2 The effect of nutrition on the occurrence of premature 
regression  in the superovulated sheep ewe 
 
 
Jabbour et al  (1991) [296] investigated the effect of a high energy, high 
protein supplement like lupin  grain  on the incidence  of premature  regression  in  
Autumn  (Table 2).  It was found that feeding lupin grain reduces the incidence of 
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premature regression to levels normally experienced in spring [250, 296].   This 
supports the hypothesis that the higher incidence of premature regression in autumn 
is caused by lower nutrition levels.  Nutritional values of pastures vary from year to 
year, depending on environmental conditions.  Thus, the fact that nutrition has an 
influence on the incidence of premature regression could also explain why a higher 
incidence  was seen in  the  study   by Ryan [250], than the study by Jabbour [296] 
in the same region in Western Australia, because their studies were conducted in 
different years. 
 
Table 2 The effect of supplementary lupin grain feeding on the endocrine and                 
steroidogenic responses and luteal function of superovulated Merino                  
ewes [296] 
 + Lupin Grain - Lupin Grain 
Incidence of premature luteal regression 1/44 (2%) 20/45 (44%) 
Time to onset of estrous from sponge 
removal  (hours) (mean ± SD) 
32.9 ± 1.1 
(n=24) 
35.4 ± 1.2 
(n=24) 
Peak E2 concentration (pg/ml)     (mean ± SD) 14.2 ± 4.7 * 
(n=5) 
11.5 ± 2.4 
(n=4) 
Peak E2 concentration per follicle 
(pg/ml/follicle) **  (mean ± SD) 
1.2 ± 2.9 * 
(n=5) 
0.5 ± 0.3 
(n=4) 
Time to LH peak from sponge removal 
(hours)(mean ± SD) 
36.0 ± 4.0 * 
(n=2) 
46.6 ± 1.3 
(n=3) 
Peak LH concentration (ng/ml)    (mean ± SD) 6.3 ± 1.3 
(n=2) 
5.3 ± 0.9 
(n=4) 
 
 
*   Values between the two groups are significantly different (p<0.05) 
**  The peak E2-17β concentration in plasma is corrected for the number of preovulatory follicles in each group, i.e. the 
peak E2-17β concentration is devided by the number of preovulatory follicles.  The total of the corpora lutea and large 
unruptured follicles are assumed to represent the total number of preovulatory follicles. 
 
In the study by Jabbour et al  (1991) [296] the endocrine and steroidogenic 
responses of superovulated ewes were also measured.  Unfortunately, the authors 
used a small number of subjects for the E2-17β and LH determinations, but it seems 
that although the synthesis of protein and peptide hormones are not influenced, the 
production of steroids are affected.  The advancement of the LH surge can also be 
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explained by the effect on E2-17β synthesis.  Thus, the argument that high protein 
supplementation abolishes the shortage of essential amino acids does not seem to 
play a role in the incidence of premature luteal regression (Table 2). 
2.11 Superovulatory hormones used and the influence  
of the dosage 
 
2.11.1 Superovulation theory and methods of inducing  superovulation 
 
Superovulation can be defined as “an increase in the normal ovulation rate by 
affecting levels of gonadotropins from exogenous or endogenous sources.  Three 
mechanisms of actions have been suggested for the effects of gonadotropins on 
follicular development. 
 
i) follicles already undergoing atresia are “rescued” presumably as a result of 
vigorous mitotic activity in granulosa and/or thecal compartments. 
ii) smaller healthy follicles are recruited into a more active growth phase. 
iii) the rate of follicular atresia is reduced. 
 
These mechanisms are not exclusive and indeed the most likely explanation 
for superovulation is a combination of the mechanisms mentioned.  Methods of 
inducing superovulation in the sheep include:  [315] 
 
1. Administration of equine chorionic gonadotropin (eCG) 
2. Administration of  follicle stimulating hormone (FSH) 
3. Active and passive immunization against androstenedione and E2-17β  
4. Administration of bovine follicular fluid 
5. Administration of GnRH in a pulsatile fasion 
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6. Administration of human menopausal gonadotropin (hMG) 
7. Administration of horse LH 
8. Administration of anti-LH. 
The following discussion will be limited to the two most commonly used hormones 
used to achieve superovulation in sheep, namely  eCG and FSH. 
 
2.11.1.1 Equine chorionic gonadotropin 
 
In 1930 equine chorionic gonadotropin was discovered at the Department of 
Animal Science of the University of California by the late Professors Harold Cole and 
George Hart [316].  Until recently, their discovery was known as Pregnant Mare 
Serum Gonadotropin (ECG)[316].  In their classic paper announcing the discovery of 
equine chorionic gonadotropin (eCG), Cole & Hart (1930) demonstrated, with 
remarkable accuracy, the general pattern of secretion of the hormone during 
pregnancy [316].  Many other similar studies undertaken since then to monitor eCG 
secretion patterns in pregnant mares and other equids, using a wide variety of in 
vivo biologic [317-321], hemogglutination-inhibition [316, 322], radioimmunologic 
[323, 324], and in vitro radioreceptor [325, 326] assay methods, have all confirmed 
the essential shape of the secretion curve and the variability between individual 
animals in terms of peak concentration of eCG measurable in blood (Figure 19).  
Soon after their discovery of eCG in 1930, Cole and his colleagues drew attention to 
the close relationship that exists between secretion of gonadotropic hormone and 
the considerable degree of secondary luteal development that occurs in the mare’s 
ovaries [327].  They noted that on or soon after the first appearance of eCG in 
maternal blood around day 40 after conception, one or more accessory ovulations 
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occurred in the maternal ovaries, with further secondary structures appearing in an 
accumulative fashion during the next 100 or more days of gestation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 19  Concentrations of eCG (ECG) measured by hemagglutination-inhibition 
(H-I) assay in the serum of nine pony mares between 40 and 110 days 
of gestation.  Note  the  individual  variation  between  mares  in the    
peak concentrations (31 to 173 IU/ml) reached between days 54 and 
73 [322]. 
 
 
Amoroso et al (1948) [328] described the same phenomenon, and Allen 
(1970) [329] counted as many as 35 distinct luteal structures in the ovaries of one 
mare at day 140 of pregnancy. This led to the general assumption that eCG provided 
both gonadotropic and luteotropic stimuli. Serial measurements of the concentrations 
of pituitary FSH and LH in the serum of cycling and pregnant mares throughout the 
spring and summer months of the physiologic breeding season showed FSH is 
released from the pituitary gland in mares at intervals of approximately 10 to 12 days 
[330, 331]. The rhythmic pattern of release is controlled essentially by day length 
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and the secretion of follicular inhibin and / or E2-17β, but it is not influenced by 
negative feedback effects of P4.  Thus, releases of pituitary FSH continue 
unchanged during early pregnancy just as in the estrous cycle.  This finding 
coincides well with the earlier observations of Bain (1967) [332], and Van Rensburg 
& Van Niekerk (1968) [333], that considerable follicular growth occurs in the mare’s 
ovaries around days 18 to 23 of gestation.  This corresponds with the time the mare 
could have been expected to have returned to oestrus and re-ovulate had she not 
been pregnant.  However, these large follicles do not ovulate, and they tend to 
regress and make way for a further wave of follicular growth some 10 to 12 days 
later.  This normally coincides with the initial onset of eCG secretion between days  
36 and 40 when two significant changes in ovarian steroid hormone production 
occur. First, as demonstrated originally by Terqui & Palmer (1979) [334], and 
confirmed by Jeffcott et al (1987) [335], there is a sharp and pronounced rise in 
plasma E2-17β concentration.  Second, in most mare’s a pronounced rise in plasma 
P4 concentration is observed as a result of the first secondary ovulation [329].  
Clearly the continuing secretion of pituitary FSH, not eCG, stimulates the waves of 
follicular growth in the pregnant mare.  The LH-like action of eCG, in the absence of 
pituitary LH, merely acts to induce final maturation of the dominant follicle in the 
wave and to either ovulate or luteinize it. 
   
Perhaps the most unusual and interesting feature of the eCG molecule is its 
unique ability to express both FSH-like and LH-like biological activities when 
administered to other mammalian species [316, 336] (Figure 20).  This is in contrast 
with the mare and stallion where it only has an LH-like action [337, 338].  This duel 
capacity of eCG as an FSH and LH-like molecule makes it the ideal candidate to 
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induce superovulation in other mammalian species. Not only would it stimulate 
excessive follicular development and recruitment and protect the non-dominant 
follicles from the lack of FSH caused by negative feedback via inhibin from the FSH 
independent dominant follicle, but the LH properties would also ovulate the follicles 
and give luteotropic support to the newly formed corpora lutea. 
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Figure 20 An comparison of the dual capacity of eCG as an FSH and LH like                      
hormone when administered to various domesticated animals [316, 
336]. 
 
This unique molecule shows structural similarities to human chorionic 
gonadotropin (hCG) [339].  It is a high molecular weight (70 000 Da) acidic 
glycoprotein with an abnormally high carbohydrate content (45 %) consisting mainly 
of sialic acid, galactose and glucose amine [339]. The high sialic acid content has 
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been linked with the long biological half life of this molecule (7 days).  Like the 
pituitary and chorionic gonadotropins in all the mammalian species, eCG is a 
heterodimeric glycoprotein that consists of an α and a β-subunit joined noncovalently 
[340].  The  α-subunits are identical in pituitary and chorionic gonadotropins within 
each species, whereas the β-subunit differ, indicating that the specificity of action 
must reside in the  β-subunit.  This has been experimentally confirmed by 
interchanging the α-subunits between different species, without altering their 
specificity of action.  The amino acid sequence of the  α-subunit is highly 
homologous across species and the horse sequence show 68 to 79% homology with 
the other available mammalian  α-subunits sequences from both pituitary and 
chorionic gonadotropins.  However, it shows several unique substitutions, including 
transposition between tyrosine and histidine at positions 87 and 93, which may be 
related to some of the unusual properties of the equine gonadotropins [340].  The  α-
subunit has been shown to be encoded by a single gene across species. 
 
In general, each β-subunit is also encoded by a single gene.  Across species 
these genes form a family of closely related genes that have clearly arisen through 
gene duplication.  It was discovered some time ago that both horse and human CG  
β-subunits are longer than all pituitary  β-subunits by 30 residues at the C-terminal.  
This implied a possible evolutionary linkage between primate and equine CG, but 
has now been established that these hormones evolved independently.  The primate 
CG  β-subunit genes have apparently arisen via duplication of the LH  gene, followed 
by a mutation leading to the C-terminal extension and further gene duplication [341, 
342] probably before divergence of baboons and humans [343].  Bousfield and 
colleagues (1987) showed that the horse LH  β-subunit is, in fact, identical in amino 
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acid sequence to the horse CG  β-subunit   except for the C terminal extension [344].  
This provided an explanation for the previous somewhat surprising observation that 
horse LH exhibits the same intrinsic FSH-like activity when administered to non-
equine species [345]. Thus the FSH-like properties is most likely not linked to the C 
terminal extension but linked to minor amino acid sequence differences between 
hCG and eCG in the β-subunit.  
      
The use of the hormone in large and small domestic species has 
unfortunately been associated with the formation of follicles that fail to ovulate and 
lutenize to form cysts.  This results in a decrease ovulation rate and a lower yield of 
viable quality  embryos for transfer [346]. The abnormal endocrine status associated 
with the presence of these large follicles is also thought to be detrimental to 
fertilization and development of embryos in vivo [347, 348].  The occurrence of cysts 
increase with dose of eCG and has been attributed to the prolonged half-life of the 
gonadotropin [349].   
 
Generally superovulation with 1600 IU eCG can yield 230 grade 1  embryos 
per 100 ewes superovulated [350]. Table 3 and 4 represents the typical response to 
superovulation with eCG in sheep ewes, with and increased dose of eCG. 
 
Table 3 Numbers of corpora lutea (Cl) and total ovarian response (Cl +                     
persistent large follicles (< 5 mm)) (mean ± SD) assessed on day 6 of                   
the oestrous cycle for ewes treated with eCG [350] 
 
Dose eCG IU No ewes Cl’s Total ovarian response 
800 IU 36 2.7 ± 0.2 3.5 ± 0.3 
1600 IU 35 9.0 ± 0.8 11.8 ± 1.1 
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Table 4 Proportion of ewes that fail to superovulate in response to treatment 
with eCG [350] 
 
Dose of eCG IU Proportion of ewes that fail to superovulate (< 3 CL’s or 
large follicles) 
800 75 % 
1200 12% 
1600 10% 
 
 
2.11.1.2 Follicle stimulating hormone 
 
Follicle stimulating hormone (FSH) stimulates follicular development in the 
ovary, and in particular the granulosa cells of the follicle.  FSH along with LH 
prepares the follicle for ovulation and luteinization.  FSH specifically stimulates the 
production of the enzyme system aromatase P450, for converting androstenedione 
and testosterone to E2-17β. It also stimulates the production of the enzymes 
involved in plasminogen activation which plays an important role in ovulation.  
Studies on the induction of follicular development by exogenous gonadotropins in 
women and domestic species have been accelerated by their application in in vitro 
fertilization and embryo transfer [351]. 
 
In most species the pituitary contain 5% FSH and 95 % LH during most of the 
estrous cycle.  The highest FSH:LH ratio is achieved just after the LH surge when 
the pituitary LH store is almost depleted [315, 350].   
 
There are three types of commercial FSH available including : 
 
a) FSH-P : The earliest form of commercially available FSH was a crude extract 
from the pituitary known as FSH-P.  The biggest problem with this source of 
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commercial FSH is that usually the amount of LH contamination is extensive 
and undisclosed.  If the commercial company producing this type of FSH 
would use only pituitaries from animals just after the LH surge, LH 
contamination could be limited.  From experience in the field, researchers 
have found that LH contamination varies from batch to batch. 
 
 
b) Purified FSH extracts like Ovagen™: More purified forms of FSH became 
available during the later years.  One of the first methods to “purify” FSH  from 
LH contamination was with immunoabsorption with antiserum to the   β-
subunit of LH.  Today there are various methods used but even purified 
preparations still contains 1 - 10 % LH contamination[351]. 
 
c) Recombinant FSH: The purest form of FSH is recombinant FSH (recFSH).  
The genes for FSH is transferred into bacteria like Escherichia coli ,  which 
then produce the FSH in a culture medium.  The FSH can then be recovered 
and purified from the culture medium.  This is the purest form of FSH (<0.01 
% LH contamination), but expensive to produce. 
 
The biggest problem with FSH is the relative short half-life of pituitary 
gonadotropins.  FSH has a half-life of approximately 2.5 hours, which means that 
after 6 hours almost all of the FSH is catabolised. To achieve superovulation, FSH 
must therefore be administered frequently.   A significant proportion of ewes treated 
with FSH alone fail to show a superovulatory response, thus reducing  yields of 
embryos available for transfer or cryopreservation[315, 352].  
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 Generally superovulation with 18 mg FSH can yield 230 grade 1 embryos per 
100 ewes superovulated.  Table 5 and 6 represent the typical response to 
superovulation with an increased dosage of FSH-P. 
 
Table 5 Numbers of corpora lutea (Cl) and total ovarian response (Cl + 
persistent large follicles (> 5 mm)) (mean ± SD) assessed on day 6 of 
the oestrous cycle for ewes treated with FSH-P[317] 
 
 
Dose FSH-P No ewes Cl’s Total ovarian response 
12 mg 37 6.7 ± 1.0 8.2 ± 1.0 
18 mg 37 10.8 ± 1.3 12.8 ± 1.3 
 
Table 6 Proportion of ewes that fail to superovulate in response to treatment 
with FSH-P[317]  
 
        
Dose of FSH-P mg Proportion of ewes that fail to superovulate (> 3 CL’s or 
large follicles) 
12 32% 
18 19 % 
 
2.11.1.3   Combination of pregnant mare serum gonadotropin and 
follicle stimulating hormone 
 
 
In an attempt to increase the amount of normal grade 1 embryos for transfer 
or cryopreservation, a lower dose of eCG is sometimes used in combination with  a 
high dose of FSH.  This is done to decrease the amount of animals that do not 
superovulate with FSH alone. This approach will also decrease the incidence of 
large unruptured follicles observed in animals superovulated with a high dose of 
eCG.  A moderate dose of eCG (800 IU) in conjunction with 18 mg of FSH-P 
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increased the ovulatory response above that observed when FSH-P was used alone 
[350].  
 
By using a purified extract of FSH like Ovagen TM with LH contamination 
limited to 1 - 10 % of protein mass, resulted in a reduced variability in ovulatory 
response [351].  Commercial purified extracts of FSH like Ovagen TM are, however, 
still extremely expensive resulting in a limited application.  The conventional method 
of superovulating small stock with Ovagen TM is by injecting a total dose of 7 to 10 
mg at 12 hour intervals in decreasing doses for 3 to 4 days.  It was reported by King 
et al (1997) [350]  that the total dose of this treatment can be reduced by 55 % if the 
FSH is dissolved in a 3.2 % gelatin-saline vehicle and combined with 400 IU eCG.  
This dosage of eCG is even less than the conventional 800 IU eCG used in 
combination the FSH.  The yield in grade 1 embryos by using this approach was 444 
per 100 ewes superovulated.  This is considerably better than either eCG or FSH 
alone. 
 
2.11.2 The influence of the type and dose of superovulatory  
hormones on the incidence of premature luteal regression 
 
 
It is difficult to exclude the influence of nutritional factors when accessing the 
influence of the type and dose of superovulatory gonadotropins on the occurrence of 
premature luteal regression, since nutritional status may vary from animal to animal.  
However, it is generally accepted that the use of eCG and FSH in combination is 
associated with a higher incidence of premature regression than if only eCG or FSH 
is used alone.  Irrelevant of the type of gonadotropin used, the incidence of 
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premature regression increase with an increase of dose of the particular 
gonadotropin (see Tables 7 - 9). 
Table 7  The dose responsive increase in the incidence of premature luteal 
regression in eCG treated ewes [316, 350] 
 
Dose of eCG in IU Insidence of premature regression / ewes 
superovulated (%) 
Average 
0 1/32 (3%), 17/98 (17 %), 10 % 
400 2/15 (13%) 13 % 
800 0/35 (0%), (30/104) (29%), 14.5 % 
1000 6/12 (50%), 1/10 (10%) 30 %% 
1200 4/4 (100%) 100 %* 
1600 12/34 (35 %), (38/97) (39%) 37 % 
 
This study by Cole (1975)[316] used a very small amount of experimental animals & and also used 16 day progesterone priming instead of 
the usual 10  or 12 days. 
 
Table 8 The dose responsive increase in the incidence of premature luteal 
regression in FSH treated ewes [316, 350] 
 
Dose FSH (mg) Incidence of premature regresion / ewes 
superovulated (%) 
Average 
0 13/101 (13%), 1/32 (3%) 8 % 
12 32/99 (32%), 7/32 (22%) 27 % 
18 40/99 (40%), 9/34 (26%) 33 % 
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Table 9 The dose responsive increase in the incidence of  premature luteal              
regression in ewes treated with a combination of eCG and FSH[316, 
350] 
 
Dose of eCG 
(IU) 
Dose of FSH-P (mg) 
 0 12 18 
0 1/32 (3%) 7/32 (22%) 9/34 (26%) 
800 0/35 (0%) 16/35 (46%) 14/34 (41%) 
1600 12/34 (35%) 9/32 (28%) 17/31 (55%) 
 
2.11.3 The influence of the day of administration of superovulatory 
hormones on the incidence of premature luteal regression 
 
In a study on ferral goats (Capra hircus), Armstrong et al (1982) studied the 
effect of the timing of the administration of eCG with regard to synchronisation with 
P4 pessaries [348]. In that study it was found that administration of eCG on the day 
of P4 pessary removal, the incidence of premature luteal regression was reduced 
compared to the traditional introduction of eCG two days before  P4 pessary removal.   
Interestingly in this study, the serum E2-17β values of the does where eCG was 
administered on the day of P4 pessary removal exceeded the values where eCG was  
administered two days before  removal of the pessaries (Figure 21).  These results 
were unexpected since E2-17β  plays an important role in the initiation of luteal 
regression at the end of the normal cycle if no embryo is present in the uterus. 
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Figure 21 Serum E2 - 17β levels (mean ± SD) in ferral does given 1000 IU eCG.  
Progestagen pessaries removed (PR) either at the same time or two 
days after treatment [348]  
 
2.12 Gonadotropin releasing hormone administration 
 
There is conflicting evidence in the literature on the influence of GnRH 
administration in addition to ECG with regard to the incidence of premature luteal 
regression.  The rational behind the use of GnRH or LH supplementation is that 
hyper-stimulated animals with more corpora lutea, might experience an LH shortage.  
This might lead to a sub-functional corpus luteum rather than a regressed corpus 
luteum. In the first four days after estrus there has to be adequate amounts of LH, 
because LH plays an important role in the completion of morphological development 
and establishment of intercellular channels formed by microvilli within the corpus 
luteum [353].  Some of the events that are mediated by LH includes the down 
regulation of C21- P450SCC in small luteal cells.  In large luteal cells, LH induces an 
enhancement of cholesterol availability and increased transcription of 3β -HSD. This 
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poses the question: Does depletion of  LH stores in superovulated animals lead to 
inadequate function?  
 
In 1991 Jabour et al reported that GnRH administration 24 hours after sponge 
removal had no effect on the incidence of ewes with regressed corpora lutea in 
either autumn or spring [296] in either the breeding and non-breeding season in 
superovulated sheep. In contrast to the findings of Jabour et al (1991), Armstrong et 
al (1982) found that administration of a synthetic LH releasing hormone 38 hours 
after ECG administration, improved the maintenance of corpora lutea by 20 % in 
ferral goats [348].  The actual measurement of LH profiles in Suffolk ewes showed 
that there was no significant difference in LH secretion between ECG treated ewes 
and control animals [354].  Thus, it appears that although LH deficiency may play a 
role in ferral goats, it doesn’t seem to be a factor in sheep. 
 
2.13 Implication of estrogen 
 
Particularly implicated in premature luteal regression, is E2-17β, secreted by 
large follicles that are stimulated over a prolonged period after ECG administration 
and which often fail to ovulate and luteinise [355-358].  Reports of the E2-17β profile 
of superovulated ewes vary dramatically.  This can be attributed to the fact that the 
concentration of E2-17β  in the peripheral circulation is very low, only to be measured 
with extremely sensitive radioimmunoassays.  Radioimmunoassays also differ with 
regard to specificity, and frequently this is not disclosed. These factors make it 
difficult to compare results between laboratories, but despite the technical problems, 
there seems to be consensus that E2-17β levels are significantly greater in 
superovulated sheep ewes compared to normal cycling ewes (Figure 22). 
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Figure 22 Serum E2-17β profiles of ewes superovulated with 1000 IU ECG 
compared to normal cycling ewes not treated with ECG [48, 355]. 
 
 
 
There are also differences between species.  The increased response in E2-
17β  secretion to superovulation with ECG is more profound in ferral goats [251] 
(Figure 21).  In this latter report E2-17β levels did not follow the normal pattern seen 
in sheep, but stayed elevated for a prolonged period. 
 
Administration of exogenous E2-17β is known to induce luteal regression in 
sheep [359] and in some wild deer species [253]  if administered during metestrus 
(day 3-5 of the estrous cycle).  It was shown by Bainbridge et al (1996) [253] working 
with Red Deer (Cervus elapus) that the highest incidence of premature regression 
occurred if eCG was administered in combination with estradiol benzoate (EDB). It 
must be mentioned that the dose used by Bainbridge et al (1996) [253] produced E2-
17β  peak levels ten times higher than those seen in eCG treated hinds.  
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 The luteolytic effect of E2-17β in sheep can be prevented by hysterectomy 
[359].  The role of E2-17β in normal regression at the end of the cycle involving 
PGF2α, is known.  A logical conclusion from the fact that E2-17β-induced regression 
could be prevented by hysterectomy, is that E2-17β induces premature luteal 
regression via up-regulation of rOx and the production and release of PGF2α. 
 
2.14 Implication of PGF2α
 
Although there was always the suspicion that PGF2α may be involved in 
premature luteal regression, because of it being the signal responsible for luteal 
regression at the end of the natural cycle, there was no scientific evidence published 
until 1988.  In 1988, Battye et al published a paper implicating the involvement of 
PGF2α in early regression in the superovulated ferral goat (Capra hircus)[360]. In 
their experiment Battye et al (1988) [360] used does of various ages treated with 
intravaginal P4 sponges for 16 days to synchronize estrus.  Two days before sponge 
removal the goats were given 1200 IU eCG to induce superovulation. The day of 
sponge removal was designated as day 0.  The experimental animals were divided 
into two groups.   Group 1 received no other treatment and served as controls. 
Group 2 received 2.2 mg / kg body mass flunixin meglumine (Finadyne: Schering, 
Heriot Agvet, Melbourne) intra muscular (i.m) every 12 hours starting on day 3 after 
sponge removal and finishing on day 7. Flunixin meglumine is a inhibitor of  
prostaglandin synthesis.  Like aspirin and indomethacin, it inhibits the enzyme 
prostaglandin-endoperoxide-synthase with a cyclooxygenase component that is 
responsible for the conversion of arachidonic acid to PGG2. The same enzyme with 
a peroxidase component convert PGG2 to PGH2 which serves as substrate for 
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endoperoxide reductase to produce PGF2α  (see section 2.4).  The hormone PGF2α 
is never stored in endometrial cells and is released after production.  The argument, 
therefore, was that if administration of flunixin meglumine prevents the occurrence of 
premature regression, it will prove that the phenomenon is caused by the premature 
release of PGF2α early in the cycle. 
 
At first glance the results obtained in this study appear very convincing.  All 
the control animals presented with premature luteal regression while all those 
treated with flunixin meglumine had functional corpora lutea on the 7th day after 
sponge removal.  In their paper the authors reported that 70 % of the does had 
premature ovulations before sponge removal.  The P4 concentration in animals with 
premature ovulations were significantly higher than the animals where no premature 
ovulations occurred (see Table 10). 
Table 10 Progesterone concentration (ng/ml) in superovulated ferral goats with 
and without premature ovulations on the first two days after sponge 
removal[360].
 
Day after sponge 
removal 
Progesterone 
concentration (ng/ml) in 
does with premature 
ovulations 
Progesterone 
concentration (ng/ml) in 
does without premature 
ovulations 
0 0.30 ± 0.05 0.08 ± 0.04 
1 1.08 ± 0.11 0.17 ± 0.05 
 
 
It is known that P4 stimulates the mobilization of amphipathic 
phosphoacylglycerols leading to the formation of lipid droplets in the cytoplasm.  The 
hydrolytic    action   of   P-lase   A2   will   yield    increased   free    arachidonic   acid.  
Armstrong  et  al  (1982) [251] reported increased estradiol concentrations over a 
prolonged period in ferral goats (see Figure 21).  E2-17β will activate r-E2-17β in the 
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endometrium, which will in turn lead to synthesis and up-regulation of rOx.   The 
increased number of rOx will make the endometrium more sensitive for basal levels 
of Ox. In order for arachidonic acid to be turned into PGF2α, three enzymes are 
necessary namely a) prostaglandin endoperoxide synthase with cyclooxygenase 
component, b) prostaglandin endoperoxide synthase with peroxidase component 
and  c) endoperoxide reductase.  It is not clear how these enzymes are regulated, 
but it seems likely that the activated rOx via the second messenger c-AMP, plays a 
role in their up-regulation.  Because of the similarity between prostaglandin 
endoperoxide synthase with the cyclooxygenase component and prostaglandin 
endoperoxide synthase with peroxidase component, they are possibly transcribed by 
the same gene. The two proteins resulting  from the process known as alternative 
splicing, allows one piece of unprocessed mRNA to code for more than one protein.  
The result would be the rapid production and release of  PGF2α.  Note that this 
process requires two sets of protein synthesis, namely the production of the rOx, and 
the enzymes responsible for the conversion of arachidonic acid to PGF2α. 
 
At first glance this hypothesis looks very convincing, but there are a few 
troublesome areas.  In the study by Battye et al (1988) [360], the experimental 
groups were small.  There were four animals in the control group (two had to be 
excluded because one animal didn’t superovulate and the other animal had 
adhesions that prevented clear visualization of the ovaries at laparascopy) and six 
animals in the group that received the flunixin meglumine.  The incidence of 
premature corpus luteum  regression in goats is in the order of 30 %, although it 
varies because of the influences of season, nutrition, and type and dose of 
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gonadotropin used.  It would be more convincing if bigger experimental groups were 
used.   
 
In their paper  Battye et al (1988) [360] used the pulmonary metabolite of  
PGF2α, namely PGFM, as a indication of PGF2α  synthesis and release, because 
unlike PGF2α, it can be easily detected in jugular venous blood.  As mentioned 
earlier in this chapter, the usefulness of PGFM measurements has been questioned 
[127].  It continues to be a point of controversy in this field, [361] since it also reflects 
turnover of other prostaglandins, produced at other sites in the body.  Battye et al   
(1988) [360] also stated that the RIA they used did not distinguish between PGFM 
and 13,14-dihydro-15-keto-PGF-1.  But despite these objections, the study 
presented with a major paradox in that two out of six animals that received the 
flunixin meglumine showed significant peaks of PGFM without a reduction in 
progesterone synthesis. These animals also did not show macroscopic signs of 
regression when examined by laparoscopy on the 7th day after sponge removal. 
 
Another point of concern is the occurrence of both normal and regressed 
corpora lutea in the red deer reported by Bainbridge et al   (1996)[253].  Induction of 
premature regression by administration of exogenous PGF2α always causes 
regression of all the corpora lutea present on the ovary.  This can be compared to 
natural regression at the end of the cycle which always causes total regression of all 
the corpora lutea present on both ovaries .  This raises the question: Is PGF2  really 
involved in the Red Deer and other animals? 
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There are definitive differences between species with regard to physiological 
mechanisms.  There are adequate examples of this fact in nature, but conceivably 
the best example for this argument is the different E2-17β patterns observed 
between superovulated goats and sheep (see Figures 21 and 22).  All the evidence 
for PGF2α involvement in premature regression is possibly limited to goat and deer 
species.  Although the hypothesis raised in this section seems very appealing, one 
must refrain from making generalizations across species.  More evidence is needed 
to unravel the mechanism of premature regression in the superovulated sheep ewe. 
 
Therefore the aims of the current thesis were: 
1. To try and unravel the mechanism behind premature luteal regression. 
 
2. To formulate a new hypothesis that explain the mechanism behind the 
phenomena. 
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Chapter 3 
 
PGF2α Induced Regression and Premature Luteal 
Regression: A Comparative Study 
 
3.1 Introduction 
 
Luteal regression at the end of the natural cycle of the sheep ewe is well 
characterized.  Knowledge on the mechanisms involved has grown tremendously 
from 1923 when Loeb made the observation that hysterectomy lengthens the 
lifespan of the corpus luteum [1].  Today it is known that the signal of uterine origin 
that is responsible for the initiation of luteal regression at the end of the natural cycle 
is PGF2α [2-38].  It is also known how PGF2α is synthesized [39], how secretion is 
controlled [40-71] and what pattern this hormone follows during the estrous cycle of 
the ewe [6, 72-90].  Maternal recognition of pregnancy is also well understood. The 
mechanism of how the presence of an embryo in the uterus inhibits PGF2α synthesis, 
and release, is clear [74-78, 91-98].   An antagonist of PGF2α, namely PGE2 ,has also 
been identified and it was shown that the embryo secretes this antagonist to prevent 
the actions of PGF2α [99-103]. The mechanism of PGF2α action on cellular and 
molecular level is still studied extensively and although a lot is known, the availability 
of molecular techniques will clarify the action of this hormone on luteal cells in the 
near future.  Chapter 2 Section A gives a brief review of what is now known of 
natural regression in the sheep ewe. 
 
In contrast to natural regression, literature on the phenomenon of premature 
luteal regression in superovulated sheep ewe is limited. Studies focussed primarily  
on the incidence of the phenomenon and factors influencing the incidence.  Several  
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factors have been identified, and include seasonal influences [104, 105], nutrition 
[104, 105], superovulatory hormone(s) used [106], timing of administration [107], the 
dose of superovulatory hormones, etc. [106].  The rational behind this approach is 
that the identification of a specific factor that influences the incidence could lead to 
the exact mechanism of the phenomenon.  A difficulty experienced with this 
approach is that  these factors are often dependent of other factors.     
 
Studies by Ryan et al [104] and Jabbour et al [105] have shown that the 
incidence of premature regression is higher in autumn (breeding season) than in 
spring (non-breeding season).  This finding was unexpected because during the 
non-breeding season (spring) the active suppression of the GnRH pulse generator 
by the E2-17β sensitive inhibitory neurons should be at it’s strongest.  The question 
was raised whether the effect observed by these authors, was not merely a 
nutritional effect, because pastures will carry higher nutritional value in spring than in 
autumn.  In their paper Jabbour et al [105] showed that they could reverse the effect 
of season by supplementation of the diet with lupin grains.  This illustrated the fact 
that some of these influences observed are not independent.  A problem with the 
use of lupin grains is that they alleviate E2-17β  levels [108, 109] complicating the 
scenario more because E2-17β  is also implicated in the phenomena in sheep [108, 
110],  goats [111],  deer species [112] and cows [113].  The first aim of this study is 
to clarify the effect of season and nutrition.                      
 
Since it is known that PGF2α is the signal of uterine origin, responsible for 
natural  luteal regression at the end of the estrous cycle of the ewe, it seems logical 
that this hormone could possibly be involved in premature regression.  Although 
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there is some convincing evidence that supports this hypothesis, there are 
unfortunately also some questions.  To add to the confusion, the evidence for the 
involvement of PGF2α in premature regression is limited to studies in deer species 
[112] and goats [114].  Chapter 2 section 2.14 gives a brief summary of the evidence 
for and against this hypothesis.   
 
Central to the PGF2α hypothesis is the role that E2-17β plays.  It is known that 
E2-17β levels are much greater  in superovulated goats if compared to unstimulated 
does [115].  Also the E2-17β  levels reported in superovulated ewes [110] differ from 
those reported in does [115]. Complicating the interpretation of E2-17β data are 
technical difficulties in the measurement of E2-17β.  The concentration of E2-17β in 
the peripheral circulation is very low ranging from 0 - 20 pg/ml in the superovulated 
sheep [110]  and 0 - 350 pg/ml in goats [115].  Even in the E2-17β pattern in 
untreated normally cycling ewes there is a degree of disagreement among scientists.  
It is generally agreed that the principal E2-17β rise occurs during the two to three-day 
follicular phase.  There is less agreement on whether or not significant increments in 
E2-17β secretion occur at other times of the cycle.  There have been several reports 
that E2-17β secretion peaks for a second time around the 4th day of the cycle [7, 109, 
116-119].  This increment, however, has not been observed in other studies [120, 
121] and does not occur in all animals [116-118].   
 
In 1996 Abbott diagnostics developed a Microparticle Enzyme Immunoassay 
(MEIA)  for E2-17β [122]  that uses a solution of suspended, submicron sized latex 
particles to measure E2-17β.  The particles are coated with a capture molecule for E2-
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17β.  The effective surface area of microparticles increases assay kinetics and 
decreases assay incubation time.  This results in a quicker E2-17β assay with higher 
accuracy and sensitivity.  By using this technology, and by comparing PGF2α 
induced regression, with premature luteal regression the present study finally aims to 
clarify the profile of E2-17β and critically evaluate the PGF2α hypothesis.  
 
Although the identification of factors that can influence the incidence of 
premature regression plays an important role in the identification of a possible 
mechanism for the phenomenon, it will always be limiting without functional 
physiological data like steroid profiles and tissue studies on microscopic and ultra 
structural level.  This study aims to breech this gap while addressing the questions 
mentioned. 
 
3.2 Materials & methods 
 
3.2.1 Experimental Animals and Experimental Design 
 
 
The study was conducted in spring (August – October 1996, non-breeding 
season) and autumn (March – May 1997, breeding season) at the Elsenburg 
experimental farm, near Stellenbosch in the Western Cape Province in South Africa.  
The farm is situated at 33’51 S, 18’50 O and is 177 metres above sea level.  The 
average rainfall is 605 mm per annum and the average temperature 16,8 ºC with 
wind speeds of up to 75 km per hour. 
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 Figure 23 Mutton Merino’s grazing on Kikuyu at Elsenburg Agricultural Farm, 
near Stellenbosch in the Western Cape Province in South Africa 
 
 
Mature Mutton Merino ewes (n = 50) were used in the experiment.  They were 
kept on   Kikuyo (Pennisetum clandestinum) pastures.  The ewes received oats hay 
(Avena sativa L.) and lucerne (Medicago sativa L. sativa) as additional feeding.   
 
The ewes were divided in two groups (n = 25).  Group A was superovulated in 
autumn (March – May 1996, breeding season) and group B in spring (August – 
October 1997, non-breeding season).  In group A, two animals had to be excluded 
because of retained intravaginal sponges. In group B, seven ewes were pregnant  
when the animals were  laprascopically  inseminated and had to be excluded. In 
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each group the ewes were subdivided in two further subgroups.  Subgroup one  (n = 
20) was treated with a progestagen-impregnated intravaginal sponge (Repromap TM 
60 mg, Upjohn,) for 12 days in combination with 1000 IU PMSG (Folligon) and 5 mg 
Estradiol Cypionate (ECP) (Pharmacia & Upjohn)  as an intramuscular injection.  
The PMSG was administered at 08h00 48 hours before sponge removal and the 
ECP at 08h00 24 hours after sponge introduction.  Subgroup two (n = 5) received a 
single intramuscular injection of 5 mg Lutalyze (Pharmacia & Upjohn) a PGF2α 
analogue (dinoprost promethamine) on the 6th day after sponge removal above the 
treatment of subgroup one.  The rational behind choosing (n=5) in subgroup two is 
that it was expected that 25% of the ewes would have premature regressed corpora 
lutea.  Ideally sample size between PGF2α  induced and premature regressed 
corpora lutea should be the same.  The same protocol was used for Group A and 
Group B. 
 
After the exclusion of the animals with retained intravaginal sponges and the 
ewes that were pregnant there were 23 ewes in Group A (n =18 in Subgroup one 
and n=5 in Subgroup two) and 18 ewes in Group B (n=16 in Subgroup one and n=2 
in Subgroup two). 
 
3.2.2 Macroscopic examination of ovaries 
 
The ovaries of all the ewes were removed 9 days after sponge removal when 
the ewes were slaughtered.  The ovaries were transported to the laboratory and 
inspected within two hours of removal.    Numbers of normal and regressed corpora 
lutea (CL) were recorded.  Small and pale CL were recorded as regressed CL.   The 
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total ovulatory response to the superovulatory treatment was given as the number of 
corpora lutea (normal and regressed) recorded.  Old corpora albicans were not 
recorded. 
 
3.2.3 Progesterone and estrogen analysis 
3.2.3.1 Blood Sampling 
Blood samples were collected from the jugular vein by venipuncture with a 18-
gauge needle in an SST (Serum Separating Tube) vacutainer (Becton 
Dickinson,MacMed South Africa).  Samples were collected at 24 hour intervals 
beginning at the time of sponge removal.  Serum was removed after centrifugation at 
300 x g and stored at – 10  ºC for later analysis for progestrogen and E2-17β by 
Microparticle Enzyme Immunoassay (MEIA). 
 
3.2.3.2 Microparticle Enzyme Immunoassay  
The Microparticle Enzyme Immunoassay (MEIA) described by Buster and 
Abraham [122] with slight modifications to compensate for the reference range of the 
hormones of interest in sheep. In short the MEIA technology uses a solution of 
suspended, submicron sized latex particles to measure analytes.  The particles are 
coated with a capture antibody specific for the analyte being measured.  The 
effective surface area of microparticles increases assay kinetics and decreases 
assay incubation time.  This permits MEIA assays to be completed in less time than 
other immunoassays. The concentrations of all reagents have been optimized by 
Abbot by tittering them out for use in diagnostic ranges [122]. 
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 The analysis was done on the Abbot AxSYM TM.  The reaction sequences are 
different for the E2-17β and P4 analysis and would be dealt with separately. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24 Typical MEIA schematic reaction sequence [122] 
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Figure 25 Immune complex bound to glass fibre matrix [122] 
 
The P4 assay uses a one step MEIA.  P4 reagents and sample are pipetted in 
the following sequence.  In the sampling centre serum, anti-P4: alkaline phosphatase 
conjugate and the progesterone buffer are combined in a well of the reaction vessel 
(RV).  The P4 microparticle reagent is added to a second well of the RV.  The RV is 
immediately transferred into the processing centre.  Further pipetting is done in the 
processing centre by the processing probe.   
 
In the processing centre the reaction mixture is incubated.  P4 in the sample 
binds to the anti-P4: alkaline phosphatase conjugate.  An aliquot of the reaction 
mixture is transferred to the well containing the P4 microparticle reagent.  The P4 
microparticle reagent binds to anti-P4: alkaline phosphatase conjugate not bound to 
P4 from sample, forming the final reaction mixture.  An aliquot of the final reaction 
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mixture is then transferred to the matrix cell.  The microparticles bind irreversibly to 
the glass fibre matrix.  The matrix cell is washed to remove unbound materials.  The 
substrate, 4-Methylumbelliferyl Phosphate (MUP), is added to the matrix cell and the 
rate of conversion to the fluorescent product Methylumbelliferone (MU) is measured 
by the optical system.  In samples with low progesterone concentrations lower anti-
P4: alkaline phosphatase conjugate will bind to the P4 microparticles.  This will result 
in a longer time to complete the reaction from MUP to MU. 
 
The E2-17β assay uses a two step MEIA.  The AxSYM E2-17β reagents and 
sample are pipetted in the following sequence:   
 
In the sampling centre the serum and all the AxSYM  E2-17β reagents for one 
test are pipetted by the sampling probe into various wells of a RV.  Serum, anti- E2-
17β coated microparticles, E2-17β assay buffer and line diluents are combined in a 
well of the RV.  This is the reaction mixture.  E2-17β: alkaline phosphatase conjugate 
is added to a second well of the RV.  The RV is immediately transferred into the 
processing centre.  Further pipetting is done in the processing centre by the 
processing probe. 
 
In the processing centre the reaction mixture is incubated.  E2-17β in the 
serum binds to the anti- E2-17β on the microparticles forming an antibody-antigen 
complex.  After incubation, an aliquot of the reaction mixture is transferred to the 
matrix cell.  The microparticles bind irreversibly to the glass fibre matrix.  The matrix 
cell is washed to remove unbound materials.  E2-17β: alkaline phosphatase 
conjugate is then dispensed onto the matrix cell and incubated.  The steroid portion 
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of the conjugate binds to the available sites on the anti- E2-17β coated 
microparticles.  The matrix is washed to remove unbound materials. The substrate, 
MUP, is added to the matrix cell and the rate of conversion to the fluorescent product 
MU is measured by the optical system.  In samples with low estrogen concentrations 
lower anti- E2-17β: alkaline phosphatase conjugate will bind to the E2-17β 
microparticles.  This will result in a longer time to complete the reaction from MUP to 
MU. 
 
3.2.3.3 Calibration 
a) Progesterone 
 
 
A standard calibration for P4 on the AxSYM™ was performed.  Calibrator A 
contains stripped human serum non-reactive for antibodies to HIV1/HIV2 (Human 
Immune Deficiency Virus 1 and 2), HCV (Human Cytomegalo Virus) and non-
reactive for HbsAg (Hepatitus B Surface Antigen) by FDA  (Food and Drug 
Administration) licensed tests. Callibrators B through E contain P4 in TRIS buffer with 
chemical stabilizers and preserved in sodium azide to yield the following 
concentrations. 
 
Table 11 Progesterone calibrator concentrations 
 
Calibrator Progesterone 
 ng/ml nmol/l 
A 0 0 
B 0.7 2.23 
C 2 6.36 
D 7 22.26 
E 20 63.60 
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The reaction rate for each calibrator was determined in triplicate by a fluorescent 
detector.  The reaction rate was plotted on the y-axis and the concentration on the x-
axis.  Linear regression was performed fitting a straight line using least squares. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26 Calibration curve for progesterone analysis 
 
Line Fitted (Regression equation)   : y=(-24.57 X) + 496.38 
Intercept with y-axis     : 496.38 seconds 
Slope       : -24.57 
Coefficient of determination (R2)   : 0.99 
Coefficient of determination adjusted for small : 0.99  
sample size (R2adjusted) 
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Table 12 Calibration data for progesterone analysis 
 
Calibrator 1 2 3 Ave SD Fitted 
Rate 
Error 
in 
Fitted 
Rate 
 Span 
A 496.33 492.41 499.18 495.97 3.40 496.43 -0.46 A-B 16.15 
B 479.10 474.18 486.18 479.82 6.03 479.82 0.63 B-C 32.92 
C 447.18 442.31 451.21 446.90 4.46 447.28 -0.38 C-D 122.21
D 324.29 322.61 327.16 324.69 2.30 324.40 0.29 D-E 319.85
E 4.79 5.11 4.63 4.84 0.24 4.92 -0.09 A-E 491.13
 
Before a calibration could be accepted it had to comply to the following rules as well. 
a) The Standard deviation (SD) for the reaction rate for all five calibrators had 
to be less than 10 seconds. 
b) The error in the fitted rate had to be in the range 1.00 to –1.00. 
c) The span between calibrators had to be in the 95% confidence interval.  
The span ranges is as follows. 
A-B 6.72 – 25.58   seconds 
B-C 22.43 – 43.41  seconds 
C-D 115.45 – 128.97 seconds 
D-E 317.31 – 322.39 seconds 
A-E 487.49 – 494.77 seconds 
d) R2 adjusted  had to be ≥ 0.95. 
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b) Estrogen 
The calibration curve for E2-17β was adjusted from the standard calibration 
for estrogen on the AxSYM™ system.  This was done because the range of 
measurements for humans (38 pg/ml - 300 pg/ml for normal menstruating females, 
and up to 1500 pg/ml for females on fertility treatment) differs from that of the sheep 
in this experiment  (2.7 pg/ml  - 16 pg/ml).  The adjustment was made to make the 
analysis more sensitive to the range of measurements to show significant 
differences from day to day in estrous cycle of the sheep. 
 
In short, five calibrators were used that contained E2-17β, TRIS buffer, a protein 
stabilizer (bovine) and sodium azide as preservative. The concentration of the 
calibrators was standardized with gas chromatography/mass spectrometry (GC/MS).  
The concentration of the calibrators was as follows: 
 
Table 13 Estrogen calibrator concentrations 
 
Calibrator 
 
Estradiol Concentration 
 pg/ml pmol/l 
A 0 0 
B 5 18.35 
C 10 36.70 
D 15 55.05 
E 20 73.40 
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The reaction rate for each calibrator was determined in triplicate by a fluorescent 
detector.  The reaction rate was plotted on the y-axis and the concentration on the x-
axis.  Linear regression was performed fitting a straight line using least squares. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 Calibration curve for estrogen analysis 
 
Line Fitted (Regression equation)   : y=(-3.753 x 10-4X) + 704.404 
Intercept with y-axis     : 704.404 seconds 
Slope       : -3.753 x 10-4
 R2       : 0.989 
R2adjusted      : 0.982  
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Table 14 Calibration data for estrogen analysis 
 
Calibrator 1 2 3 Ave SD Fitted 
Rate 
Error in 
Fitted 
Rate 
 Span
A 704.32 704.99 704.01 704.44 0.50 704.10 0.34 A-
B 
1.23 
B 703.04 703.41 703.18 703.21 0.19 703.09 0.12 B-
C 
1.65 
C 701.78 701.71 701.18 701.56 0.33 701.77 -0.21 C-
D 
1.21 
D 700.51 700.18 700.36 700.35 0.17 700.45 -0.10 D-
E 
1.07 
E 699.24 699.18 699.43 699.28 0.13 699.13 0.15 A-
E 
5.16 
 
Before a calibration could be accepted it had to comply to the following rules as well. 
a) The SD for the reaction rate for all five calibrators had to be less than 0.65 
seconds. 
b) The error in the fitted rate had to be in the range 0.50 to –0.50. 
c) The span between calibrators had to be in the 95% confidence interval.  The 
span ranges is as follows. 
A-B 0.54 – 1.92   seconds 
B-C 1.13 – 2.17   seconds 
C-D 0.71 – 1.71  seconds 
 Page 122 
D-E 0.77 – 1.37  seconds 
A-E 4.53 – 5.79  seconds 
 
d) R2 adjusted had to be ≥ 0.95. 
 
3.2.3.4 Specific performance characteristics 
3.2.3.4.1 Precision 
 
Precision was determined as described in the National Committee for Clinical 
Laboratory Standards (NCCLS) protocol EP5-T2 (including an estimate of between 
run and between day precision).  Three buffer based panel members (2,3 and 4) and 
one processed human serum-based panel members were assayed (1), in replicates 
of three, at two separate times per day, for 20 days, using a single lot of reagents 
and a single calibration per instrument. 
 
a) Progesterone 
Table 15 Progesterone precision determined by panel member 1 
 
Instrument N Mean Conc Value Inter-assay Intra-assay 
   SD %CV SD %CV
1 80 0.60 0.19 9.66 0.06 3.91 
2 80 0.54 0.13 7.06 0.06 2.86 
3 80 0.56 0.13 6.96 0.03 1.14 
4 80 0.54 0.16 9.58 0.06 2.85 
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Table 16 Progesterone precision determined by panel member 2 
 
Instrument N Mean Conc Value Inter-assay Intra-assay 
   SD %CV SD %CV
1 80 1.05 0.16 5.10 0.06 1.72 
2 80 0.99 0.16 5.42 0.09 1.94 
3 80 1.00 0.19 5.63 0.05 1.83 
4 80 0.97 0.13 4.22 0.16 5.01 
 
Table 17 Progesterone precision determined by panel member 3 
 
Instrument N Mean Conc Value Inter-assay Intra-assay 
   SD %CV SD %CV
1 80 5.40 0.57 3.32 0.06 1.62 
2 80 5.58 0.51 2.84 0.38 2.23 
3 80 5.55 0.54 3.03 0.25 1.44 
4 80 5.66 0.54 2.92 0.19 0.91 
 
Table 18 Progesterone precision determined by panel member 4 
 
Instrument N Mean Conc Value Inter-assay Intra-assay 
   SD %CV SD %CV
1 80 21.67 3.21 4.62 0.98 1.41 
2 80 21.08 2.77 4.11 1.14 1.70 
3 80 21.33 2.73 4.00 1.84 2.70 
4 80 21.90 2.54 3.61 1.81 2.53 
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Based on the available data the inter- and intra-assay coefficients of variation (CV) 
were 4.82% and 2.22% respectively. 
 
b) Estrogen 
 
Table 19 Estrogen precision determined by panel member 1 
 
Instrument N Mean Conc Value Inter-assay Intra-assay  
   SD %CV SD %CV
1 80 5.41 5.42 10.92 3.11 6.43 
2 80 4.49 4.42 8.54 1.44 2.66 
3 80 5.22 5.24 10.67 2.00 3.11 
4 80 4.82 4.89 9.55 2.77 5.21 
 
Table 20 Estrogen precision determined by panel member 2 
 
Instrument N Mean Conc Value Inter-assay Intra-assay 
   SD %CV SD %CV
1 80 24.11 6.32 7.11 3.12 3.22 
2 80 25.34 5.32 5.86 3.00 3.39 
3 80 23.11 5.91 6.98 2.55 2.90 
4 80 24.11 5.33 5.81 3.99 4.31 
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Table 21 Estrogen precision determined by panel member member 3 
 
Instrument N Mean Conc Value Inter-assay Intra-assay  
   SD %CV SD %CV 
1 80 87.11 13.91 4.30 8.56 2.66 
2 80 85.23 8.63 2.77 7.52 2.44 
3 80 83.22 12.87 4.25 5.41 1.89 
4 80 87.22 10.91 3.48 6.22 4.11 
 
Table 22 Estrogen precision determined by panel member 4 
 
Instrument N Mean Conc Value Inter-assay Intra-assay  
   SD %CV SD %CV 
1 80 204.13 13.21 6.62 10.93 6.51 
2 80 208.43 12.77 7.21 11.16 7.60 
3 80 204.59 8.73 8.40 9.84 8.72 
4 80 206.88 7.54 7.67 8.81 7.53 
 
Based on the available data the inter- and intra-assay CV were 6.88% and 4.54% 
respectively. 
 
3.2.3.4.2 Recovery 
a) Progesterone 
Known concentrations of P4 were added to 3 normal human serum samples. 
The concentration of P4 was determined using the AxSYM P4 assay and the 
resulting percent recovery was calculated. 
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Equation 1 Progestrone recovery 
 
% Recovery =  Progestrone Value Observed – Endogenous Level  x 100 
     Progesterone added 
 
Table 23 Recovery of exogenous progesterone added to biological specimens 
 
Sample Endogenous 
level ng/ml 
Progesterone 
added ng/ml 
Progesterone 
observed ng/ml 
% 
Recovery
1 7.60 4.84 12.47 100.6 
2 4.38 9.72 13.97 98.7 
3 4.38 9.72 14.21 100.1 
 
Based on the available data the average recovery was 99.8% 
 
b)  Estrogen 
 
Known concentrations of E2-17β were added to 3 normal human serum 
samples. The concentration of E2-17β was determined using the AxSYM E2-17β 
assay and the resulting percent recovery was calculated. 
Equation 2 Estrogen recovery 
 
% Recovery =  Estrogen Value Observed – Endogenous Level  x 100 
     Estrogen added 
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Table 24 Recovery of exogenous estrogen added to biological specimens. 
 
Sample Endogenous 
level ng/ml 
Progesterone 
added ng/ml 
Progesterone 
observed ng/ml 
% 
Recovery
1 15.99 5.00 21.12 100.6 
2 5.99 15.00 20.71 98.7 
3 21.00 20.00 42.11 100.5 
 
Based on the available data the average recovery was 99.9% 
 
3.2.3.4.3 Sensitivity 
a) Progesterone 
The sensitivity of the AxSYM P4 assay was calculated to be better than or 
equal to 0.20 ng/ml (n=36 runs in replicates of 10).  The sensitivity is defined as the 
concentration at two standard deviations from the AxSYM P4 calibrator A (0 n/mol/l) 
and represents the lowest concentration of P4 that could be distinguished from zero. 
 
b) Estrogen 
Based on the modified calibration, the sensitivity of the AxSYM E2-17β assay 
was calculated to be better than or equal to 1.5 pg/ml (n=40 runs in replicates of 10).  
The sensitivity is defined as the concentration at two standard deviations from the 
AxSYM E2-17β calibrator A (0 n/mol/l) and represents the lowest concentration of E2-
17β that could be distinguished from zero. 
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3.2.3.4.4 Specificity 
a) Progesterone 
The specificity of the AxSYM P4 assay was determined by studying cross-
reactivity of the following compounds.  The AxSYM P4 calibrator A was spiked with 
1000 ng/ml of the test compound and assayed for P4. The percent cross-reactivity of 
the compounds is listed for the AxSYM P4 assay. 
 
Table 25 Cross-reactivity of progesterone related compounds in the Abbott 
AxSYM progesterone MEIA assay 
 
Compound % Cross-
reactivity 
Corticosterone 2.1 
11-Deoxycorticosterone 1.3 
17-Hydroxyprogesterone acetate 1.4 
20α-Dihydroxyprogesterone 0.4 
20β-Dihydroxyprogesterone 2.2 
17-Hydroxyprogesterone 0.8 
5α-Pregnan-3,20-dione 6.3 
5α-Pregnan-3α-ol-20-one 1.7 
5-Pregnan-3-ol-20-one 3.2 
Pregnenolone 0.2 
Pregnenolone-3-s 0.5 
Pregnanolone 1.5 
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b) Estrogen 
 
Table 26 Cross-reactivity of estrogen related compounds in the modified Abbott 
AsXYM estrogen MEIA assay 
 
Compound % Cross-reactivity 
Estrone 0.1 
Estriol 0.1 
Ethinyl Estradiol 0.1 
17α-Estradiol 0.1 
Estradiol-3-glucuronide 0.0 
Estradiol-17-glucuronide 0.0 
Estradiol-3-sulfate 0.0 
Estradiol-16-glucuronide 0.0 
Estradiol-17-proprionate 0.3 
Estradiol-17-valerate 0.1 
Ethisterone 0.0 
Mestranol 0.0 
Norethindrone 0.0 
Norethynodrel 0.0 
Norgestrel 0.0 
Danazol 0.0 
Equilenin 0.1 
Equilin 0.0 
DHEAS 0.0 
Androstene-diol 0.0 
19-Nortestosterone 0.0 
DHT 0.0 
Testosterone 0.0 
Corticosterone 0.0 
11-Deoxycorticosterone 0.0 
11-Deoxycortisol 0.0 
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The specificity of the modified AxSYM E2-17β assay was determined by 
studying cross-reactivity of the above mentioned compounds.  The AxSYM E2-17β 
calibrator A was spiked with 1000 ng/ml of the test compound and assayed for E2-
17β. The percent cross-reactivity of the compounds is listed for the AxSYM E2-17β 
assay. 
 
3.2.3.4.5 Interference 
a) Progesterone 
Interference from billirubin, hemoglobin and triglycerides was studied in the 
AxSYM P4 assay.  A human serum specimen was spiked with the interfering 
substance and assayed for P4.  The AxSYM P4 assay demonstrated the interference 
stated in the following table. 
Table 27 Interference from billirubin, hemoglobin and triglycerides in the Abbott 
AxSYM progesterone MEIA assay 
 
Sample 
Progesterone 
Concentration 
ng/ml 
Interfering 
Substance 
Interfering 
Substance 
Concentration 
% Interference 
6.53 Billirubin 15 mg/dl <5 
6.25 Hemoglobin 1 g/dl <5 
34.5 Triglycerides 2000 mg/dl <10 
 
b) Estrogen 
Potential interference from billirubin, hemoglobin and triglycerides was studied 
in the modified AxSYM E2-17β assay.  The modified AxSYM E2-17β assay 
demonstrated the interference stated in the following table. 
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 Table 28 Interference from billirubin, hemoglobin and triglycerides in the 
modified AxSYM estrogen MEIA assay 
 
Sample Estrogen 
Concentration 
pg/ml 
Interfering 
Substance 
Interfering 
Substance 
Concentration 
% Interference 
10.56 Billirubin 15 mg/dl <10 
5.11 Hemoglobin 1 g/dl <10 
14.77 Triglycerides 2000 mg/dl <10 
 
3.2.3.5 Quality Control 
 
The multi-rule procedure developed by Westgard and associates [123] was 
utilized to verify the analytical correctness of the analytical procedure for both P4 and 
E2-17β. 
 
3.2.4  Histology 
3.2.4.1 Preparation and staining 
The ewes were slaughtered 9 days after sponge removal and their ovaries 
removed.  The ovaries were macroscopically inspected 2 hours after removal.  
Mased on the macroscopic appearance and treatment, five groups of corpora lutea 
were identified.   Taking into account macroscopic appearance and treatment five 
groups of corpora lutea were identified. 
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Group 1 Corpora lutea from ovaries where only normal appearing corpora lutea 
were present. 
 
Group 2 Corpora lutea from ovaries where only prematurely regressed corpora 
lutea were present. 
 
Group 3 Normal appearing corpora lutea from ovaries where regressed corpora 
lutea occurred with normal appearing corpora lutea (Mixed normal) 
 
Group 4 Regressed corpora lutea from ovaries where regressed corpora lutea 
occurred with normal appearing corpora lutea (Mixed regressed) 
 
Group 5 Corpora lutea from ovaries where regression was induced with the 
PGF2α analogue Dinoprost tromethamine (Lutalyse ®, Pharmacia & 
Upjohn). 
 
Five corpora lutea from each of these five groups were randomly selected 
using random numbers generated.  These corpora lutea were removed from the 
ovary with a scalpel blade and fixed in formal-saline for 24 hours.  The (formal-
saline) fixed corpora lutea were then processed with a Tissue Tek II automatic tissue 
processing system.  The tissue was dehydrated in a graded alcohol series for 12 
hours 30 minutes, cleared in xylol for 3 hours 30 minutes and impregnated in paraffin 
wax (Histosec paraffin wax with a melting point of 56 – 58 °C) for 4 hours.  The 
paraffin impregnated tissue was then mounted in wax blocks and air bubbles were 
removed with a vacuum pump. (Townson & Mercer)  Tissue were sectioned with an 
 Page 133 
Optolab 820 microtome (Optolabor, Braamfontein, Johannesburg, South Africa) at 5 
μm and stained with haematoxylin and eosin for evaluation of apoptotic nuclei and 
with Masson’s trichrome stain for connective tissue replacement. 
 
3.2.4.2 Evaluation of apoptotic nuclei 
Five haematoxylin and eosin stained sections were examined by three 
technologists in each of the five defined groups.  The technologists did not know to 
what group a particular slide belonged when they examined it.  The number of 
apoptotic nuclei per field at 400 times enlargement on a light microscope (Olympus 
EC-2) was recorded.  Ten fields per section were scored by each technologist and 
the average per section was calculated.  These averages were then used to 
calculate means and SEM’s for the five sections in each group. 
 
A 
 
 
 
 
 
 
 
 
 
 
Figure 28 Apoptotic nuclei (A) are indicated by the arrows (H & E at 400 times 
enlargement) 
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3.2.4.3 Evaluation for connective tissue replacement 
Five sections stained with Masson’s trichrome stain were examined by three 
technologists in each of the defined groups.  The technologists did not know to what 
group a particular slide belonged when they examined it.  Three categories of 
connective tissue infiltration were defined and a numerical value assigned to every 
category.  Connective tissue stains green with Masson’s trichrome stain.  The 
defined categories are: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29 Category 1: Little or no connective tissue infiltration.  This amount of 
connective tissue is present in healty normal functioning corpora lutea 
 Numerical value : 1 
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Figure 30 Category 2: Moderate connective tissue infiltration 
 Numerical value: 2 
 
 
 
 
 
 
 
 
 
 
 
Figure 31 Category 3: Extensive connective tissue infiltration 
  Numerical value: 3 
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  All three technologists scored a particular slide and an average score 
was calculated.  Using these averages, means and SEM’s were calculated for the 
five slides in each one of the five groups. 
 
3.2.5 Scanning Electron Microscopy  
Ultra structural analysis was done on a JOEL JSM – 6100 scanning electron 
microscope equipped with a cryotrans system. 
 
3.2.5.1 Selection 
One formalin-saline fixed corpora lutea were obtained from each of the following 
three groups. 
 
Group 1 Corpora lutea with normal appearing corpora lutea. 
 
Group 2 Corpora lutea with prematurely regressed corpora lutea. 
 
Group 3 Corpora lutea where regression was indused with the PGF2α analogue 
dinoprost tromethamine (Lutalyse ®, Pharmacia & Upjohn). 
 
3.2.5.2 Preparation 
a) The tissue was cut with a scalpel blade into a pyramid form with a base of 
5 mm x 5mm and a height of 7mm. 
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b) The tissue was then bonded to the specimen holder at the base of the 
pyramid with Silver DAG in MIBK (Wirsam) followed by a 5 minute wait for 
the DAG to dry. 
 
Figure 32 A range of specimen holders for the CT 1500 cryotrans 
 
 
c) The specimen holder was then connected to the vacuum transfer device. 
d) Using the vacuum transfer device, the tissue was then inserted in a 
slushing chamber and cooled with liquid nitrogen under a vacuum of 0.1 
mBar to –200 °C. 
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e) Following the initial cooling in the slushing chamber the specimen was 
transferred with the vacuum transfer device to the preparation chamber 
while the vacuum of 0.1 mBar was kept constant. 
 
Figure 33  The vacuum transfer device used to transfer the liquid nitrogen cooled 
specimen to the slushing chamber at – 200 °C 
 
f) In the preparation chamber under a vacuum 0.1 mBar the tissue was 
heated to –70 °C. 
g) Once the temperature was stable at – 70 °C the apex of the pyramid was 
fractured with the fracturing device. 
h) The fractured tissue was then transferred to the microscope stage with the 
vacuum transfer device and heated to –40 °C to dehydrate the tissue 
surface. 
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 Figure 34  CT 1500 preparation chamber and gold stage nitrogen dewar with 
transfer device interfaced to an scanning electron microscope chamber 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 35 Cr 15-318 fracturing and honing device 
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i) Using the vacuum transfer device the dehydrated tissue was transferred to 
the preparation chamber where the tissue was coated with 24 ct scanning 
electron microscope gold. 
j) Using the vacuum transfer device the gold coated tissue was transferred 
to the microscope stage and the tissue was examined at low tension of 4 
kV (tension would normally be 8kV). 
 
3.2.5.3 Evaluation of stage of apoptosis 
 
By using a scanning electron microscope the morphological changes 
involving the nucleus, cytoplasm and plasma membrane [124] were studied.  The 
progression of apoptosis follows a specific pattern with distinct stages and events 
that can clearly be identified by using a scanning electron microscope [125]. 
Characteristic scattered single cells, rather than groups of contiguous cells showing 
signs of apoptosis were observed.  No signs of associated inflammation as seen in 
necrosis were observed. To be able to compare the progression of apoptosis 
between the three groups,  three morphological stages of apoptosis were identified. 
 
Stage 1 
 
During the first stage apoptotic cells round up, loose contact with neighbours 
and condense or shrink.  This is why the phenomenon was originally called 
“shrinkage necrosis” [126]. During this shrinkage they loose surface features such as 
microvilli and desmosomes [127] (figure 36).  This stage is characterised by the loss 
of water.  This lead to compaction of the cytoplasm, which results in an increased 
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cell density. On occasion the cells may collapse and appear flattened (figure 37).  
On an intracellular level chromatin appears to condense and aggregates into dense 
compact masses along the margin of the nucleus, a process often referred to as 
margination of chromatin (figure 38).  The endoplasmic reticulum including the outer 
nuclear envelope dilates.  The cisternae of the reticulum swell to form vesicles and 
small vacuoles, many of which fuse with the plasma membrane, giving the apoptotic 
cell a characteristic spongy appearance [128] (figure 37). 
 
 
 
 
 
 
 
 
 
 
 
 
 
MV 
S
Figure 36 Early shrinking apoptotic cell rounding up and loosing contact with 
neighbouring cells. During this shrinkage they loose surface features 
such as microvilli (MV) and desmosomes. Notice the spongy 
appearance (S) typical of this early stage 
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Figure 37 Collapsing early shrinking apoptotic cell.  During early apoptosis cells 
loose water, leading to increased cell density and sometimes 
collapsing into flattened cells as can be seen here 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M 
NE 
Figure 38 Margination of chromatin (M) and dilation of the nuclear envelope (NE) 
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Stage 2 
 
 Stage two is characterised by extensive intracellular remodelling.  There is a 
rapid loss of the cytoskeleton due to hydrolytic and degrading enzymes.  These 
include RNAase leading to rapid lysis of ribosomal and messenger RNA, acid 
phosphatase, collagenase, cathepsins and proteases like the Caspases.  However 
these enzymes are contained in large vacuoles.  Membranes bud around these 
vacuoles leading to the formation of discrete apoptotic bodies enclosed by a cell 
membrane (See figure 39).  These bodies sometimes enclose well preserved 
organelles like mitochondria which plays a vital role in controlling the process[129] 
(figure 40).  The containment of the dangerous enzymes prevents damage to 
surrounding cells typical of necrosis. 
 
 
 
 
 
 
 
 
 
 
 
MV 
BM 
OR 
Figure 39 Stage 2 apoptotic cell displaying large membrane bound vacuoles 
(MV) with well-preserved organelle remnants (OR).  The cell 
membrane buds (BM) around these vacuoles to prevent leaking of 
proteolytic enzymes 
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Figure 40 Well-preserved mitochondria inside apoptotic vesicles.  Note the 
clearly visible cristae and matrix 
 
 
Stage 3 
 
 During this stage the plasma membrane becomes active and convoluted, 
eventually budding or “blebbing” in such a way that the cell breaks up in a florid 
manner leading to a falling away (or, in Greek, apoptosis) of several membrane-
bound spheres or apoptotic bodies of various sizes.  Under physiological conditions 
these bodies remain viable and will exclude vital dyes such as trypan blue or 
nigrosine (figure 42). 
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AB 
 
Figure 41 Blebbing apoptotic cell with several membrane bound apoptotic bodies 
of various sizes visible (AB) 
 
In each of the three groups 100 cells were scored as either normal or stage 1-3 
apoptotic. 
 
3.2.6 Statistics methodology 
3.2.6.3 Incidence of premature regression 
The Fisher’s exact test was carried out to determine if there was any 
significant differences in the incidence of premature luteal regression and mixed 
cases between the breeding and non-breeding season.  The test was performed on 
the NCSS 2000 software and a p-value of P<0.05 were considered  significant. 
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 3.2.6.4 Ovulatory response 
A Chi-Squire test (4x2 matrix) was carried out to determine if there was a 
statistically significant difference in the amount of corpora lutea recorded between: 
 
a) animals with only normal appearing corpora lutea, 
b) animals with only premature regressed corpora lutea, 
c) animals with PGF2α induced regression and 
d) animals with both normal and regressed corpora lutea. 
 
The tests were done on the NCSS 2000 software. A value of p< 0.05 was 
considered statistically significant. 
 
3.2.6.5 Steroidogenic profiles 
The progesterone, estrogen and progesterone : estrogen ratios were 
compared separately.   The comparison was done by three-way analysis of variance 
(2 x 4 x 10 matrix).  It was done for both the breeding and non-breeding seasons 
between: 
 
a) animals with only normal corpora lutea, 
b) animals with only premature regressed corpora lutea, 
c) animals with PGF2α induced regression and  
d) animals with both normal and regressed corpora lutea. 
 
 Page 147 
The analysis also extended for ten days from the day of sponge removal (day 
0) to 9 days after sponge removal.  The test was done on NCSS 2000 software with 
a P-value of  P<0.05 considered statistically significant. 
 
The correlation between the estrogen levels on the 6th day after sponge 
removal and the progesterone on the 7th day after sponge removal were done by 
means of regression analysis using the least squares method on the NCSS 2000 
software.  A R2 of ≥ 0.9 was considered an indication of a correlation between the 
two parameters.  The analysis were carried out for linear, logarithmic, exponetial and 
powered mathematical models. 
  
3.2.6.6 Histology 
3.2.6.6.1 Evaluation of the number of apoptotic nuclei 
The five group means of the number of apoptotic nuclei recorded per 100 
evaluated cells were compared by one-way analysis of variance with a P-value of 
<0.05 considered as significant.  Once significant difference among group means 
were established, the Tukey-Kramer adhock test was performed to examine all 
possible comparisons among the five means. The analysis was done on the NCSS 
2000 software. 
 
3.2.6.6.2 Evaluation of the amount of connective tissue infiltration 
The five group means of the relative connective tissue infiltration were 
compared by means of one-way analysis of variance with a P-value of <0.05 
considered as statistically significant.  Once it was established that the group means 
do differ significantly the Kruskal-Wallis Z adhock test were performed to examine 
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all possible comparisons among the five means.  This was done since the data was 
discrete with only three possible categories possible. The analysis was done on 
NCSS 2000 software. 
 
3.2.6.7 Scanning Electron Microscopy 
 
 Two-way analysis of variance were performed in a 5 x 4 factorial design with 
p<0.05 considered statistically significant.  Following the establishment of significant 
differences between the stage of apoptosis between the five defined groups, a 
Tukey-Kramer adhock test was performed to establish all possible comparisons 
between the five defined groups and four defined stages of apoptosis with P<0.05 
considered statistically significant. The analysis was done on the NCSS 2000 
software. 
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3.3 Results 
 
3.3.1 Occurrence of premature luteal regression 
  
22%
67%
11%
Premature Regressed CL's Normal Functioning Cl's Premature Regressed & Normal Functioning Cl's
 
 
 
 
 
 
 
 
Figure 42 Incidence of premature luteal regression in ewes superovulated in the 
breeding season (Autumn, August-October 1996) 
 
 
 
 
 
 
 
 
 
igure 43 Incidence of premature luteal regression in ewes superovulated in the 
non-breeding season (Spring, March-May 1996) 
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 There were no significant differences in the incidence of premature luteal 
gression (p>0.05) and the incidence of mixed cases (both normal and regressed 
l’s) between the breeding and non-breeding season.  Superovulated Mutton Merino 
wes received no grain supplementation in the breeding season.  In both the 
reeding and non-breeding season about one third of the ewes showed signs of 
remature regression. This attributes to substantial losses in viable embryo’s. 
.3.2 Ovulatory response 
ormal 
ppearing and regressed corpora lutea (P=094, P=0.91).  There was no significant 
 corpora lutea recorded between ewes with only 
prema
re
C
e
b
p
 
3
The number of corpora lutea recorded between ewes superovulated in the 
breeding season and the non-breeding season (P=0.96).  In the ewes with only 
normal appearing corpora lutea in both the breeding season and non-breeding 
season, there was no significant difference in the number of corpora lutea recorded 
compared with ewes with only premature luteal regression (P=0.93,P=0.98), ewes 
with PGF2α induced regression (P=0.80, P=0.87) and ewes with both n
a
difference in the number of
ture regression in the breeding season and the non-breeding season and 
ewes with PGF2α induced regression (P=0.65, P=0.85) and ewes with both normal 
appearing and regressed corpora lutea (P=0.85, P=0.67).  Finally there was no 
significant difference in the amount of corpora lutea recorded between ewes with 
PGF2α induced regression and ewes with both normal appearing and regressed 
corpora lutea (P= 0.77, P=0.79).  Thus, it appears that the response to 
superovulation with eCG was similar in the breeding and non-breeding season. 
 
 Page 151 
Table 29 Ovulatory response in Mutton Merino ewes superovulated in the 
breeding season  
Category of response No. of 
ewes 
Ovarian response in numbers of 
corpora lutea Cl’s (Mean ± SEM) 
  Left ovary Right ovary Total 
Normal Cl’s 12 3.5 ± 0.8 4.2 ± 1.2 7.7 ± 1.1 
Premature regressed Cl’s 4 5.1 ± 1.4 4.2 ± 1.2 9.3 ± 1.3 
5 4.2 ± 0.9 4.0 ± 0.8 8.2 ± 0.9 PGF2α induced regression 
Mixed response 2    
Normal Cl’s  2.4 ± 1.2 2.6 ± 2.0 5.0 ± 1.8 
Premature regressed Cl’s  2.1 ± 1.2 2.4 ± 1.6 4.5 ± 1.4 
Total Cl’s  4.5 ± 1.2 5.0 ± 1.8 9.5 ± 1.5 
 
Table 30 Ovulatory response of ew  supero  the ing ses vulated in  non-breed eason 
Category of response No. of 
ewes 
Ovarian re  numsponse in bers of 
corpora lu ea Cl’s (Mean ± SEM) t  
  Left ovary Right ovary Total 
Normal Cl’s 10 4.0 ± 1.6 3.8 ± 2.4  7.8 ± 2.6 
Premature regressed Cl’s 3 4.3 ± 0.6 6.0 ± 4.0 10.3 ± 4.0 
3 3.6 ± 0.6 4.7 ± 3.1  8.3 ± 3.5 PGF2α induced regression 
Mixed response 2    
Normal Cl’s  2.0 ± 1.4 2.0 ± 0.0  4.0 ± 1.4 
Premature regressed Cl’s  1.5 ± 2.1 4.5 ± 0.7  6.0 ± 2.8 
Total Cl’s  3.5 ± 0.7 6.5 ± 0.7 10.0 ± 1.4 
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 3.3.3 Steroidogenic profiles 
files 
rone profiles of the ewes superovulated in the breeding season 
gnificantly different from the pro pro he a
reeding sea on (P>0.05).  For the day of sponge remov
e was no significant difference in 
progesterone profiles between: 
a) animals with only normal appearing corpora lutea, 
b) animals with only premature regressed corpora lutea, 
c) animals with PGF  induced regression and 
d) animals with both normal and regressed corpora lutea. 
 
 
On the 7th, 8th and 9th day after the sponges were removed there were a 
ioned groups of animals (P<0.01).  The 
progesterone levels of the animals with only normal appearing corpora lutea were 
still increasing in the normal fashion.  The progesterone levels of the other three 
groups all showed a decline in progesterone concentration.  The decrease in 
progesterone concentration in the animals with only premature regressed corpora 
lutea was more profound than in the animals with PGF2α induced regression.  In 
animals with premature regressed corpora lutea progesterone levels dropped to 
baseline v
3.3.3.1 Progesterone pro
The progeste
were not si gesterone files of t nimals 
superovulated in the non-b s al 
up to 6 days after sponge removal ther
2α
significant difference between the four ment
alues (1 ng/ml) within 24 hours while it took 72 hours in the ewes where 
regression were induced with the PGF2α analogue (dinoprost promethamine) until 
there were no significant difference between these two groups on day 9 (P>0.05).  In 
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the cases where regressed corpora lutea occurred with normal appearing corpora 
lutea there were an initial drop in progesterone after which the progesterone level 
was maintained at a lower concentration than the ewes with only normal appearing 
corpora lutea (P<0.01).  These trends were the same in the breeding and non-
breeding season (figures 44and 45). 
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Figure 44 Progesterone profiles of ewes superovulated in the breeding season 
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Figure 45 Progesterone profiles of ewes superovulated in the non-breeding 
season 
 
 
3.3.3.2 Estrogen profiles 
The estrogen profiles of the ewes superovulated in the breeding season were not 
significantly different from the E2-17β profiles of the animals superovulated in the 
non-breeding season (P>0.05).  From the day of sponge removal up to the 8th day 
after sponge removal there were no significant differences in the E2-17β profiles 
between: 
 
a) animals with only normal appearing corpora lutea, 
b) animals with only premature regressed corpora lutea, 
c) animals with PGF  induced regression and 
d) animals with both normal and regressed corpora lutea. 
 
2α
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 On the 9th day after the sponges were removed, there was a significant 
s groups (P<0.01).  The E2-17β levels of the animals 
with
lly come into oestrus 24 to 48 hours after sponge removal).  The peak E2-
7β levels ranged from 12.0 – 14.8 pg/ml higher than those observed in untreated 
ew n the 3rd day after sponge 
rem at baseline until the 5th 
day ponge removal (± 4th day of the 
est β (P<0.01) confirming 
ndings. 
e
difference between the animal
 only premature regressed corpora lutea started to increase while the E2-17β 
levels of the other groups were still at baseline levels. In all the ewes tested from all 
four groups in both the breeding and non-breeding season, the first principal rise 
peaked on the 2nd day after sponge removal (±day 0 of the estrous cycle, because 
ewes usua
1
es with peak levels ranging from 6.2 – 10.0 pg/ml.  O
oval estrogen levels dropped to baseline and remained 
 after sponge removal.  On the 6th day after s
rous cycle) there was a significant additional rise in E2-17
fi
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 46 Estrogen profiles of ewes superovulated in the breeding season. 
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Figure 47 Estrogen profiles of ewes superovulated in the non-breeding season. 
onfirming findings in some other studies [7, 118-121].  Peak E2-17β levels ranged 
om 5.4 – 8.2 pg/ml in this additional rise.  On the 7th day after sponge removal E2-
7β returned to baseline (figures 46 and 47). 
.3.3.3 Progesterone:Estrogen ratio on molar base 
The P4:E2-17β ratio on a molar base of the ewes superovulated in the breeding 
season were not significantly different from the P4:E2-17β ratio’s of the ewes 
superovulated in the non-breeding season (P>0.05).  From sponge removal up to the 
6th day after sponge removal there were no significant difference in the P4:E2-17β 
ratio’s between: 
 
 
c
fr
1
 
3
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a) animals with only normal appearing corpora lutea, 
b) animals with only premature regressed corpora lutea, 
c) animals with PGF2α induced regression and 
d) animals with both normal and regressed corpora lutea. 
 
On days 7, 8 and 9 all the groups differed significantly from each other with respect 
to their P4:E2-17β ratio on a molar base except for animals with premature luteal 
regression and animals with PGF2α induced regression on day 9 after sponge 
removal where there was no significant difference on that particular day (P>0.05) 
(see figures 48 and 49). 
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Figure 48 Profiles of the progesterone/estrogen ratio on a molar base in the 
 
 
breeding season 
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 Profiles of the progesterone/estrogen ratio on a molar base in the non-
breeding season 
 
 
 
 
3.3.3.4 Correlation of peak estrogen concentration on the 6th day after sponge 
removal and progesterone concentration on the 7th day after sponge 
removal 
 
 
 The onset of the decline in P4 levels in animals that presented signs of 
premature regression in both the breeding and the non-breeding season coincided 
with the E2-17β peak  on the 6th day after sponge removal.  There was, however, no 
correlation between the peak E2-17β level on the 6th day after sponge removal and 
the P4 level on the 7th day after sponge removal (fig 50) (R2=0.25) 
 
Figure 49
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Figure 50 Correlation of the peak estrogen concentration on the 6th day after 
ing season  
 
Slides from groups one and three showed no signs of apoptosis and very little 
connective tissue present.  The corpora lutea in these slides showed all signs of 
advanced luteinization involving elements of theca, granulosa, vascular and reticulo-
sponge removal and the progesterone concentration on the 7th day 
after songe removal in all the ewes tested in the breeding and non-
breed
 
 
3.3.4 Histology 
Upon histological evaluation by light microscopy on slides stained with 
hematoxylin and eosin and Masson’s Trichrome stains, the following findings were 
made: 
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endothelial progenitors.  There was advanced vascularization with vascular 
nsive 
 
 
 
me an 
 
 
nt 
hondria.  Especially on the Masson’s 
Trichrome stain the lipid accumulation in the cytoplasm was pronounced. 
 
Slides from groups two, four and five showed all the signs of apoptotic luteal 
otic bodies were present.  Convoluted 
ic bodies were roughly round or oval in 
n shape.  Apoptotic bodies comprised of single dense chromatin 
masse
 scattered solitary bodies.  There was extensive connective tissue infiltration 
n the Masson’s Trichrome stained slides as well as no visible lipid accumulation as 
seen i
components reaching the cavity of the collapsed follicle and vascular vessels carried 
to the internal structure of the CL by invading septa of connective tissue.  Exte
capillary branching was observed.   
Both small (theca lutein cells) and large (granulosa lutein cells) luteal cells
were present. Small lutein cells become dispersed in the septa as single entities or
in small groups.  These cells show moderate enlargement and assu
epithelioid shape. Granulosa cells underwent massive hypertrophy as they assumed 
a typical polyhedral shape.  The cells were pale staining with a lot of cytoplasm. 
The chromatin in these cells were dispersed a sign of actively transcribing cells. 
The pale staining cytoplasm had a spongy texture typical of cells with abunda
smooth endoplasmic reticulum and mitoc
regression.  Discrete well-preserved apopt
budding cells were rarely seen.  The apoptot
shape and varied i
s surrounded by barely detectable cytoplasmic rims and not numerous 
nuclear fragments as seen in thymocytes [128].   The apoptotic cells were mostly 
seen as
o
n slides of group one and three. 
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magnification.  Note the clearly visible connective tissue septa (CS) 
(VE).  The stroma (S) has numerous pale staining enlarged polyhedral 
 
 
 
 
 
 
 
 
 
 
 
 
magnification.  Note 
the pale staining polyhedral large lutein cells (LL) with dispersed 
chromatin (DC) and spongy cytoplasm (SC)  
 
 
 
 
 
Figure 51 H & E stained section of a normal corpus luteum as seen on x 100 
with groups of epithelioid small lutein cells (SL) and vascular elements 
large lutein cells (LL)  
 
 
 
 
 
 
 
 
 
Figure 52 H & E stained normal corpus luteum seen at x 400 
CS 
VE 
SL 
S 
LL 
DC 
SC 
LL 
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Figure 53 
ing orange 
) 
LA 
CI 
 
 
 
 
 
 
 
 
 
 
Masson’s Trichrome stained normal corpus luteum at x 800 
magnification.  There is very little connective tissue infiltration (CI) 
staing green with Masson’s Trichrome stain.  Clearly visible is the lipid 
accumulation (LA) stain
 
DSAB 
CI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 54 H & E stained section of a regressed corpus luteum as seen on x 100 
magnification.  Note the clusters of connective tissue infiltration (CI) 
and discrete singular apoptotic bodies (DSAB
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 DSAB 
MABSC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55 H & E stained section of a regressed corpus luteum as seen on x 400 
ell (MABSC) 
Figure 56 
 tissue infiltration (CI) 
staining green with Masson’s Trichrome stain  
magnification.  Note the scattered discrete singular apoptotic bodies 
(DSAB) roughly round or oval in shape with rims of cytoplasm.  On 
occasion, multiple apoptotic bodies with various amounts of nuclear 
material can be seen in a singular c
 
 
CI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Masson’s Trichrome stained regressed corpus luteum at x 800 
magnification.  There is extensive connective
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 An attempt was made to compare the extent of luteal regression in the five 
groups by comparing the amount of apoptotic bodies per 100 cells and the amount 
f connective tissue infiltration on a categorical scale by assigned numerical values. 
.3.4.1 Evaluation of apoptotic nuclei 
One-way analysis of variance revealed that the group means were statistically 
ignificantly different (P<0.05). The Tukey-Kramer adhock test showed that groups 
ne and three were not statistically significantly different (P>0.05) although they 
iffered statistically from groups two, four and five (P<0.05) (1).  Groups two and four 
id not differ statistically significantly (P>0.05) but they did differ significantly from 
differences fr
 
o
 
3
 
s
o
d
d
groups one, three and five (P<0.05) (2).  Finally group five sowed significant 
om all the groups (P<0.05) (3) (figure 57). 
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Figure 57 Number of apoptotic nuclei recorded per 100 cells between the five 
defined groups represented as means + SEM 
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3.3.4.2 Evaluation of connective tissue replacement 
 One-way analysis of variance revealed that the group means were 
significantly different (P<0.05). The Kruskal-Wallis Z adhock test showed that groups 
ne and three were not significantly different (P>0.05) although they differed s from 
1).  Groups two and four did not differ 
ignific
o
groups two, four and five (P<0.05) (
s antly (P>0.05) but they did differ statistically significantly from groups one, 
three and five (P<0.05) (2).  Finally group five differed statistically significantly from 
all the groups P<0.05 (3) (figure 58). 
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Figure 58 Relative connective tissue infiltration recorded between the five defined 
groups represented as group means + SEM 
 
 
3.3.5 Scanning Electron Microscopy 
 
 Scanning electron microscopy was used to establish the stage of apoptosis 
as described in section 3.2.5.2 in each of the five defined groups.  Two-way analysis
etween the five defined groups. The Tukey-Kramer adhock test showed that groups 
 
of variance revealed that there were significant differences in the stage of apoptosis 
b
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one and three were not significantly different (P>0.05) although they differed from 
groups two, four and five (P<0.05).  Groups two and four did not differ s significantly 
(P>0.05) but they did differ statistically significantly from groups one, three and five 
(P<0.05).  Finally group five differed significantly from all the groups (P<0.05)  (figure 
59). 
 
0
10
20
30
40
50
60
70
80
90
100
Normal
Group 1 Group 2 Group 3 Group 4 Group 5
%
 o
f 
C
e
ll
s
Stage 1
Stage 2
Stage 3
 
Figure 59 Evaluation of the stage of apoptosis between the five defined groups 
represented as % of cells plus Scanning electron microscope  
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Figure 60 Normal large lutein cell freeze fractured and magnification x 10 000 
with a scanning electron microscope.  Note the extensive development 
of the cyto-sceleton typical of steroid producing cells 
 
Figure 61 Apoptotic lutein cell freeze fractured and magnification x 10 000 with a 
SEM.  Note that the cytoskeleton is almost completely broken down by 
the action of proteases like caspases. 
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3.4 Discussion 
In the current study, season had no effect on the occurrence of premature 
luteal regression.  The occurrence of both only premature regressed corpora lutea
and mixed cases, where premature regressed corpora lutea occurred with normal 
appearing corpora lutea, were similar between the breeding and non-breeding 
seasons (see section 3.3.1).   This finding differs from the observations made by
Ryan et al [104] and Jabbour et al [105] in that the incidence of the phenomena is
higher in the breeding season than in the non-breeding season.   
It is known that during the non-breeding season (spring) with longer day
 
 
 
 
 
 
T 7β 
sensitive neu  breeding season 
e 
e 
 
 
, 
  
 
In granulosa cells and theca cells LH causes massive synthesis of P4 by 
 in
lengths M secretion decrease leading to up-regulation of rE2-17β in E2-1
rons that inhibit the GnRH pulse generator.  In the
with short days increased MT secretion down-regulates rE2-17β in E2-17β sensitiv
neurons and the inhibition of the GnRH pulse generator does not take place.   Th
theory is that in the non-breeding season, because of the inhibition of the GnRH 
pulse generator, the preovulatory LH surge is prevented, thus ovulation does not
take place and the animals goes into anestrus (see section 2.9 for a review) [130-
167].  It is known that the early corpus luteum needs LH to become functional [168].
The theca and granulosa cells need to differentiate into small and large lutein cells
respectively and extensive vascularisation needs to take place to make this possible.
The differentiation of the granulosa and theca cells is in part LH dependant.   
alterations  cholesterol metabolism and steroidogenic enzymes (see section 
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2.6.1.  for a review) [2 169-172].  A concurrent morphological change occurs in the 
itochondria, where some of the steroidogenic enzymes are located.  Mitochondria 
tend to
 whereas the LH 
ceptor itself can be down-regulated [181-183].   The smooth endoplasmic 
reticulu
The effect of season on premature luteal regression is interesting since it 
poses 
m
 exhibit an increasing complexity of their cristae, often with lammelliform-
villiform cristae, after exposure to LH [173-178].  A clustering of mitochondria and 
other organelles such as lysosomes in the perinuclear region has been observed, 
which presumably facilitates movement of substrates for steroidogenesis [179, 180].  
An increase in the amount of lipid inclusions has been described as well [173-178].  
A number of plasma membrane receptors are modulated in response to LH.  
Prolactin, β-adrenergic and lipoprotein receptor is increased,
re
m (SER) develops and expand to the most conspicuous organelle in luteal 
cells in response to LH.  It has been shown to occur in various forms, including 
tubular and vesicular networks.  In the SER the enzymes 3β -HSD, 17β-HSD and 
Aromatase-P450 are modulated (see section 2.6.1.2 for a review).  The effect of LH 
on the nucleus and proliferative activity is particular interesting.  Before exposure to 
LH, granulosa cells exhibit a high nuclear-cytoplasmic ratio and proliferative 
activity[184, 185].  After exposure to LH, the mitotic index falls, and a precipitous 
increase in the cytoplasmic volume occurs [184-187].  The nuclear heterochromatin 
is transformed to a lighter staining euchromatin pattern [187, 188].  Finally there is 
rearrangement of cytoskeletal elements with microvilli forming and gap junctions 
decreasing by as much as 85% upon LH exposure [189-193].   
 
the question if the phenomenon is in essence really regression, or merely 
inadequate luteal support.  It is known that ovulation rate greatly increase if the 
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release of endogenous gonadotropins is increased, or if exogenous gonadotropins 
are administrated.  Increased ovulation rate implies an increase in the amount of 
corpora lutea formed.  Does this also imply increasing amounts of LH required for 
the early corpora lutea to differentiate into functional structures?  The seasonal 
influences in the Mutton Merino is not as pronounced as in some other breeds of 
sheep, with oestrous cycles occurring throughout most of the year [135, 136].  The 
fact that the ewes ovulated in the non-breeding season and that there was no 
significant difference in the amount of corpora lutea recorded between the breeding 
and the non breeding seasons, implies that there is enough LH during the pre-
ovulatory LH surge to induce ovulation in the developing follicles.  It is possible that 
the seasonal inhibition of the GnRH pulse generator in the Mutton Merino is not 
enough to prevent the pre-ovulatory LH surge but leads to insufficient LH support 
after ovulation especially in the superovulated animal with more than usual corpora 
lutea to support early in the luteal phase.  In the current study there was on average 
more corpora lutea recorded in animals with premature regressed corpora lutea 
(only premature regression and mixed responses) than in animals with normal 
functioning corpora lutea.  This was observed in both the breeding and non-breeding 
season, but these differences were not statistically significant (see section 3.3.2).  
Were there too many structures for the extent of LH support in the animals where the 
phenomenon occurred.  
 
Although this question cannot be directly answered because LH concentration 
was not measured, there is enough indirect clues to suggest the contrary.  The first 
argument against the theory is that the incidence of premature luteal regression 
should be the highest in the non-breeding season when the active suppression of 
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the GnRH pulse generator by E2-17β sensitive inhibitory neurons should be at it’s 
strongest. The finding by Ryan et al [104] and Jabbour et al [105]  that the incidence 
of premature regression  increase in the breeding season and the observation in this 
study that there is no difference in the incidence between the breeding and non-
breeding season, does not support this theory.  Secondly, this study shows that in 
both the breeding and non-breeding season P4 levels increase for the first four days 
in animals where the phenomena did occur.   
 
The fact that there are conflicting reports on the incidence of the phenomenon 
in the breeding and non-breeding season raises the question if the seasonal 
influences observed is not really nutritional influences.  It is known that usually 
pastures carry higher nutritional value in the non-breeding season than in the 
breeding season [134, 135].  It has long been recognized that nutrition has a 
profound effect on reproductive performance in female farm animals, although the 
underlying mechanisms remain poorly understood [135, 136, 194, 195].  An increase 
in the amount of protein digested post-ruminally[196] or increased availability of 
energy-yielding substrates, like carbohydrates [197], may be responsible for the 
higher fecundity observed. One proposed theory is that higher protein intake 
increases the availability of essential amino acids, the building blocks of protein 
hormones [198, 199].  For this theory to be valid, there has to be a deficiency in 
ssential amino acids.  In at least one study, it was proven that increased protein 
intake 
e
does not increase the amplitude of the LH surge [105].  A more popular theory 
is that increasing the intake of carbohydrates leads to increasing circulating insulin 
and IGF-1 [194, 195].  It is known that due to their structural similarity, insulin will 
bind to RIGF-1, but the receptor’s affinity for insulin is not as high as for IGF-1 [200-
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202] .  The beneficial role of insulin and IGF-1 on follicular growth synergising with 
pituitary gonadotropins is well known [202-207].  These two metabolic hormones 
have also been shown to increase the number of ovulations in superovulated heifers 
[208].  Although an increase of progesterone production per cell basis, thus 
eliminating the effect of proliferation have been reported [202-205, 207]  the effect of 
these hormones on luteal function remains poorly understood [209] 
 
Perhaps the most compelling evidence that the seasonal influences observed 
by Ryan et al [104] and Jabbour et al [105] is in fact nutritional influences possibly 
acting by increasing insulin and IGF-1 is that Jabbour et al reported that they can 
reverse the effect by nutritional supplementation.  It is known that under normal 
circumstances, the inhibitory effect of photoperiod will override the stimulatory 
effects of increased nutritional state in most breeds of sheep [198].  The current 
study added a couple of interesting insights since no seasonal effects were seen and 
nutritional supplementation of oats hay (Avena sativa L.) and lucerne (Medicago 
sativa L. sativa) did not reduce the incidence of the phenomenon.  These findings 
support the idea that seasonal influences are merely nutritional influences, but which 
nutrients, and why those nutrients, need to be established.  More research on the 
effect of nutrition on the incidence of premature luteal regression is needed. 
 
By using the more sensitive MEIA technology, a second peak was observed 
in E2-17β around the 4th day of the cycle confirming previous reports [73, 109, 117-
119].   This second increment was observed in both the breeding and non-breeding 
seasons and occurred in all the animals unlike reported by some authors [73, 117, 
118].  The superovulated ewes had higher than normal E2-17β  peaks around estrus 
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(12.0-14.8 pg/ml vs 6.2-10.0 pg/ml).  The second E2-17β  peak ranged between 5.4-
8.2 pg/ml.  An interesting observation was that the second E2-17β  peak preceded 
the decline in P4 in animals with signs of premature luteal regression.  It is known 
that E2-17β  increase the recombinant oxytocin, mediating the production and 
release of PGF2α by the uterus upon the binding of Ox.  By increasing the amount of 
rOx the uterus becomes more sensitive to basal levels of Ox (see section 2.5).  In 
is study, however, the second peak was observed in both animals with signs of 
prema
2 2  
,
2
cycle) and the P4 level on the 7  day, but failed to find any correlation, thus 
concluding that there is no threshold level of E2-17β that will initiate the early release 
of PGF2α.  In an interesting study by McCracken [89] using the autotransplanted 
uterus in ovariectomized ewes, it was shown that E -17β exposure can lead to 
 
4 exposure.  However, in P4 primed animals this effect will be prevented 
if animals were primed for 2 or 6 days whil
 
In the current experiment, animals were exposed to P  for 4 days.  According 
to the mentioned experiments by McCracken [89], using the autotransplanted uterus 
as a model the E2-17β induced release of PGF2α should not take place.  An 
th
ture luteal regression and animals with normal functioning corpora lutea. This 
raised the question, if these high E -17β  levels leads to the early release of PGF α
why did this not happen in all the animals?  The possibility that a certain threshold 
needs to be reached was considered.   We investigated a potential correlation 
between the peak E -17β  level on the 6th day after sponge removal (4th day of the 
th
2
PGF2α release after about 6 hours and that increasing peaks will occur every 6 hours 
(It takes approximately 6 hours for the oxytocin receptors to be manufactured) in the
absence of P
e the effect will be enhanced after 10 days 
of P4 exposure.   
4
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interesting observation was that in the animals where PGF2α was administrated, the 
decline in P4 was slower than in animals displaying signs of premature luteal 
regression (see figures 45 & 46).  Upon histological examination it was shown that 
there was significantly more apoptotic nuclei in premature regressed corpora lutea 
(see section 3.3.4.1) and connective tissue replacement (see section 3.3.4.2) than in 
corpora lutea where regression was induced by PGF2α.  Scanning electron 
microscopy also demonstrated that premature regressed corpora lutea were in later 
stages of apoptosis than in PGF2α induced regression (see section 3.3.5). In several 
species the newly formed corpus luteum shows considerable resistance to the 
luteolytic effect of PGF2α, including sheep[210], horse[211], cow[212, 213], rat[214] 
and pig[215]. In the sheep, horse, cow and rat the corpus luteum is resistant to the 
luteolytic effects of PGF2α for the first 4 days after its formation while in the pig the 
corpus luteum is resistant to PGF2α for up to 12 – 14 days.   
 
The effects of PGF2α on both functional and structural luteolysis have been 
described (see sections 2.6.1 & 2.6.2). The enzyme 20α-hydroxysteroid 
dehydrogenase (20α-HSD) is considered a marker of functional luteolysis[216].  The 
predominantly cytosolic enzyme is NADP–dependent and catalyzes the reduction of 
progesterone to the inactive 20α-hydroxyprogesterone (20αOHP).  It was shown that 
the early corpus luteum of eCG treated immature rats, PGF2α can’t up-regulate the 
expression of this enzyme in the first 4 days [217].  It was also shown that the block 
 the LH-induced c-AMP increase does not take place in the early corpus luteum of 
the rat
in
 [214].  In agreement with the mentioned studies slow functional and structural 
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regression in corpora lutea where regression was induced  by PGF2α was shown.  
This was not the case in premature regressed corpora lutea. 
 
Another interesting observation was that in premature luteal regression, 
normal appearing corpora lutea sometimes occurred with regressed corpora lutea on 
the same ovary.  This was also observed by Bainbridge et al [218] in the 
superovulated red deer (Cervus elaphus).  The occurrence of these mixed 
responses was never observed in animals where regression was indused by PGF2α.  
We confirmed that these regressed corpora lutea were from the same cycle and not 
merely corpora albicans from previous cycles by doing a histological examination.  
The regressed corpora lutea were in the same stage of regression than the corpora 
lutea of animals only displaying premature regressed corpora lutea.  In the animals 
where there was mixed responses, there were also multiple corpora lutea in the 
ame stage of regression.  The animals we used in the experiment were only 
supero u
[86] of the PGF  produced in the uterus is transferred from the uterine vein to the 
ovarian artery by a counter current transfer mechanism (see figure 1).  The branches 
of the ovarian artery will reach all the corpora lutea upon the completion of 
vascularization following ovulation and luteinization.  The only possible explanations 
to the occurrence of mixed responses is a) that Prostaglandin F2α receptor (r-PGF2α) 
is not present in all the corpora lutea, b) that vascularization is not complete in these 
corpora lutea or c) that PGF   is not the stimulus that initiates premature luteal 
regression.  If vascularization is incomplete the corpora lutea will be devoid of LH, 
Prolactin and other systemic trophic factors, O2  and nutrients.  Therefore this option 
s
vulated once.  Th s premature luteal regression does not necessarily 
influence all the corpora lutea present on the ovary at the time. It is known that 2% 
2α
2α
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is unlikely.  The fact that the administration of  PGF2α cause regression of all corpora 
lutea in ewes under the same experimental conditions, although at a slower rate 
an in premature luteal regression, suggests the presence r -PGF2α .  This poses an 
interes
2α
2α
3.5 Conclusions 
The following conclusions were made: 
 
th
ting question:  Is PGF2α responsible for premature luteal regression? 
    
The concept that PGF2α is the only signal to indicating luteal regression in the 
normal estrous cycle, was challenged by Sugimoto et al [219] in perhaps the most 
groundbreaking paper on luteal function published in the 1900’s.  They created 
knockout mice with homozygous null mutations for R- PGF2α.  Very surprisingly the 
mice had normal estrous cycles with luteal regression occurring in cycles where 
animals did not become pregnant.  Ovulation and implantation were also normal in 
the R- PGF2α knockout mice. But in pregnant mice the animals did not give birth, 
because the timely regression of corpora lutea of pregnancy had been prevented, 
and this in turn prevented the up-regulation of rOx, thus preventing myometrial 
contractility.  Ovariectomy released this inhibition of rOx and allowed myometrial 
contractility to resume.  Thus, in mice at least, PGF   is not the only signal initiating 
luteal regression.  It is, therefore, possible that premature luteal regression in the 
superovulated Mutton Merino can be caused by a signal other than PGF .  
 
 
1. Premature luteal regression is not merely inadequate luteal support, but 
indeed early luteal regression, since seasonal influences could merely be 
nutritional influences, and a definitive increase in P4 were recorded in 
animals exhibiting the phenomena. 
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2. Nutritional influences could play a role, but the type and quality of nutrients 
and mechanism involved, is still unclear. 
3. PGF2α-induced regression differs from premature luteal regression in that: 
a) The progression of functional and structural regression in PGF2α -
induced regression is slower than in premature luteal regression. 
 
 
 
 
b) Regressed corpora lutea do not occur with normal functioning corpora 
lutea. 
4. There is a distinct second E2-17β peak preceding the decline in P4 in animals 
that exhibits signs of premature luteal regression. 
5. A threshold initiating premature luteal regression was not established. 
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Chapter 4 
 
A Potential Role for Estrogen Receptors in 
Premature Luteal Regression  
 
4.1 Introduction 
 
 
Administration of exogenous E2-17β in metestrus (day 3-5 of the estrous 
cycle) causes luteal regression in sheep [1] and some wild deer species [2].  At 
the end of the normal estrous cycle, it is known that E2-17β, upon binding to its 
nuclear receptor, leads to transcription of the gene encoding the ROx, which in 
turn results in up-regulation in the membrane receptor making endometrial cells 
more responsive to basal levels of Ox.  If Ox binds to its membrane receptor, 
cyclase is activated and intracellular c-AMP increases, resulting in activation of 
Phospholipase A2, Prostaglandin endoperoxide synthase with cyclooxygenase 
and peroxidase components and endoperoxide reductase represent the 
machinery necessary for the production of PGF2α. PGF2α is never stored and is 
released within minutes upon production.   
 
In the corpus luteum, PGF2α cause a influx of Ca++ into the cytoplasma [3, 
4] leading to activation of phosphokinase C [5] and decreasing progesterone 
syntheses [6].  Other effects of PGF2α exposure includes uncoupling of the LH 
receptor from adenylate cyclase [7] thus decreasing the LH induced increase in 
c-AMP levels. This is  associated with increased production of progesterone seen 
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in luteinized granulosa cells by modulating metabolic and steroidogenic enzymes 
[8]. Finally a rapid decrease in luteal blood flow [9, 10]  leading to increased 
formation in oxygen-derived free radicals [11] have been shown to induce 
apoptosis in a variety of cell types [12, 13]. It is generally accepted that these 
events initiates luteal regression at the end of the estrous cycle in the sheep if a 
viable embryo doesn’t implant in the uterus.  Therefore it seems logic that the 
luteolytic action of E2-17β in metestrus is caused by the described mechanism. 
 
It is known that induction of superovulating in sheep by administration of 
eCG, also increases circulation levels of E2-17β [14].  One theory to explain the 
phenomenon of premature luteal regression is that increased E2-17β levels leads 
to the early release of PGF2α.  But resistance to the luteolytic actions of PGF2α in 
the early corpora have been described in several species[15-19],including the 
sheep [20]. In a previous study (see Chapter 3) we showed that premature luteal 
regression differs from PGF2α -induced regression in that both functional and 
structural regression in PGF2α induced regression in the early corpus luteum is 
slower than premature luteal regression.  Secondly, it was found that in 
premature luteal regression, regressed corpora lutea sometimes occurs with 
normal functioning corpora lutea while this was never the case in PGF2α induced 
regression.  Sugimoto et al [21] showed in r-PGF2α knockout mice, that mice had 
normal estrous cycles with luteal regression occurring if a viable embryo didn’t 
implant despite the absence of r-PGF2α. This challenged the notion that PGF2α is 
the only signal to induce luteal regression.  In the mentioned study (see chapter 
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3) it was observed that there is a definitive second peak in E2-17β peaking on the 
4th day of the estrous cycle preceding the decline in progesterone observed in 
premature luteal regression.  There was, however, no correlation between the E2-
17β level on the 4th day of the cycle and the progesterone outcome the following 
day, dismissing the notion that there is a threshold of E2-17β that needs to be 
reached before premature luteal regression will occur. 
 
A common misconception is that only hormone levels follows a pattern,  
increasing and decreasing during the estrous cycle and that cells will always be 
receptive to their actions.  In fact, hormone receptors are highly dynamic and are 
up- and down-regulated by various stimuli. E2-17β acts via specific nuclear 
receptors that in turn regulate transcription of hormone-responsive target genes.  
In the case of E2-17β, two receptors have been identified, namely estrogen 
receptor alpha (ERα) and estrogen receptor beta (ERβ).  In the sheep ovary ERβ 
is the predominant, or the only estrogen receptor expressed in granulosa cells 
[22].  The present study investigate the possibility that E2-17β rather than PGF2α, 
initiates premature luteal regression by acting directly on luteal cells via the ERβ 
and that the presence of ERβ will determine the fate of the early corpus luteum 
on the 4th day of the cycle when the E2-17β peaks for a second time.          
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4.2 Materials & methods 
 
 
4.2.1 Experimental animals and experimental design 
 
 
Refer to section 3.2.1 and 3.2.2 
 
4.2.2 Progesterone & estrogen analysis 
4.2.2.1 Blood collection 
Refer to section 3.2.3.1 
4.2.2.2 Progesterone 
 
The concentration of progesterone in serum were measured by MEIA on a 
Abbot AxSYM™ described by Buster and Abraham[23]. The sensitivity of the 
assay was 0.20 ng/ml. The inter- and intra-assay coefficients of variation (C.V.) 
were 4.82 % and 2.22 % respectively and the recovery was 99.8%. 
 
4.2.2.3 Estrogen 
 
The concentration of estrogen in serum were measured by MEIA on a 
Abbot AxSYM™ described by Buster and Abraham[23]. The sensitivity of the 
assay was 1.5 pg/ml. The inter- and intra-assay coefficients of variation (C.V.) 
were 6.88% and 4.54% respectively and the recovery was 99.9%. 
 
See section 3.2.3 for more detailed information.  
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4.2.3 Immunohistochemistry 
 
 
The ovaries of all the ewes were removed and macroscopically inspected 
9 days after sponge removal when the ewes were slaughtered.  Taking into 
consideration macroscopic appearance and treatment, five groups were 
identified. 
 
 
Group 1 Corpora lutea from ovaries where only normal appearing corpora 
lutea were present. 
 
Group 2 Corpora lutea from ovaries where only prematurely regressed 
corpora lutea were present. 
 
Group 3 Normal appearing corpora lutea from ovaries where regressed 
corpora lutea occurred with normal appearing corpora lutea (Mixed 
normal) 
 
Group 4 Regressed corpora lutea from ovaries where regressed corpora 
lutea occurred with normal appearing corpora lutea (Mixed 
regressed) 
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Group 5 Corpora lutea from ovaries where regression was induced with the 
PGF2α analogue Dinoprost tromethamine (Lutalyse ®, Pharmacia & 
Upjohn). 
 
Six corpora lutea from each of the five defined groups were randomly 
selected using random numbers generated. The corpora lutea were removed 
from the ovary with a scalpel blade and fixed in formal-saline for 24 hours.  The 
formal-saline fixed tissue were processed for histology (see section 3.2.4.1) A 
standard immunohistochemical technique  (avidin-biotin-peroxidase) was used to 
visualize ERβ in the sheep corpora lutea as described previously[22].  Briefly a 
polyclonal rabbit anti-rat ERβ antibody (PA1-310; Affinity Bioreagents, Golden, 
CO), raised against a C-terminal synthetic peptide which corresponds to the C-
terminal amino acid residues 530-549, was used for detection of oERβ.  Antigen 
retrieval was achieved by pre-treatment in a microwave oven at high power, in 
0.01 M sodium citrate buffer (pH 6.0) for 10 min, and then allowed to cool for a 
further 20 minutes. After washing in buffer (0.1 M PBS, pH 7.4) non-specific 
endogenous peroxidase activity was blocked by treatment with 3% hydrogen 
peroxide (Merck) in methanol for 10 minutes at room temperature.  After a 10 
minute wash in buffer, samples were exposed to a 30 minute non-immunoblock 
using diluted normal goat serum (Santa Cruz Biotechnology, Santa Cruz, CA) in 
TBS containing 5% (w:v) BSA in a humidified chamber at room temperature. The 
samples were then incubated with the primary antibody.  The ERβ antibody was 
diluted 1:200 in TBS with 5% BSA and incubated at 4°C overnight. Negative 
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controls were obtained by replacing the primary antibody with non-immunoserum 
of equivalent concentration. In addition, the ERβ antibody was preabsorbed with 
neutralizing synthetic ERβ peptide (PEP-007, Affinity Bioreagents) overnight to 
demonstrate antigen specificity.   After primary antibody binding, the samples 
were incubated for 30 minutes at room temperature with a biotinilated goat anti-
rabbit IgG secondary antibody (Santa Cruz Biotechnology) diluted in normal goat 
serum.  Thereafter, samples were incubated for 45 minutes at room temperature 
with a horseradish peroxidase-avindin-biotin complex (BD Biosciences 
Pharmingen).  The site of the bound enzyme was visualized by the application of 
3,3’-diaminobenzidene in H2O2  (DAB kit BD Biosciences Pharmingen), a 
chromogen that produces a brown, insoluble precipitate when incubated with 
enzyme.  The samples were counterstained with hematoxylin and dehydrated 
before they were mounted with Pertex.  For each slide, 100 cells were scored as 
either positive or negative.  Each slide was scored by three independent 
technologists and the mean score for each slide was calulated.  Six slides in 
each of five groups were scored.  
 
4.2.4 Statistical analysis 
 
4.2.4.1 Progesterone & estrogen analysis 
 
The progesterone and estrogen levels were compared separately.   The 
comparison was done by three-way analysis of variance (2 x 4 x 10 matrix).  It 
was done for both the breeding and non-breeding seasons between: 
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a) animals with only normal corpora lutea, 
b) animals with only premature regressed corpora lutea, 
c) animals with PGF2α induced regression and  
d) animals with both normal and regressed corpora lutea. 
 
The analysis also extended for 10 days from the day of sponge removal (day 
0) to 9 days after sponge removal.  The test was done on NCSS 2000 software 
with a P value of  (P<0.05) considered significant. 
 
4.2.4.2 Immunohistochemistry 
 
The five group means of the percentage ERβ positive cells recorded per 
100 evaluated cells were compared by means of one-way analysis of variance 
with a p-value of <0.05 considered as statistically significant.  Once it was 
established that the group means do differ significantly the Tukey-Kramer adhock 
test were performed to examine all possible comparisons among the five means. 
The analysis was done on NCSS 2000 software. 
 
4.3 Results 
 
4.3.1 Steroidogenic Profiles 
 
4.3.1.1 Progesterone profiles 
 
The progesterone profiles of the ewes superovulated in the breeding season 
were not significantly different from the progesterone profiles of the animals 
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superovulated in the non-breeding season (P>0.05).  Form the day of sponge 
removal up to 6 days after sponge removal, there was no significant difference in 
progesterone profiles between: 
a) animals with only normal appearing corpora lutea, 
b) animals with only premature regressed corpora lutea, 
c) animals with PGF2α induced regression and  
d) animals with both normal and regressed corpora lutea. 
 
On the 7th, 8th and 9th day after the sponges were removed, there was a 
significant difference between the four mentioned groups of animals (p<0.01).  
The progesterone levels of the animals with only normal appearing corpora lutea 
were still increasing in the normal fashion.  The progesterone levels of the other 
three groups all showed a decline in progesterone concentration.  The decrease 
in progesterone concentration in the animals with only premature regressed 
corpora lutea was more profound than in the animals with PGF2α induced 
regression.  In animals with premature regressed corpora lutea progesterone 
levels dropped to baseline (1 ng/ml) within 24 hours while it took 72 hours in the 
ewes where regression was induced with the PGF2α analogue (dinoprost 
promethamine) to do so (P>0.05).  In the cases were regressed corpora lutea 
occurred with normal appearing corpora lutea, there were an initial drop in 
progesterone after which the progesterone level was maintained at a lower 
concentration than the ewes with only normal appearing corpora lutea (p<0.01).  
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These trends were the same in the breeding and non-breeding season (see 
figures 63-70). 
 
4.3.1.2 Estrogen profiles 
The estrogen profiles of the ewes superovulated in the breeding season were 
not significantly different from the estrogen profiles of the animals superovulated 
in the non-breeding season (p>0.05).  From the day of sponge removal up to the 
8th day after sponge removal there were no significant differences in the estrogen 
profiles between: 
 
a) animals with only normal appearing corpora lutea, 
b) animals with only premature regressed corpora lutea, 
c) animals with PGF2α induced regression and 
d) animals with both normal and regressed corpora lutea. 
 
On the 9th day after the sponges were removed there were a significant 
difference between the mentioned groups of animals (P<0.01).  The esterogen 
levels of the animals with only premature regressed corpora lutea started to rise 
while the estrogen levels of the other groups were still at baseline. In all the ewes 
tested from all four groups in both the breeding and non-breeding season the first 
principal rise peaked on the 2nd day after sponge removal (±day 0 of the oestrous 
cycle, because ewes usually come into oestrous 24 to 48 hours after sponge 
removal).  The peak estrogen levels ranged from 12.0 – 14.8 pg/ml higher than 
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those observed in untreated ewes with peak levels ranging from 6.2 – 10.0 pg/ml.  
On the 3rd day after sponge removal estrogen levels dropped to baseline and 
remained at baseline until the 5th day after sponge removal.  On the 6th day after 
sponge removal (± 4th day of the oestrous cycle) there was a significant 
additional rise in estrogen (P<0.01) confirming findings in some other studies[24-
28].  Peak estrogen levels ranged from 5.4 – 8.2 pg/ml in this additional rise.  On 
the 7th day after sponge removal, estradiol returned to baseline (figures 62-69). 
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Figure 62 Progesterone and estrogen profiles of superovulated Mutton Merino 
ewes with normal appearing corpora lutea.  The ewes were 
superovulated in the breeding season (March – May 1996) 
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Figure 63 Progesterone and estrogen profiles of superovulated Mutton Merino 
ewes with normal appearing corpora lutea.  The ewes were 
superovulated in the non-breeding season (August - October 1997) 
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Figure 64 Progesterone and estrogen profiles of superovulated Mutton Merino 
ewes with premature regressed corpora lutea.  The ewes were 
superovulated in the breeding season (March – May 1997) 
 
igure 65 Progesterone and estrogen profiles of superovulated Mutton Merino 
ewes with premature regressed corpora lutea.  The ewes were 
superovulated in the non-breeding season (August - October 1997) 
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Figure 66 Progesterone and estrogen profiles of superovulated Mutton Merino 
ewes with PGF2α induced regression of the corpora lutea.  The 
ewes were superovulated in the breeding season (March – May 
1997) 
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Figure 67 Progesterone and estrogen profiles of superovulated Mutton Merino 
ewes with PGF2α induced regression of the corpora lutea.  The 
ewes were superovulated in the non-breeding season (August - 
October 1997) 
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Figure 68 Progesterone and estrogen profiles of superovulated Mutton Merino 
ewes with mixed responses.  The ewes were superovulated in the 
breeding season (March – May 1997) 
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Figure 69 Progesterone and estrogen profiles of superovulated Mutton Merino 
ewes with mixed responses.  The ewes were superovulated in the 
non-breeding season (August - October 1997) 
 
 
 Page 210 
4.3.2 Immunohistochemistry 
 
The polyclonal rabbit antibody directed against a 19 amino acid C-terminal 
synthetic peptide of the rat ERβ (CSSTEDSKNKESSQNLQSQ) with 9 residues 
(47%) identical to the equivalent ovine sequence (RNLAEDSESKEGSQKPQAQ) 
proved to be effective in localising the full length 527 amino acid oERβ (the red 
letters indicate common residues).  The full-length rat ERβ is 87.3% homologous 
with the oERβ while the region homology varies between 83% and 99% (table 
31) [22].      
 
Table 31 nd the oERβ per region [22] Percent homology between the rERβ a
 
 A/B 
(1-145) 
C 
(146-211) 
D 
(212-245) 
E/F 
(246-527) 
oERβ 100 100 100 100 
rERβ 83 99 88 87 
 
Skeletal muscle from the musculus biceps brachii in Mutton Merino sheep 
stained negative (figure 70) and in the antral follicle, granulosa cells stained 
strong positive and theca interna weak, positive (figure 71) as described by 
Cárdenas et al [22]. 
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A Cross section of skeletal muscle cells from the Musculus Biceps Brachii 
of the Mutton Merino stained immunohistochemically and counterstained 
with hematoxylin.  LM x 800 magnification As can be seen there is no 
brown insoluble precipitate confirming the absence of ERβ in the skeletal 
 
 
as a negative control 
 
 
 
 
 
 
 
 
igure 71 A Cross section from an antral follicle in the mutton merino. LM x 800 
magnification  The granulosa cells G stain strong positive while the theca 
interna T stain weak positive.  The antal follicle served as a positive 
control 
 
 
 
 
 
Figure 70 
A B
muscle cell. A Note the multiple elongated peripheral nuclei typical of
skeletal mucle. B Cross section of mucles cells. Skeletal muscle served
 
 
 
G 
 
 
 
 
T 
 
F
 Page 212 
A section from a premature regressed corpus luteum stained by using a 
on specific polyclonal rabbit antibody stained negative proving that there is no 
on-specific binding (figure 72) while a section from a normal corpus luteum pre-
dsorbed with the control peptide stained positive (figure 75) showing antigen 
pecificity.  Note that only the cytoplasm stained with the pre-adsorbed section. 
ppel et al [29] reported that on average, 6 amino acids constitute antigenic 
eterminants in peptides.  There is evidence that the 9 common residues 
etween the amino acid sequence of the rat ERβ and the oERβ account for the 
 
igure 72 Premature regressed corpus luteum staind by a non-specific polyclonal 
rabbit antibody staining negative proving there is no non-specific binding 
 
n
n
a
s
A
d
b
antigenic determinants. 
 
 
 
 
 
 
 
 
 
 
 
 
A
 
F
present.  LM x 800 magnification Note apoptotic nuclei A present.  
 Page 213 
 
Figure 73 Normal corpus luteum pre-adsorbed with the control peptide.  LM x 800 
magnification 
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igure 74 Number of ERβ positive cells recorded per 100 cells between the five 
defined groups represented as means + SEM 
F
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One-way analysis of variance revealed that the group means were 
significantly different (P<0.05).  The Tukey-Kramer adhock test showed that 
groups 1,3 and 5 were not s different (P>0.05) although they differed from groups 
2 and 4 (P<0.05).  Groups 2 and 4 were not different (P>0.05) but the differed 
statistically from groups 1,3 and 5 (P<0.05) (figure 74).    We can thus conclude 
that animals with only normal corpora lutea had insignificant amounts of oERβ on 
the 9th day after sponge removal (roughly 7th day of the estrous cycle) (see figure 
75).  
 
 
 
 
 
g 
0 
 
 
 
 
 
 
 
 
 
 
 
Figure 75 Immunostaining for oERβ in a Mutton Merino with only normal functionin
corpora lutea.  There is no positive staining present. LM x 80
magnification 
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Figure 76 Immunostaining for oERβ in a Mutton Merino with normal functioning and
premature regressed corpora lutea.  There is no positive staining present
LM x 800 magnification 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 77 Immunostaining for oERβ in a Mutton Merino where regression was 
induced by PGF2α.  There is no positive staining present. Note the clearly 
visible apoptotic bodies. LM x 800 magnification 
A 
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In some cases normal functioning corpora lutea occurred with premature 
regressed corpora lutea on the same ovary.  The normal functioning corpor
lutea in these cases also showed no significant staining for the oERβ (figure 76). 
In Mutton Merino sheep where luteal regression was induced with PGF2α ,
was also no significant staining although clearly visible apoptotic bodies wer
observed (figure 77). 
In the corpora lutea from ewes with only premature regressed corpora lutea there 
were very pronounced positive nuclear and cytoplasmic staining for immuno-
reactive oERβ.  This was also observed in premature regressed corpora lutea 
a 
 
there 
e 
at occurred with normal corpora lutea on the same ovary (see figures 78 and 
magnification 
th
79). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 78 Immunostaining for oERβ in a Mutton Merino sheep with only premature 
regressed corpora lutea.  There is very pronounced nuclear and 
cytoplasmic staining for immuno-reactive oERβ. LM x 800 
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Figure 79 Immunostaining for oERβ in a Mutton Merino sheep with  premature 
ovary.  There is very pronounced nuclear and cytoplasmic staining for 
immuno-reactive oERβ. LM x 800 magnification 
 
 Discussion 
It is known that in the sheep, staining intensity of the oERβ protein in 
ranulosa cells on different days of the oestrous cycle is similar, suggesting that 
ERβ might be important for regulation of most stages of follicular growth [30]. 
ollowing the LH surge, oERβ is down regulated with oERβ mRNA levels 
eclining from day 2 through 10 and increasing at the end of the estrous cycle 
2].  It is thus expected that there will be very little to no oERβ present in the 
orpus luteum of the normal functioning corpus luteum on the 7th day of the 
estrous cycle.  It was significant to find oERβ expressed in premature regressed 
corpora lutea
 
 
 
 
regressed corpora lutea occurring with normal corpora lutea on the same 
4.4
 
 
g
o
F
d
[2
c
o
 occurring in animals with only prematurely regressed corpora lutea 
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present on the ovaries and in animals where prematurely regressed corpora lutea 
occurred with normal functioning corpora lutea.  Insightful as well, was the fact 
normal functioning corpora lutea that occurring with prematurely regressed 
corpora lutea had no oERβ expression.  In this study, like in the previous study 
(Chapter 3) a second rise in E2-17β was observed on the 4th day of the cycle.  
This rise in E2-17β preceded the rapid decline in progesterone in animals with 
premature regressed corpora lutea.   
 
As reported previously (Chapter 3) there are some distinct differences 
etween premature luteal regression and PGF2α induced regression.  This study 
e of the early corpus luteum to the luteolytic actions of 
GF2α observed in the previous study (slower decline in progesterone) (Chapter 
) and reported in other studies [15-20].  It was also observed in the mentioned 
tudy (Chapter 3) that prematurely regressed corpora lutea sometimes occurred 
ith normal functioning corpora lutea while this was never the case with PGF2α 
duced regression.  In the current study another difference was noted in that 
rematurely regressed corpora lutea express oERβ while no oERβ expression is 
found in corp
 
In the sheep as in many other species, the LH surge plays a vital role in 
1-38].  The LH surge represents a brief, massive outpouring 
f LH from the anterior pituitary gland.  LH rise rapidly within 4 to 8 hours to a 
peak of 100 to 200 ng/ml (50 –100 times basal levels) and then decline just as 
b
confirms the resistanc
P
3
s
w
in
p
ora lutea where regression was induced by PGF2α. 
initiating ovulation[3
o
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rapid
TM
average 48 hours after sponge removal.      
 
  A unique property of eCG, the hormone used to superovulate the ewes, is 
its ability to express both FSH-like and LH-like biological properties in other 
mammalian species [44, 45].  In sheep eCG acts 60% as FSH and 40% as LH, 
thus 1000 IU of PMSG is equivalent to 400 IU of LH [46, 47](see section 
2.11.1.1).  eCG is a high molecular weight acidic glycoprotein (70 000 Da) with 
very high carbohydrate content, i.e 45% containing sialic acid.  The high sialic 
acid content has been linked to the long biological half life of 7 days [46, 47].  The 
ly so that the surge lasts approximately 12 hours.  The onset of the LH 
surge is usually closely coupled to the onset of estrus behaviour[37, 39, 40], 
except for breeds with high ovulation rates in which it begins 8 to 12 hours after 
the start of estrus[39, 41].  The interval between the LH surge and ovulation (22 
to 26 hours) is remarkably constant[42]. 
 
In the current experiment ewes were synchronized with a progestagen-
impregnated intravaginal sponge (Repromap  60 mg, Upjohn) for 12 days and 
the use of 5 mg ECP administered as an intra-muscular injection 24 hours after 
sponge induction, to induce luteolysis of any early corpora lutea.  Ewes were 
superovulated by administrating 1000 eCG 48 hours before sponge removal.  In 
superovulated synchronized ewes, as in this experiment, the LH surge starts 
usually on average 59 ± 4.7 hours after progestagen withdrawal[43].  In the 
Mutton Merino sheep used in this experiment estrus behaviour was observed on 
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exogenous long acting LH biological activity in the form of eCG, extends the LH 
surge (which in the normal oestrous cycle lasts only 12 hours) to a wave of LH 
lasting 7 days or longer.  Follicular dynamic studies have shown that resulting 
from the extended exposure of biologically active LH in the form of eCG, is the 
ct that the time of ovulation is now also extended over a period of up to 120 
hour
 
The next question that should be asked is, why did these corpora lutea 
regress and what was the signal initiating the event?  It is very interesting that 
only corpora lutea expressing oERβ, underwent premature luteal regression, with 
the decline in progesterone starting the day after the second estrogen peak.  This 
strongly suggest that estrogen could be the signal initiating premature luteal 
regression, not acting via PGF  released from the uterus, but by acting directly 
fa
s, instead of the usual 22 to 26 hours after the endogenous LH surge in 
ewes not exposed to eCG [43, 48].  Confirming the extended time of ovulation, is 
the fact that embryos of various stages of development are usually collected 
spanning up to 36 hours apart in development.  Taking the mentioned facts into 
account. A possible explanation for the fact that prematurely regressed corpora 
lutea expressed oERβ, is that these corpora lutea resulted from late ovulations 
and that there was insufficient time for the cells to down regulate their oERβ. 
2α
on the granulosa lutein cells by binding to the oERβ.   This would then also 
answer the question why estrogen is luteolytic on the first two days of the 
oestrous cycle in the normal cycling sheep ewe.  It probably takes two days to 
down regulate oERβ. 
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Estrogens are key molecules in development, differentiation, prolifferation 
 
 
[55] 
contribute to the functional domains of the receptors.  Of the functional domains 
of the receptors, the three major domains are the ligand binding domain (LBD), 
receptor specificity for the specific hormone or molecule that regulates the 
transcriptional activ
and growth. Their actions are mediated by specific cellular receptor proteins 
localized in the nucleus of the cell [49-53].  Estrogen signalling is mediated by 
one of two receptors, estrogen receptor alpha (ERα) and estrogen receptor beta 
(ERβ) [54].  It was demonstrated that ERβ was the predominant estrogen 
receptor expressed in the ovine ovary[22].  Estrogen receptors are members of 
the nuclear receptor family that represent the largest family of transcription 
factors.  These are transcription factors that share similar structure homology [50, 
53, 55-58]. The structure of these receptors is shown in figure 80. 
 
 
 
Figure 80 The schematic structure of the domains of the nuclear receptors 
 
   
As shown in figure 80, these receptors contain six regions of similarity that 
A/B 
Activation Domain 
C 
DNA Binding 
Domain
D E 
Ligand Binding and 
Activation Domain 
F 
the DNA binding domain (DBD), and the activation domain (AF).  The LBD is 
located at the carboxyl terminus of the molecule, region E.  The LBD gives the 
ity of the receptor.  The DBD gives the receptor specificity for 
the target genes the receptor will regulate.   This specificity is determined by 
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which DNA sequences the DBD will recognizes.  These sequences or hormone 
response elements (HRE) (in the case of ERβ they are called “estrogen response 
elements” (ERE)), are located in enhancer/promoter regions of target genes.  
The classical ERE consists of a palandromic sequence of GGTCA in an invert 
repeat separated by a three-base “spacer” (GGTCACAGTGACC), although most 
estrogen-responsive genes contain ERE sequences that diverge to varying 
degrees from this consensus sequence. The AF’s are located throughout the 
molecule, regions A/B and E [58].  These domains are responsible for linking the 
recept
 
activated is by binding of the hormone to the LBD.  The second mechanism by 
which receptors can be activated, is though a ligand-independent mechanism 
0, 61].  The ligand-independent activation of the receptor is a result of the 
tegration of other signalling pathways, usually membrane receptor signalling 
he 
ed receptor undergoes conformational change that results 
ors to the cellular transcriptional machinery and regulate transcription of 
target genes. 
 
The molecular mechanisms by which the ovarian steroid hormones 
regulate the transcription of the target genes through their receptors have been 
actively investigated over the last 30 years [55, 58, 59].  In the absence of ligand, 
the receptors are associated with chaperone proteins that are transcriptionally 
inactive.  The steroid hormone receptors can be activated by two mechanisms. 
The first, traditional ligand-dependent, mechanism by which receptors can be 
[6
in
that results in the activation of kinases and ultimately the phosphorilation of t
receptor.  The activat
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in dim
ter of the target gene to the activated receptor, and basal 
anscription machinery.  This remodelling of the chromatin serves to facilitate 
transc
erization of the receptors.  In turn, these receptors attain the ability to bind 
specific DNA ERE’s in the enhancer/promoter of the target gene. 
 
ERβ does not always bind to DNA via the DBD.  It was recently discovered 
that ERβ could mediate transcription via activator proteins.  One such activator 
protein is called activator protein-1 (AP-1).  AP-1 binds to the sequence (TGA 
GTC A) in the enhancer/promoter regions of some ERE’s only after binding to a 
ligand-bound ERβ.  In addition to binding of the ligand-bound ERβ, AP-1 also 
need the transcription factors c-fos and c-jun, which binds to DNA as a dimer at 
the AP-1 site mediating ERβ action [62-64].  
 
The activator protein AP-1 should not be confused with coactivators also 
needed for successful transcription of estrogen responsive genes.  The 
coactivators link the receptor to the transcription machinery, but also facilitate 
transcription by covalently modifying chromatin structure.  These coactivators 
have histone actetyl transferase activity that function to acetylate histone 
proteins, allowing DNA to achieve a conformation that increases the accessibility 
of the promo
tr
ription of specific genes.  These coactivators include the Steroid Receptor 
Coactivator (SRC) family, CREB binding protein and related p300 (CBP/p300), 
High Mobility Group proteins (HMG’s), and E3 ubiquitin protein ligases (E6-AP 
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and RPF-1) [65, 66].  It is also known that coactivators can bind dimers of nuclear 
receptors including heterodimers of ERα/ERβ [67, 68].   
 
Estrogen, as mentioned earlier, is associated with growth and proliferation, 
but this study suggests involvement in the exact opposite cell death by apoptosis.  
In the growing follicle estrogen is one of the factors initiating unprecedented 
mitotic activity of granulosa cells.  This is also seen in ER-positive mammary 
carcinomas [69-71].  Following ovulation under the influence of progesterone, 
among other, these cells differentiate into progesterone producing granulosa 
lutein cells. But why will these cells undergo apoptosis if they contain ERβ on the 
th day of the cycle?  To find an answer to this compelling and intriguing question 
two oth
se? 
Du
4
er questions must be asked: 
 
a) What is different in the environment between the estrogen-induced 
surge of mitosis and the initiation of apoptosis on the 4th day when the 
second estrogen rise is present? 
 
b) Why is there a second estrogen ri
 
ring the mitotic surge in the final days of the growing follicle progesterone 
levels are very low.  There should be virtually no ligand-bound PR present in 
cells.  On the 4th day of the cycle when cells undergo apoptosis, cells are 
exposed to both progesterone and estrogen with both ligand-bound ER and PR 
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present in the cells.  Secondly, very interestingly, on the 4th day apoptosis in 
atretic follicles that were not selected to ovulate, is pronounced.  Could the 
second rise in estrogen function to remove unovulated antral follicles to prevent 
them of becoming systic in the following cycle? 
 
The following theory to explain the observations in this experiment.  A 
coactivator protein exist  capable of binding homodimers of either PR or ER, and 
heterodimers of ER/PR in the nucleus.  If a homodimer of ER’s binds, mainly 
mitogenic genes and the genes of growth factors are transcribed.  If a homodimer 
f PR binds, genes necessary for the differentiation to granulosa lutein cells are 
tran
plore this hypothesis. 
4.5 onc
There could therefore  be a potential role for ERβ in premature luteal regression. 
 
                                                                                                                                                             
o
scribed.  But if a hetrodimer of ER/PR binds, it leads to transcription of 
apoptotic genes.  This theory would explain why ERβ containing corpora lutea 
from late ovulating follicles will undergo premature luteal regression following the 
second rise of estrogen.  This would also explain why prematurely regressed 
corpora lutea sometimes occur with normal functioning corpora lutea.     
 
The in vivo experimental animal is a problematic model for investigating this 
hypothesis further, because of numerous influences on live animal.  A tissue 
culture model will be necessary to ex
 
 C lusions 
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General Conclusion 
 
It is clear from the research in this thesis and from the discovery by Sugimoto 
et al in 1997 that R-PGF2α knockout mice had normal estrous cycles, that PGF2α  is 
not the only signal to induce luteal regression.  The process is indeed complex and 
there are many factors affecting it.  The precise efficiency of the reproductive system 
in animals is execptional.  
 
This thesis presents some interesting observations on premature regressed 
corpora lutea and provides a new hypothesis to explaining premature luteal 
regression in the superovulated sheep. (see discussion Chapter 4).   
 
Severe shortcomings have been encountered in the in vivo study and the proposed 
hypothesis could not be proven conclusively.  A more controlled tissue culture model 
is needed to study the complex interactions of multiple factors in this cellular 
process.  Proving this hypothesis would present us with a better understanding of 
luteal regression in more evolved species like the human and primates. The model 
also presents us with some interesting options in the study of ER and PR positive 
breast cancers. 
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